<SEC-DOCUMENT>0001193125-17-116196.txt : 20170407
<SEC-HEADER>0001193125-17-116196.hdr.sgml : 20170407
<ACCEPTANCE-DATETIME>20170407165100
ACCESSION NUMBER:		0001193125-17-116196
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20170518
FILED AS OF DATE:		20170407
DATE AS OF CHANGE:		20170407
EFFECTIVENESS DATE:		20170407

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MANNKIND CORP
		CENTRAL INDEX KEY:			0000899460
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133607736
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50865
		FILM NUMBER:		17750390

	BUSINESS ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
		BUSINESS PHONE:		6617755300

	MAIL ADDRESS:	
		STREET 1:		25134 RYE CANYON LOOP
		STREET 2:		SUITE 300
		CITY:			VALENCIA
		STATE:			CA
		ZIP:			91355
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d366702ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(RULE 14a-101) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>INFORMATION REQUIRED IN </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities
Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp; ) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp;&#9744;</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167; 240.14a-12</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>MANNKIND CORPORATION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified in its Charter)
</B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N/A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of
Filing Fee (Check the appropriate box): </FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9746;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials:</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount previously paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>25134 Rye Canyon Loop, Suite 300 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Valencia, CA 91355 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(661)&nbsp;775-5300 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held On Thursday, May&nbsp;18, 2017 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Stockholder: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cordially invited to
attend the Annual Meeting of Stockholders of MannKind Corporation, a Delaware corporation (&#147;MannKind&#148;). The meeting will be held on Thursday, May&nbsp;18, 2017 at 10:00&nbsp;a.m. U.S. Eastern time at the office of MannKind at 40 Taylor
Street, Danbury, Connecticut 06810 for the following purposes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. To elect the seven nominees named herein as directors to
serve for the ensuing year and until their successors are elected; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. To approve, on an advisory basis, the compensation
of the named executive officers of MannKind, as disclosed in MannKind&#146;s proxy statement for the Annual Meeting; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. To
indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. To ratify the selection by the Audit Committee of the Board of Directors of Deloitte&nbsp;&amp; Touche LLP as the
independent registered public accounting firm of MannKind for its fiscal year ending December&nbsp;31, 2017;&nbsp;and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
To transact such other business as may properly come before the meeting or any adjournment or postponement thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These items of
business are more fully described in the proxy statement accompanying this notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The record date for the Annual Meeting is
March&nbsp;27, 2017. Only stockholders of record on that date may vote at the meeting or any adjournment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the
Availability of Proxy Materials for the Annual Meeting of Stockholders of MannKind Corporation to be Held on May&nbsp;18, 2017 at 10:00 a.m. U.S. Eastern time at the office of MannKind Corporation located at 40 Taylor Street, Danbury, Connecticut
06810. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The proxy statement and annual report to stockholders are available at <U>www.mannkindcorp.com</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:54%; text-indent:-2%">


<IMG SRC="g366702g09k79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">David Thomson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Vice President, General Counsel and Secretary </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Valencia, California </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;7, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>You are cordially invited to attend the meeting in person. Whether or not you expect to attend the meeting, please vote by proxy pursuant to the
instructions set forth herein as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held
of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>All visitors to the MannKind Danbury site will be required to present a government-issued photo identification. Thank you, in advance, for your
cooperation. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MANNKIND CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>25134 Rye Canyon Loop, Suite 300 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Valencia, California 91355 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
2017 ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">To be held on May&nbsp;18, 2017 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why did I receive a notice regarding the availability of proxy materials on the internet? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to rules adopted by the Securities and Exchange Commission (the &#147;SEC&#148;), we have elected to provide access to our proxy
materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#147;Notice&#148;) because the Board of Directors (sometimes referred to as the &#147;Board&#148;) of MannKind Corporation
(sometimes referred to as, &#147;we,&#148; &#147;us,&#148; the &#147;Company&#148; or &#147;MannKind&#148;) is soliciting your proxy to vote at the 2017 Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;), including any adjournments or
postponements of the Annual Meeting. You are invited to attend the annual meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. All stockholders will have the ability
to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the
Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notice is expected to be first mailed to our stockholders of record entitled to vote at the Annual Meeting on or about
April&nbsp;7, 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Will I receive any other proxy materials by mail? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may send you a proxy card, along with a second Notice, on or after April&nbsp;17, 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only
stockholders of record at the close of business on March&nbsp;27, 2017 will be entitled to vote at the Annual Meeting. On this record date, there were 95,776,246 shares of common stock outstanding and entitled to vote. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares&nbsp;Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on March&nbsp;27, 2017 your shares were registered directly in your name with MannKind&#146;s transfer agent, Computershare, then you are a
stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy pursuant to the instructions set forth below to ensure your
vote is counted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares&nbsp;Registered in the Name of a Broker or Bank </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on March&nbsp;27, 2017 your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or other similar
organization, then you are the beneficial owner of shares held in &#147;street name&#148; and Notice is being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of
voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, because you are not the stockholder
of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker or other agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What am I voting on? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Management is presenting four proposals for stockholder vote. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;1. Election of Seven Directors </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first proposal to be voted on is the election of the seven nominees named herein as directors for a one-year term. The Board has nominated
these seven people as directors. You may find information about these nominees, as well as information about MannKind&#146;s Board of Directors and its committees, director compensation and other related matters beginning on page&nbsp;7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; all the nominees, &#147;Withhold&#148; your votes as to all nominees or &#147;Withhold&#148; your votes as to
specific nominees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a vote FOR all the director nominees named herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;2. Advisory Vote on Executive Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second proposal to be voted on is an advisory vote by the stockholders of MannKind regarding the compensation of the Company&#146;s named
executive officers as described in this proxy statement, including the disclosures under &#147;Compensation Discussion and Analysis,&#148; the compensation tables and the narrative discussion following the compensation tables. The Company is seeking
the stockholders&#146; approval, on an advisory basis, of the compensation of the named executive officers. You may find information about this proposal beginning on page&nbsp;16. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; or &#147;Against&#148; the proposal or &#147;Abstain&#148; from voting on the proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a vote FOR Proposal 2. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;3. Advisory Indication on the Preferred Frequency of Stockholder Advisory Vote on Executive Compensation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The third proposal is an advisory vote on the frequency of solicitation of stockholder approval of executive compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders are provided with the opportunity to choose among four options (holding the vote every one, two or three years, or abstaining)
and, therefore, stockholders will not be voting to approve or disapprove the recommendation of the Board of Directors. The option among those choices that obtains a majority of votes cast by the shares present or represented by proxy and entitled to
vote at the Annual Meeting will be deemed to be the frequency adopted for advisory purposes by our stockholders in accordance with our Amended and Restated Bylaws; however, in the event that no frequency receives a majority, we will consider
whichever frequency receives a plurality of the votes to be the frequency preferred by our stockholders. You may find information about this proposal on page&nbsp;18. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board and the Compensation Committee value the opinions of our stockholders in this matter, and the Board of Directors intends to hold
say-on-pay votes in the future in accordance with the alternative that receives the most stockholder support. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors
unanimously recommends one year as the preferred frequency of stockholder advisory vote on executive compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Proposal&nbsp;4. Ratification of
Selection by the Audit Committee of the Board of Directors of Deloitte&nbsp;&amp; Touche LLP as the Company&#146;s Independent Registered Public Accounting Firm for the Fiscal Year Ending December&nbsp;31,&nbsp;2017 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fourth proposal to be voted on is to ratify the selection by the Audit Committee of the Board of Deloitte&nbsp;&amp; Touche LLP as the
Company&#146;s independent registered public accounting firm for the fiscal year </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ending December&nbsp;31, 2017. It is expected that representatives of Deloitte&nbsp;&amp; Touche LLP will attend the Annual Meeting and be available to make a statement or respond to appropriate
questions. You may find information about this proposal beginning on page&nbsp;19. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may vote &#147;For&#148; or &#147;Against&#148;
the proposal or &#147;Abstain&#148; from voting on the proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors unanimously recommends a vote FOR Proposal 4.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if another matter is properly brought before the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are
properly brought before the Annual Meeting, it is the intention of the persons named in the proxy to vote on those matters in accordance with their best judgment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The procedures for voting
are fairly simple: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder of Record: Shares&nbsp;Registered in Your Name </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, you may vote in person at the Annual Meeting, vote by proxy over the telephone, vote by proxy through the
internet or vote by proxy using a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still
attend the Annual Meeting and vote in person if you have already voted by proxy. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. For directions to the meeting, please visit the following web address:
http://www.google.com/maps/place/40+Taylor+St,+Danbury,+CT+06810. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote using the proxy card, simply complete, sign and date the proxy card that may be delivered and return it promptly in the envelope provided. Your signed proxy card must be received by 5:00&nbsp;PM
U.S.&nbsp;Eastern time on May&nbsp;17, 2017 to be counted. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote over the telephone, dial toll-free (866)&nbsp;437-3716 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the control number from the Notice. Your vote must be received
by 5:00&nbsp;PM U.S.&nbsp;Eastern time on May&nbsp;17, 2017 to be counted. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">To vote through the internet, go to http://www.proxypush.com/mnkd to complete an electronic proxy card. You will be asked to provide the control number from the Notice. Your vote must be received by 5:00&nbsp;PM
U.S.&nbsp;Eastern time on May&nbsp;17, 2017 to be counted. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide internet proxy voting to allow you to vote your
shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet
access providers and telephone companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Beneficial Owner: Shares&nbsp;Registered in the Name of Broker or Bank </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a Notice
containing voting instructions from that organization rather than from MannKind. Simply follow the voting instructions in the Notice to ensure that your vote is counted. To vote in person at the Annual Meeting, you must obtain a valid proxy from
your broker, bank, or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On each matter to be voted upon, you have one vote for each share of common stock you owned as of March&nbsp;27, 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I return a proxy card or otherwise vote by proxy but do not make specific choices? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you voted by proxy without marking any voting selections, your shares will be voted &#147;For&#148; the election of each of the seven
nominees for director listed in Proposal&nbsp;1, &#147;For&#148; the advisory approval of the executive compensation of the Company&#146;s named executive officers as provided in Proposal&nbsp;2, &#147;For&#148; one year as the preferred frequency
of stockholder advisory vote on executive compensation as provided in Proposal&nbsp;3 and &#147;For&#148; the ratification of the selection of Deloitte&nbsp;&amp; Touche LLP as our independent registered public accounting firm for the fiscal year
ending December&nbsp;31, 2017 as provided in Proposal&nbsp;4. If any other matter is properly presented at the Annual Meeting, your proxy (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is paying for this proxy solicitation? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit
proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We will also reimburse brokerage firms, banks and other agents for the cost of
forwarding proxy materials to beneficial owners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one Notice? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you receive more than one Notice, your shares are registered in more than one name or are registered in different accounts. Please follow
the voting instructions with respect to <B>each </B>Notice to ensure that all of your shares are voted. Similarly, if you are a stockholder of record and you receive more than one Notice, your shares are registered in more than one name. Please
follow the voting instructions with respect to <B>each </B>Notice to ensure that all of your shares are voted. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I change my vote after submitting
my proxy? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are a stockholder of record,
you may revoke your proxy in any one of the following ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may send a written notice that you are revoking your proxy to MannKind&#146;s Corporate Secretary at 25134 Rye Canyon Loop, Suite 300, Valencia, CA 91355. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may grant another proxy by telephone or through the internet. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may submit another properly completed proxy card with a later date. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may attend the Annual Meeting and vote in person. Simply attending the Annual Meeting will not, by itself, revoke your proxy. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your most current proxy, whether submitted by proxy card, telephone or internet, is the one that is counted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How are votes counted? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Votes will be
counted by the inspector of election appointed for the meeting, who will separately count, with respect to the proposal to elect directors, votes &#147;For,&#148; &#147;Withhold&#148; and broker non-votes; with respect to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proposal regarding frequency of stockholder advisory votes to approve executive compensation, votes for frequencies of one year, two years or three years, abstentions and broker non-votes; and
with respect to other proposals, &#147;For&#148; and &#147;Against&#148; votes, abstentions and, if applicable, broker non-votes. Abstentions will be counted towards the vote total for each of Proposals 2 and 4, and will have the same effect as
&#147;Against&#148; votes. For Proposal 3, abstentions will be counted towards the vote total, and will have the same effect as votes against each of the proposed voting frequencies. Broker non-votes will have no effect and will not be counted
towards the vote total for any proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker non-votes&#148;? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker non-votes occur when a beneficial owner of shares held in street name does not give instructions to the broker or nominee holding the
shares as to how to vote on matters deemed &#147;non-routine.&#148; Generally, if shares are held in street name (shares are held by your broker as your nominee), the beneficial owner of the shares is entitled to give voting instructions to the
broker or nominee holding the shares. If you do not give instructions to your broker, your broker can vote your shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to &#147;non-routine&#148; matters.
Under the rules and interpretations of the New York Stock Exchange, &#147;non-routine&#148; matters are generally those involving a matter that may substantially affect the rights or privileges of stockholders, such as mergers or stockholder
proposals, election of directors (even if not contested) and executive compensation, including the stockholder advisory votes on executive compensation. Proposals 1, 2 and 3 regarding the election of directors, the advisory vote regarding executive
compensation and advisory indication on the preferred frequency of stockholder advisory vote on executive compensation are non-routine matters. Proposal 4 to ratify Deloitte&nbsp;&amp; Touche LLP as our independent registered public accounting firm
is a routine matter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes are needed to approve each proposal? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the election of directors, the seven nominees receiving the most &#147;For&#148; votes (among votes properly cast in person or by proxy)
will be elected. Only votes &#147;For&#148; or &#147;Withhold&#148; will affect the outcome. Only the seven nominees named herein have been properly nominated for election as directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposals 2 and 4 regarding, respectively, approval on an advisory basis of the compensation of the Company&#146;s named executive officers
and ratification of the Audit Committee&#146;s selection of the independent registered public accounting firm, must receive a &#147;For&#148; vote from the majority of shares present and entitled to vote either in person or by proxy in order to be
approved. If you &#147;Abstain&#148; from voting, it will have the same effect as an &#147;Against&#148; vote. Broker non-votes will have no effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For Proposal&nbsp;3, stockholders are provided with the opportunity to choose among four options (holding the vote every one, two or three
years, or abstaining) and, therefore, stockholders will not be voting to approve or disapprove the recommendation of the Board of Directors. The option among those choices that obtains a majority of votes cast by the shares present or represented by
proxy and entitled to vote at the Annual Meeting will be deemed to be the frequency adopted for advisory purposes by our stockholders in accordance with our Amended and Restated Bylaws; however, in the event that no frequency receives a majority, we
will consider whichever frequency receives a plurality of the votes to be the frequency preferred by our stockholders. The Board and the Compensation Committee value the opinions of our stockholders in this matter, and the Board of Directors intends
to hold say-on-pay votes in the future in accordance with the alternative that receives the most stockholder support. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement?
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid Annual Meeting. A quorum will be present if at least a majority of the
outstanding shares entitled to vote are represented by stockholders present at the Annual Meeting or by proxy. On the record date, there were 95,776,246 shares outstanding and entitled to vote. Thus, 47,888,124 shares must be represented by
stockholders present at the Annual Meeting or by proxy to have a quorum. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is
submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the chairman of the Annual
Meeting or a majority of the votes present at the Annual Meeting may adjourn the meeting to another date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find out the results of the voting
at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preliminary voting results will be announced at the Annual Meeting. Final voting results will be published in a
current report on Form&nbsp;8-K that we expect to file no later than four business days following the date of the Annual Meeting. If final voting results are not available to us in time to file a Form&nbsp;8-K on or before such date, we intend to
file a Form&nbsp;8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form&nbsp;8-K to publish the final results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When are stockholder proposals due for next year&#146;s annual meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered for inclusion in MannKind&#146;s proxy material for next year&#146;s annual meeting, your proposal must be submitted in
writing by December&nbsp;8, 2017 to Attn: Corporate Secretary, MannKind Corporation, 25134 Rye Canyon Loop, Suite 300, Valencia, CA 91355. If you wish to submit a proposal that is not to be included in MannKind&#146;s proxy materials or nominate a
director, you must do so not later than February&nbsp;17, 2018 and not earlier than January&nbsp;18, 2018. You are also advised to review the Company&#146;s Amended and Restated Bylaws, which contain additional requirements about advance notice of
stockholder proposals and director nominations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL&nbsp;1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MannKind&#146;s Board of Directors consists of seven directors. There are seven nominees for director this year, all of whom were nominated by
our Board of Directors. Each director to be elected will hold office until the next annual meeting of stockholders and until his successor is elected, or until the director&#146;s earlier death, resignation or removal. All nominees listed below are
currently our directors and were previously elected by our stockholders at the 2016 Annual Meeting of Stockholders. It is our policy that directors are invited and expected to attend annual meetings. All directors attended the 2016 Annual Meeting of
Stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Directors are elected by a plurality of the votes properly cast in person or by proxy. The seven nominees receiving the
highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the seven nominees named below. If any nominee becomes unavailable for election as
a result of an unexpected occurrence, your shares may be voted for the election of a substitute nominee proposed by our Nominating and Corporate Governance Committee. Each person nominated for election has agreed to serve if elected. Our management
has no reason to believe that any nominee will be unable to serve. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>N<SMALL>OMINEES</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief biography of each nominee for director and a discussion of the specific experience, qualifications, attributes or
skills of each nominee that led our Board of Directors to conclude that each nominee should serve as a member of the Board. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="55%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position Held With the Company</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chairman of the Board of Directors</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer, Chief Financial Officer and Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald&nbsp;J. Consiglio(2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;A. Friedman,&nbsp;M.D.(1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James S. Shannon, M.D., MRCP (UK)(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Compensation Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Nominating and Corporate Governance Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Member of the Audit Committee. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Kent Kresa</I> has been a member of our Board of Directors
since June 2004 and has served as Chairman of the Board since February 2017. From November 2011 until his appointment as our Chairman, Mr.&nbsp;Kresa served on our Board of Directors as our lead independent director. Mr.&nbsp;Kresa is Chairman
Emeritus of Northrop Grumman Corporation, a defense company and from September 1990 until October 2003, he was also its Chairman. He also served as Chief Executive Officer of Northrop Grumman Corporation from January 1990 until March 2003 and as its
President from 1987 until September 2001. From 2003 to August 2010, Mr.&nbsp;Kresa served as a director of General Motors Company (or its predecessor). From December 2005 to April 2010, Mr.&nbsp;Kresa served as a director of Avery Dennison
Corporation. Mr.&nbsp;Kresa has been a member of the Caltech Board of Trustees since 1994. Mr.&nbsp;Kresa has served on the board of Fluor Corporation since 2003, and he also serves on the boards of several non-profit organizations and universities.
As a graduate of Massachusetts Institute of Technology, he received a B.S. in 1959, an M.S. in 1961, and an E.A.A. in 1966, all in aeronautics and astronautics. The Board believes that Mr.&nbsp;Kresa&#146;s business experience, including his
experience as a director and executive officer of Northrop Grumman, and his service on other public company boards, combined with his business acumen and judgment provide our Board with valuable operational expertise and leadership and qualifies him
to serve on our Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Matthew J. Pfeffer </I>has served as our Chief Executive Officer and as one of our directors
since January 2016, and as our Chief Financial Officer since April 2008. Mr.&nbsp;Pfeffer also served as a Corporate Vice President from April 2008 until January 2016. Previously, Mr.&nbsp;Pfeffer served as Chief Financial Officer and Senior Vice
President of Finance and Administration of VaxGen, Inc. from March 2006 until April 2008, with responsibility for finance, tax, treasury, human resources, IT, purchasing and facilities functions. Prior to VaxGen, Mr.&nbsp;Pfeffer served as Chief
Financial Officer of Cell Genesys, Inc. During his nine year tenure at Cell Genesys, Mr.&nbsp;Pfeffer served as Director of Finance before being named Chief Financial Officer in 1998. Prior to that, Mr.&nbsp;Pfeffer served in a variety of financial
management positions at other companies, including roles as Corporate Controller, Manager of Internal Audit and Manager of Financial Reporting. Mr.&nbsp;Pfeffer began his career at Price Waterhouse. Currently, Mr.&nbsp;Pfeffer serves on the board of
directors of Second Sight Medical Products in Sylmar, California. Mr.&nbsp;Pfeffer graduated from the University of California, Berkeley and is a Certified Public Accountant. The Board believes that Mr.&nbsp;Pfeffer&#146;s knowledge and
understanding of accounting and finance and his extensive experience with our company, combined with his business acumen and judgment, provide our Board with valuable accounting, financial and operational expertise and leadership and qualifies him
to serve on our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Ronald J. Consiglio</I> has been one of our directors since October 2003. Since 1999,
Mr.&nbsp;Consiglio has been the managing director of Synergy Trading, a securities-trading partnership. From 1999 to 2001, Mr.&nbsp;Consiglio was Executive Vice President and Chief Financial Officer of Trading Edge, Inc., a national automated
bond-trading firm. From January 1993 to 1998 Mr.&nbsp;Consiglio served as Chief Executive Officer of Angeles Mortgage Investment Trust, a publicly traded Real Estate Investment Trust. His prior experience includes serving as Senior Vice President
and Chief Financial Officer of Cantor Fitzgerald&nbsp;&amp; Co. and as a member of its board of directors. Mr.&nbsp;Consiglio has served as a member of the board of trustees for the Metropolitan West Funds since 2003. Mr.&nbsp;Consiglio is a
certified public accountant and holds a bachelor&#146;s degree in accounting from California State University at Northridge. The Board believes that Mr.&nbsp;Consiglio&#146;s knowledge and understanding of accounting and finance, his experience as a
board member and executive officer at financial services firms, combined with his business acumen and judgment provide our Board with valuable accounting, financial and operational expertise and leadership and qualifies him to serve on our Board of
Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Michael A. Friedman,&nbsp;M.D. </I>has been one of our directors since December 2003. In 2014, Dr.&nbsp;Friedman completed
a decade of service as the President and Chief Executive Officer of the City of Hope National Medical Center. Previously, from September&nbsp;2001 until April 2003, Dr.&nbsp;Friedman held the position of Senior Vice President of Research and
Development, Medical and Public Policy, for Pharmacia Corporation and, from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, Dr.&nbsp;Friedman served as Deputy
Commissioner for Operations for the Food and Drug Administration, and was Acting Commissioner and Lead Deputy Commissioner from 1997 to 1998. He joined the board of Celgene Corporation in February 2011 and the board of Smith&nbsp;&amp; Nephew plc in
April 2013. Dr.&nbsp;Friedman received a bachelor of arts degree, magna cum laude, from Tulane University, New Orleans, Louisiana, and a doctorate in medicine from the University of Texas, Southwestern Medical School. The Board believes
Dr.&nbsp;Friedman&#146;s business experience, including his experience as an executive officer at biopharmaceutical companies and a leading clinical and research center specializing in cancer and diabetes, and his service at the Food and Drug
Administration, combined with his business acumen and judgment provide our Board with valuable scientific and operational expertise and leadership and qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>David H. MacCallum</I> has been one of our directors since June 2004. Since 2002, Mr.&nbsp;MacCallum has served as the Managing Partner of
Outer Islands Capital, a hedge fund specializing in health care investments. From June 1999 until November 2001, he was Global Head of Health Care investment banking for Salomon Smith Barney, part of Citigroup, a financial institution. Prior to
joining Salomon Smith Barney, he was Executive Vice President and Head of the Health Care group at ING Barings Furman Selz LLC, an investment banking firm and subsidiary of ING Group, a Dutch financial institution, from April 1998 to June 1999.
Prior to that, Mr.&nbsp;MacCallum formed the Life Sciences group at UBS Securities, an investment banking firm, where he was </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Managing Director and Global Head of Life Sciences from May 1994 to April 1998. Before joining UBS Securities, he built the health care practice at Hambrecht&nbsp;&amp; Quist, an investment
banking firm, where he was Head of Health Care and Co-Head of Investment Banking. From 2005 to October 2010, Mr.&nbsp;MacCallum served as a director of Zymogenetics, Inc. From 2002 to 2008, he served as a director of Vital Signs, Inc.
Mr.&nbsp;MacCallum received an A.B. degree from Brown University and an M.B.A. degree from New York University. He is a Chartered Financial Analyst. The Board believes that Mr.&nbsp;MacCallum&#146;s knowledge and understanding of accounting and
finance, his business experience in the investment banking industry, combined with his business acumen and judgment provide our Board with valuable accounting, financial and operational expertise and leadership and qualifies him to serve on our
Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Henry L. Nordhoff</I> has been one of our directors since March 2005. He has served as a director of BioTime, Inc.
since June 2013 and as a director of Asterias Biotherapeutics, Inc. since October 2013. Mr.&nbsp;Nordhoff retired as Chairman of the Board of Gen-Probe Incorporated, a clinical diagnostic and blood screening company, at the end of 2011, after
serving as its Chairman since September 2002. He also served as Chief Executive Officer and President of Gen-Probe from July 1994 until May 2009. Prior to joining Gen-Probe, he was President and Chief Executive Officer of TargeTech, Inc., a gene
therapy company that was merged into Immune Response Corporation. Prior to that, Mr.&nbsp;Nordhoff was at Pfizer, Inc. in senior positions in Brussels, Seoul, Tokyo and New York. He received a B.A. in international relations and political economy
from Johns Hopkins University and an M.B.A. from Columbia University. The Board believes that Mr.&nbsp;Nordhoff&#146;s business experience, including his experience as a director and executive officer at pharmaceutical and biotech companies,
combined with his business acumen and judgment provide our Board with valuable operational expertise and leadership and qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>James S. Shannon</I>, <I>M.D., MRCP (UK)</I> rejoined our board in May 2015 after previously serving as a director from February 2010 until
April 2012. From May 2012 until his retirement in April 2015, Dr.&nbsp;Shannon was the Chief Medical Officer of GlaxoSmithKline. He formerly held the position of Global Head of Pharma Development at Novartis AG, based in Basel, Switzerland from 2005
until 2008. After joining Sandoz in 1994 as Head of Drug Regulatory Affairs, Dr.&nbsp;Shannon led the Integration Office for R&amp;D overseeing the creation of the Novartis R&amp;D groups from those of Ciba-Geigy Ltd and Sandoz. Following the merger
he was appointed Head of the Cardiovascular Strategic Team and subsequently became Global Head of Project Management before being appointed Global Head of Clinical Development and Medical Affairs in 1999, a position that he held until 2005 when he
was appointed to Head Pharma Development. Between 2008 and joining GSK, Dr.&nbsp;Shannon served on the boards of a number of companies, including Biotie, Circassia, Crucell, Endocyte and MannKind. He also sat on the board of Cerimon Pharmaceuticals
where he held the position of interim Chief Executive Officer and President from January 2009 until April 2010. He first entered the pharmaceutical industry in 1987 joining Sterling Winthrop Inc., working initially in Europe and subsequently in the
USA, where he held positions of increasing responsibility in the management of research and development ultimately serving as Senior Vice-President, Clinical Development. Dr.&nbsp;Shannon is trained in Medicine and Cardiology. He received his
undergraduate and postgraduate degrees at Queen&#146;s University of Belfast and is a Member of the Royal College of Physicians (UK).&nbsp;The Board believes that Dr.&nbsp;Shannon&#146;s business experience and his extensive experience in drug
development, combined with his business acumen and judgment provide our Board with valuable scientific and operational expertise and leadership and qualifies him to serve on our Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A <SMALL>VOTE</SMALL> <SMALL>FOR</SMALL> <SMALL>THE</SMALL> E<SMALL>LECTION</SMALL> <SMALL>OF</SMALL> <SMALL>ALL</SMALL>
D<SMALL>IRECTOR</SMALL> N<SMALL>OMINEES</SMALL> <SMALL>NAMED</SMALL> <SMALL>ABOVE</SMALL> </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE GOVERNANCE PRINCIPLES AND BOARD
AND COMMITTEE MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>NDEPENDENCE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL>
D<SMALL>IRECTORS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under the Nasdaq Stock Market (&#147;Nasdaq&#148;) listing standards, a majority of the members
of a listed company&#146;s board of directors must qualify as &#147;independent,&#148; as affirmatively determined by the board of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
directors. Our Board of Directors consults with the Company&#146;s counsel to ensure that the Board&#146;s determinations are consistent with all relevant securities and other laws and
regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent listing standards of Nasdaq, as in effect time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with these considerations, after review of all relevant transactions or relationships between each director or any of his family
members and the Company, its senior management and its independent auditors, the Board of Directors affirmatively has determined that all of the Company&#146;s directors other than Mr.&nbsp;Pfeffer is independent within the meaning of the applicable
Nasdaq listing standards. In making this determination, the Board found that none of the directors has a material or other disqualifying relationship with the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>NFORMATION</SMALL> R<SMALL>EGARDING</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> <SMALL>AND</SMALL>
<SMALL>ITS</SMALL> C<SMALL>OMMITTEES</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are committed to maintaining the highest standards of business conduct and ethics. Our
Board of Directors has adopted a Code of Business Conduct and Ethics and adheres to corporate governance guidelines to assure that the Board will have the necessary authority and practices in place to review and evaluate our business operations as
needed and to make decisions that are independent of our management. The guidelines are also intended to align the interests of directors and management with those of our stockholders. The charters for various Board committees set forth the
practices the Board will follow with respect to board composition and selection, board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning, and board committees and compensation. Our
Board of Directors adopted these measures to, among other things, reflect changes to the Nasdaq listing standards and SEC rules adopted to implement provisions of the Sarbanes-Oxley Act of 2002, as amended. Our Code of Business Conduct and Ethics,
as well as the charters for each committee of the Board, may be viewed on our website at <I>www.mannkindcorp.com. </I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>B<SMALL>OARD</SMALL>
L<SMALL>EADERSHIP</SMALL> S<SMALL>TRUCTURE</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors is currently chaired by Mr.&nbsp;Kresa. As a general policy,
our Board of Directors believes that separation of the positions of Chairman and Chief Executive Officer reinforces the independence of the Board of Directors from management, creates an environment that encourages objective oversight of
management&#146;s performance and enhances the effectiveness of the Board of Directors as a whole. As such, Mr.&nbsp;Pfeffer serves as our Chief Executive Officer while Mr.&nbsp;Kresa serves as our Chairman of the Board of Directors but is not an
officer. We expect and intend the positions of Chairman of the Board of Directors and Chief Executive Officer to continue to be held by separate individuals in the future. If in the future we conclude there is a compelling reason for the positions
of Chairman of the Board and Chief Executive Officer to be occupied by the same individual, we would except to appoint one of our other directors to the position of lead independent director to help reinforce the independence of the Board from
management. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>R<SMALL>OLE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>IN</SMALL> R<SMALL>ISK</SMALL>
O<SMALL>VERSIGHT</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the key functions of our Board of Directors is informed oversight of the Company&#146;s risk
management process. The Board of Directors does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various standing committees that address risks
inherent in their respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for the Company. Our Audit Committee
has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and
management is undertaken. Our Compensation Committee reviews and approves individual and corporate performance goals, advises the Board regarding the adoption, modification, or termination of compensation plans and policies and assesses and monitors
whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMMITTEES</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL>
D<SMALL>IRECTORS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has three standing committees: an Audit Committee, a Compensation Committee, and a
Nominating and Corporate Governance Committee. All three committees operate under written charters adopted by our Board, all of which are available on our website at <I>www.mannkindcorp.com. </I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its
responsibilities. The Board of Directors has determined that each member of each committee meets the applicable rules and regulations regarding &#147;independence&#148; and that each member is free of any relationship that would interfere with his
or her individual exercise of independent judgment with regard to the Company. Below is a description of each committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Audit
Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee consists of Mr.&nbsp;Consiglio (chair), Mr.&nbsp;MacCallum and Mr.&nbsp;Nordhoff, each of whom is an
independent member of our Board of Directors (as determined by our Board based on its annual review of the independence requirement of Audit Committee members provided in Rule&nbsp;5605(c)(2)(A)(i) and (ii)&nbsp;of the Nasdaq listing standards). Our
Audit Committee was established by the Board in accordance with Section&nbsp;3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), to oversee the Company&#146;s corporate accounting and financial reporting
processes and audits of its financial statements. The functions of this committee include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">evaluating the independent registered public accounting firm&#146;s qualifications, independence and performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">determining the engagement of the independent registered public accounting firm; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">approving the retention of the independent registered public accounting firm to perform any proposed permissible non-audit services; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">monitoring the rotation of partners of the independent registered public accounting firm on our engagement team as required by law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our financial statements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our critical accounting policies and estimates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discussing with management and the independent registered public accounting firm the results of the annual audit and the review of our quarterly financial statements;&nbsp;and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and evaluating, at least annually, the performance of the Audit Committee and its members, including compliance of the Audit Committee with its charter. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors has determined that Mr.&nbsp;Consiglio qualifies as an &#147;audit committee financial expert,&#148; as that term is
defined in applicable SEC rules. In making such determinations, the Board of Directors made a qualitative assessment of Mr.&nbsp;Consiglio&#146;s level of knowledge and experience based on a number of factors, including his formal education and
experience. Both our independent registered public accounting firm and internal financial personnel regularly meet privately with our Audit Committee and have unrestricted access to this committee. Our Audit Committee charter can be found on our
corporate website at <I>www.mannkindcorp.com. </I>The Audit Committee met eleven times during 2016. The report of the Audit Committee is included herein on page&nbsp;47. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee consists of Mr.&nbsp;Kresa (chair), Dr.&nbsp;Friedman and Dr.&nbsp;Shannon, each of whom is an independent member of
our Board of Directors (as independence is currently defined in Rule&nbsp;5605(a)(2) of the Nasdaq listing standards). The functions of this committee include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending policy relating to compensation and benefits of our officers and employees, including
reviewing and approving corporate goals and objectives relevant to compensation </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
of our Chief Executive Officer and other senior officers, evaluating the performance of these officers in light of those goals and objectives, and recommending compensation of these officers
based on such evaluations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">administering our benefit plans and the issuance of stock options and other awards under our stock plans; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recommending the type and amount of compensation to be paid or awarded to members of our Board of Directors, including consulting, retainer, meeting, committee and committee chair fees and stock option grants or awards;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving the terms of any employment agreements, severance arrangements, change-of-control protections and any other compensatory arrangements for our executive officers;&nbsp;and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and evaluating, at least annually, the performance of the Compensation Committee and its members, including compliance of the Compensation Committee with its charter. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Typically, the Compensation Committee meets at least quarterly and with greater frequency if necessary. The Compensation Committee met four
times during 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The processes and procedures of the Compensation Committee with respect to executive compensation are described in
greater detail in the &#147;Compensation Discussion and Analysis&#148; section of this proxy statement. Our Compensation Committee charter can be found on our corporate website at <I>www.mannkindcorp.com. </I>The report of the Compensation Committee
is included herein on page&nbsp;46. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee consists of Dr.&nbsp;Friedman (chair), Mr.&nbsp;Consiglio and Mr.&nbsp;Kresa, each of whom is
an independent member of our Board of Directors (as independence is currently defined in Rule&nbsp;5605(a)(2) of the Nasdaq listing standards). The functions of this committee include, among others: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">planning for succession with respect to the position of Chief Executive Officer and other senior officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and recommending nominees for election as directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">assessing the performance of the Board of Directors and monitoring committee evaluations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">suggesting, as appropriate, ad-hoc committees of the Board of Directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">developing guidelines for board composition;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and evaluating, at least annually, the performance of the Nominating and Corporate Governance Committee and its members, including compliance of the Nominating and Corporate Governance Committee with its
charter. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee charter can be found on our corporate website at
<I>www.mannkindcorp.com. </I>The Nominating and Corporate Governance Committee did not meet during 2016. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>ONSIDERATION</SMALL>
<SMALL>OF</SMALL> D<SMALL>IRECTOR</SMALL> N<SMALL>OMINEES</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Director Qualifications </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including
being able to read and understand basic financial statements, being over 21&nbsp;years of age and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also intends to consider such factors as possessing
relevant expertise upon which to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the ability to exercise sound
business judgment and having the commitment to rigorously represent the long-term interests of the Company&#146;s stockholders. However, the Nominating and Corporate Governance Committee retains the discretion to modify these qualifications from
time to time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Evaluating Nominees for Director </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee review candidates for director nominees in the context of the current composition of the
Board of Directors, the operating requirements of the Company and the long-term interests of the Company&#146;s stockholders. In conducting this assessment, the Nominating and Corporate Governance Committee considers age, skills, and such other
factors as it deems appropriate given the current needs of the Board of Directors and the Company, to maintain a balance of knowledge, experience and capability. In the case of incumbent directors, the Nominating and Corporate Governance Committee
reviews such directors&#146; overall service to the Company during their term, including the number of meetings attended, level of participation, quality of performance, and any other relationships and transactions that might impair such
directors&#146; independence. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee would be independent for Nasdaq purposes, which determination is based upon applicable Nasdaq
listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The Nominating and Corporate Governance Committee also focuses on issues of diversity, such as diversity of gender, race and national origin, education,
professional experience and differences in viewpoints and skills. The Nominating and Corporate Governance Committee does not have a formal policy with respect to diversity; however, the Board of Directors and the Nominating and Corporate Governance
Committee believe that it is important that directors represent diverse viewpoints. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee
uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional search firm. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into
the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee meets to discuss and consider such candidates&#146; qualifications and then selects a
nominee for recommendation to the Board by majority vote. To date, the Nominating and Corporate Governance Committee has not paid a fee to any third party to assist in the process of identifying or evaluating director candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Nominations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. The Nominating and Corporate
Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether a candidate was recommended by a stockholder or not. Stockholders who wish to recommend
individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board of Directors must do so by delivering at least 120&nbsp;days prior to the anniversary date of the mailing of
MannKind&#146;s proxy statement for its last annual meeting of stockholders a written recommendation to the Nominating and Corporate Governance Committee, c/o&nbsp;MannKind Corporation, 25134 Rye Canyon Loop, Suite 300, Valencia,
California&nbsp;91355, Attn: Corporate Secretary. Each submission must set forth: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the name and address of the MannKind stockholder on whose behalf the submission is made; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number of MannKind shares that are owned beneficially by such stockholder as of the date of the submission; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the full name of the proposed candidate; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of the proposed candidate&#146;s business experience for at least the previous five years; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">complete biographical information for the proposed candidate;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of the proposed candidate&#146;s qualifications as a director. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each submission
must be accompanied by the written consent of the proposed candidate to be named as a nominee and to serve as a director if elected. To date, the Nominating and Corporate Governance Committee has not received a timely nomination of a candidate for
election as a director at any annual meeting from a stockholder or group of stockholders holding more than 5% of our voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>M<SMALL>EETINGS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors met eleven times during the last fiscal year. Each director attended 75% or more of the aggregate number of the meetings
of the Board and of the committees on which he served, held during the period for which he was a director or committee member. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>E<SMALL>XECUTIVE</SMALL> S<SMALL>ESSIONS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under applicable Nasdaq listing standards, our independent directors meet in regularly scheduled executive sessions at which only
independent directors are present. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>TOCKHOLDER</SMALL> C<SMALL>OMMUNICATIONS</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL>
B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Board of Directors has adopted a formal process by
which stockholders may communicate with the Board or any of its directors. Stockholders who wish to communicate with the Board or an individual director may send a written communication to the Board or such director c/o&nbsp;MannKind Corporation,
25134 Rye Canyon Loop, Suite 300, Valencia, California 91355, Attn: Corporate Secretary. Communications also may be sent by e-mail to the following address: board@mannkindcorp.com. Each communication must set forth the name and address of the
MannKind stockholder on whose behalf the communication is sent. Each communication will be screened by MannKind&#146;s Corporate Secretary to determine whether it is appropriate for presentation to the Board of Directors or such director. Examples
of inappropriate communications include junk mail, mass mailings, product complaints, product inquiries, new product suggestions, resumes, job inquiries, surveys, business solicitations and advertisements, as well as unduly hostile, threatening,
illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate material. Communications determined by the Corporate Secretary to be appropriate for presentation to the Board of Directors or such director will be submitted to the Board
of Directors or such director on a periodic basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The screening procedures have been approved by a majority of the independent directors
of the Board. All communications directed to the Audit Committee in accordance with the Company&#146;s Code of Business Conduct and Ethics that relate to questionable accounting or auditing matters involving the Company will be promptly and directly
forwarded to the Audit Committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>ODE</SMALL> <SMALL>OF</SMALL> B<SMALL>USINESS</SMALL> C<SMALL>ONDUCT</SMALL> <SMALL>AND</SMALL>
E<SMALL>THICS</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Code of Business Conduct and Ethics Policy that applies to our directors and employees
(including our principal executive officer, principal financial officer, principal accounting officer and controller), and have posted the text of the policy on our website (<I>www.mannkindcorp.com</I>) in connection with &#147;Investors&#148;
materials. In addition, we intend to promptly disclose on our website (i)&nbsp;the nature of any amendment to the policy that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or
persons performing similar functions and (ii)&nbsp;the nature of any waiver, including an implicit waiver, from a provision of the policy that is granted to one of these specified individuals, the name of such person who is granted the waiver and
the date of the waiver. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMMITTEE</SMALL> I<SMALL>NTERLOCKS</SMALL> <SMALL>AND</SMALL>
I<SMALL>NSIDER</SMALL> P<SMALL>ARTICIPATION</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2016, Mr.&nbsp;Kresa and Drs.
Friedman and&nbsp;Shannon served on our Compensation Committee. None of Mr.&nbsp;Kresa or Drs.&nbsp;Friedman or Shannon has ever been one of our officers or employees. During 2016, none of our executive officers served as a member of the Board of
Directors or Compensation Committee of any other entity that had one or more executive officers who served on our Board of Directors or Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &#147;Dodd-Frank Act&#148;) and Section&nbsp;14A of the Exchange
Act enables the Company&#146;s stockholders to vote to approve, on an advisory or non-binding basis, the compensation of the Company&#146;s named executive officers as described in the &#147;Compensation Discussion and Analysis&#148; section of this
proxy statement (commonly referred to as a &#147;say on pay&#148; proposal). This vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and
practices described in this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation of our named executive officers is disclosed in the Compensation Discussion
and Analysis, the compensation tables, and the related narrative disclosure contained in this proxy statement. As discussed in those disclosures, the Company believes that its compensation policies and decisions are appropriately designed to attract
and retain the individuals needed to support the Company&#146;s business strategy and to compete effectively with pharmaceutical and biotechnology companies while aligning with the long-term interests of the Company&#146;s stockholders </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Applying these philosophies, the Board of Directors has set specific compensation goals designed to help the Company achieve our short and
long-term business and performance goals. Our executive compensation program emphasizes pay-for-performance. The compensation package for our executive officers includes both cash and equity incentive plans that align our executives&#146;
compensation with our short-term and long-term performance goals and objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors believes that the base salaries
of our executive officers should be set at approximately the median base salary levels of executive officers in our competitive market. The annual cash incentive awards under our bonus plan are intended to compensate our executive officers for
achieving our annual goals at the corporate level. The goals for the Company are established so that target attainment is not assured. The attainment of payment for performance at or above target levels requires significant effort on the part of our
named executive officers. Our named executive officers&#146; target annual cash incentive awards are expressed as a percentage of base salary and reflects what we believe are market competitive levels. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Long-term equity incentives are intended to reward executives for growth in stockholder value. In 2016, our long-term equity incentive awards
to our named executive officers reflected the grant guidelines we adopted in 2007, and are based on our determination of appropriate and competitive annual award values. The guidelines for executive officers seek to deliver approximately 75% of the
award value in stock options and 25% of the award value in restricted stock units. We believe this mix of equity aligns with the interests of stockholders and encourages both stock price growth and retention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have limited perquisite benefits (e.g. automobile allowances) for certain of our named executive officers and we currently do not provide
any deferred compensation programs or supplemental pensions to any of our named executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our pay practices are
reasonable and in the best interests of our Company and our stockholders. To that end, we do not use tax gross-ups, guaranteed bonuses, &#147;single-trigger&#148; benefits payable upon a change in control without a corresponding separation from
service, or similar pay practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the 2011 Annual Meeting of Stockholders, our stockholders indicated their preference that the
Company solicit a non-binding advisory vote on the compensation of the named executive officers every year. The Board has adopted a policy that is consistent with that preference. In accordance with that policy, this year, we are again asking our
stockholders to support the compensation of the Company&#146;s named executive officers as described in this proxy statement by casting a non-binding advisory vote &#147;FOR&#148; the following resolution: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, that the Company&#146;s stockholders approve, on an advisory basis, the
compensation of the named executive officers, as disclosed in the Company&#146;s Proxy Statement for the 2017 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the
Compensation Discussion and Analysis, the 2016 Summary Compensation Table and the other related tables and disclosure.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While this
advisory vote on executive compensation is non-binding, the Board of Directors and the Compensation Committee, which is responsible for designing and administering the Company&#146;s executive compensation program, will review the voting results and
consider the outcome of the vote when making future compensation decisions for named executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Board decides to
modify its policy regarding the frequency of soliciting say-on-pay votes, the next scheduled say-on-pay vote will be at the 2018 Annual Meeting of Stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>R<SMALL>EQUIRED</SMALL> V<SMALL>OTE</SMALL> <SMALL>AND</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>
R<SMALL>ECOMMENDATION</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of Proposal 2 requires the affirmative vote of a majority of the shares present or represented
by proxy and entitled to vote at the Annual Meeting. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the same effect as &#147;Against&#148; votes. Broker non-votes are counted towards a quorum, but will
have no effect on the outcome of the vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors recommends that you vote in favor of the compensation of the
Company&#146;s named executive officers as described in this proxy statement, including the disclosures under &#147;Compensation Discussion and Analysis,&#148; the compensation tables and the narrative discussion following the compensation tables.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A <SMALL>VOTE</SMALL> <SMALL>FOR</SMALL> P<SMALL>ROPOSAL</SMALL> 2 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL&nbsp;3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY INDICATION ON THE PREFERRED FREQUENCY OF STOCKHOLDER ADVISORY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Dodd-Frank Act also enables the Company&#146;s stockholders to indicate their preference regarding how frequently the Company should
solicit a non-binding advisory vote on the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis, the compensation tables, and the related narrative disclosure. Currently, consistent with the
preference expressed by the stockholders at the Company&#146;s 2011 Annual Meeting of Stockholders, the policy of the Board is to solicit such vote every year. In accordance with the Dodd-Frank Act, we are again asking stockholders to indicate
whether they would prefer an advisory vote once every one, two or three years. Alternatively, stockholders may abstain from casting a vote. For the reasons described below, we recommend that our stockholders select a frequency of one year, or an
annual vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In formulating its recommendation, the Board of Directors considered several factors in determining the appropriate
frequency of advisory votes on executive compensation. On the one hand, the Board of Directors recognizes the importance of receiving regular input from our stockholders on important issues, such as our compensation policies and procedures. The
Board of Directors also believes that a well-structured compensation program should include plans that drive the creation of stockholder value over the long term and do not simply focus on short-term gains. Because of that, the Board of Directors
believes that an annual advisory vote will be more limited in value than a vote which reflects the long-term executive compensation philosophy of the Compensation Committee and the long-term results of its actions. Moreover, many elements of
compensation are structured over a multi-year period, disclosure is made to cover several years, and some proxy advisory firms review total stockholder returns over multi-year periods. Also, equity awards to management are granted to compensate
management over at least a three-year period. On the other hand, the Board of Directors recognizes that even if the effectiveness of these plans cannot be adequately evaluated on an annual basis, many stockholders may want to express a preference in
a single year based on a multi-year review. An annual say-on-pay vote may represent the most effective means for some of our stockholders to express meaningful input on executive compensation. Because of that, the Board of Directors determined that
an annual say-on-pay vote would best express its commitment to take steps to align the compensation of its executives with the interests of the Company&#146;s stockholders. The Board of Directors&#146; determination was further based on the premise
that this recommendation could be modified in future years if it becomes apparent that an annual say-on-pay vote is not meaningful, is burdensome or is more frequent than recommended by best corporate governance practices. Based on these factors,
the Board of Directors determined to recommend that future say-on-pay votes occur each year until the next vote on the frequency of advisory votes on the compensation of our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholders are provided with the opportunity to choose among four options (holding the vote every one, two or three years, or abstaining)
and, therefore, stockholders will not be voting to approve or disapprove the recommendation of the Board of Directors. The option among those choices that obtains a majority of votes cast by the shares present or represented by proxy and entitled to
vote at the Annual Meeting will be deemed to be the frequency adopted for advisory purposes by our stockholders in accordance with our Amended and Restated Bylaws; however, in the event that no frequency receives a majority, we will consider
whichever frequency receives a plurality of the votes to be the frequency preferred by our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board and the Compensation
Committee value the opinions of our stockholders in this matter, and the Board of Directors intends to hold say-on-pay votes in the future in accordance with the alternative that receives the most stockholder support. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> <SMALL>RECOMMENDS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><SMALL>A</SMALL> <SMALL>VOTE</SMALL> <SMALL>IN</SMALL> <SMALL>FAVOR</SMALL> <SMALL>OF</SMALL> &#147;O<SMALL>NE</SMALL>
Y<SMALL>EAR</SMALL>&#148; <SMALL>ON</SMALL> P<SMALL>ROPOSAL</SMALL>&nbsp;3. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL&nbsp;4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF SELECTION OF DELOITTE&nbsp;&amp; TOUCHE LLP AS INDEPENDENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee of the Board of Directors has selected Deloitte&nbsp;&amp; Touche LLP (&#147;Deloitte&#148;), as the Company&#146;s
independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2017 and has directed management to submit the selection of Deloitte for ratification by the stockholders at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deloitte has audited the Company&#146;s financial statements since the fiscal year ended December&nbsp;31, 2000. Representatives of Deloitte
are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stockholder ratification of the selection of Deloitte as our independent registered public accounting firm is not required by our Amended and
Restated Bylaws or otherwise. The Board of Directors is seeking such ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection of Deloitte as our independent registered public accounting firm, the Audit
Committee of the Board of Directors will consider whether to retain that firm for the fiscal year ending December&nbsp;31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval
of Proposal 4 requires the affirmative vote of a majority of the shares present or represented by proxy and entitled to vote at the Annual Meeting. Abstentions will be counted toward the tabulation of votes cast on the proposal and will have the
same effect as &#147;Against&#148; votes. Broker non-votes are counted towards a quorum, but will have no effect on the outcome of the vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A V<SMALL>OTE</SMALL> <SMALL>FOR</SMALL> P<SMALL>ROPOSAL</SMALL> 4 </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>P<SMALL>RINCIPAL</SMALL> A<SMALL>CCOUNTING</SMALL> F<SMALL>EES</SMALL> <SMALL>AND</SMALL> S<SMALL>ERVICES</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table represents aggregate fees billed to the Company for the fiscal years ended December&nbsp;31, 2016 and 2015 by Deloitte and
its subsidiaries, the affiliates of Deloitte &amp; Touche LLP, Deloitte Tohmatsu Limited and its member firm. All entities which collectively represent the Company&#146;s principal accounting firm. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,347,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,533,552</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,565</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,442,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,684,117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents the aggregate fees billed for professional services rendered for the audit and/or reviews of our financial statements and in connection with our statutory and regulatory filings or engagements. Also includes
fees for services related to compliance under the Sarbanes-Oxley Act of 2002, as amended. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents fees for tax services rendered in the period indicated.&nbsp;The nature of those services included, without limitation: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the preparation and/or review of original income, franchise and other tax returns with respect to foreign, federal, state and local tax authorities; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">tax consultation, in terms of the application of various provisions of the Code, and consultation regarding financing transactions, foreign entities and collaborations; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">tax advice and assistance related employee benefits plans and statutory, regulatory or administrative developments, and tax credits and refund opportunities. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All fees described above were pre-approved by the Audit Committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>P<SMALL>RE</SMALL>-<SMALL>APPROVAL</SMALL> P<SMALL>OLICIES</SMALL> <SMALL>AND</SMALL> P<SMALL>ROCEDURES</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by our independent
registered public accounting firm, Deloitte. The policy generally pre-approves specified services in the defined categories of audit services, audit-related services, tax services and other services up to specified amounts. Pre-approval may also be
given on an individual explicit case-by-case basis before the independent principal accounting firm is engaged to provide each service. The pre-approval of services may be delegated to one or more of the Audit Committee&#146;s members, but the
decision must be reported to the full Audit Committee at its next scheduled meeting. The delegation of pre-approval of services is limited to non-audit services, as set forth in the Audit Committee Charter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has determined that the rendering of the services other than audit services by Deloitte is compatible with maintaining
Deloitte&#146;s independence. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information regarding the ownership of the Company&#146;s common stock as of March&nbsp;17, 2017 by:
(i)&nbsp;each person, entity or group known to the Company to be the beneficial owner of more than 5% of the Company&#146;s common stock; (ii)&nbsp;each director and nominee for director; (iii)&nbsp;each of the executive officers named in the
Summary Compensation Table (other than Mr.&nbsp;Mann), who we refer to as the named executive officers; and (iv)&nbsp;all current executive officers and directors of the Company as a group. Unless otherwise indicated in the footnotes to the table
below and subject to community property laws where applicable, we believe that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Applicable percentages are based on 95,776,246 shares outstanding on March&nbsp;17, 2017, adjusted as required by rules promulgated by the
SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include shares of common stock issuable pursuant
to the exercise of stock options or warrants that are either immediately exercisable or exercisable on or before May&nbsp;16, 2017, which is 60&nbsp;days after March&nbsp;17, 2017. These shares are deemed to be outstanding and beneficially owned by
the person holding those options or warrants for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Certain of the
options in this table are exercisable at any time but, if exercised, are subject to a lapsing right of repurchase until the options are fully </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
vested. Unless otherwise indicated, the address for each person or entity listed in the table is c/o&nbsp;MannKind Corporation, 25134 Rye Canyon Loop, Suite 300, Valencia, CA 91355. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficial Ownership</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:134.80pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent&nbsp;of&nbsp;Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Greater than 5% Stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Mann Group LLC(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,652,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12744 San Fernando Road</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sylmar, CA 91342</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Alfred E. Mann Living Trust(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,102,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12744 San Fernando Road</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sylmar, CA 91342</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers and Directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">490,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Castagna(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,703</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Urbanski(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Consiglio(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael A. Friedman(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,165</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff(11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James S. Shannon(12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current executive officers and directors as a group&nbsp;(13&nbsp;persons)(13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,528,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Less than 1%. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The Alfred E. Mann Living Trust (the &#147;Trust&#148;) is the sole member and manager of The Mann Group LLC (&#147;The Mann Group&#148;). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i) the shares described in footnote (1) above, (ii) 20,798,469 shares held of record by the Trust and (iii) 3,651,442 shares which the Trust has the right to acquire within 60 days of March&nbsp;17, 2017
pursuant to the exercise of outstanding options previously held by Alfred E. Mann prior to his passing. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Includes 17,627 shares which Mr.&nbsp;Pfeffer has the right to acquire within 60 days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Includes 2,743 shares which Dr.&nbsp;Castagna has the right to acquire within 60 days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Includes 5,038 shares which Dr.&nbsp;Thomson has the right to acquire within 60 days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Includes 4,260 shares which Dr.&nbsp;Urbanski has the right to acquire within 60 days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,767 options and 828 restricted stock units which Mr.&nbsp;Consiglio has the right to acquire within 60&nbsp;days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options and vesting of
restricted stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,767 options and 828 restricted stock units which Dr.&nbsp;Friedman has the right to acquire within 60&nbsp;days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,767 options and 828 restricted stock units which Mr.&nbsp;Kresa has the right to acquire within 60&nbsp;days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,767 options and 828 restricted stock units which Mr.&nbsp;MacCallum has the right to acquire within 60 days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,767 options and 828 restricted stock units which Mr.&nbsp;Nordhoff has the right to acquire within 60&nbsp;days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,244 options and 567 restricted stock units which Dr.&nbsp;Shannon has the right to acquire within 60&nbsp;days of March&nbsp;17, 2017 pursuant to the exercise of outstanding options and vesting of restricted
stock units. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">Includes the shares described in notes (3) through (12) above, as well as 7,759 shares underlying stock options that other executive officers have the right to acquire within 60&nbsp;days of March&nbsp;17, 2017.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE OFFICERS OF THE REGISTRANT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our current executive officers and their ages: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="57%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer, Chief Financial Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, Pharm.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, Chief Commercial Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Kocinsky</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, Chief Technology Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David B. Thomson, Ph.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, General Counsel and Secretary</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stuart A. Tross, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, Chief People Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond W. Urbanski, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Corporate Vice President, Chief Medical Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rosabel R. Alinaya</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Principal Accounting Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Matthew J. Pfeffer </I>has served as our Chief Executive Officer and one of our directors since January
2016 and as our Chief Financial Officer since April 2008. Mr.&nbsp;Pfeffer also served as our Corporate Vice President from April 2008 until January 2016. Previously, Mr.&nbsp;Pfeffer served as Chief Financial Officer and Senior Vice President of
Finance and Administration of VaxGen, Inc. from March 2006 until April 2008, with responsibility for finance, tax, treasury, human resources, IT, purchasing and facilities functions. Prior to VaxGen, Mr.&nbsp;Pfeffer served as CFO of Cell Genesys,
Inc. During his nine year tenure at Cell Genesys, Mr.&nbsp;Pfeffer served as Director of Finance before being named CFO in 1998. Prior to that, Mr.&nbsp;Pfeffer served in a variety of financial management positions at other companies, including
roles as Corporate Controller, Manager of Internal Audit and Manager of Financial Reporting. Mr.&nbsp;Pfeffer began his career at Price Waterhouse. Currently, Mr.&nbsp;Pfeffer serves on the board of directors of Second Sight Medical Products in
Sylmar, California. Mr.&nbsp;Pfeffer graduated from the University of California, Berkeley and is a Certified Public Accountant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Michael E. Castagna, Pharm.D. </I>has been our Corporate Vice President, Chief Commercial Officer since March 2016. From November 2012
until he joined us, Dr.&nbsp;Castagna was at Amgen, Inc., where he initially served as Vice President, Global Lifecycle Management and was most recently Vice President, Global Commercial Lead for Amgen&#146;s Biosimilar Business Unit. From 2010 to
2012, he was Executive Director, Immunology, at Bristol-Myers Squibb Co. Before BMS, Dr.&nbsp;Castagna served as Vice President&nbsp;&amp; Head, Biopharmaceuticals, North America, at Sandoz. He has also held positions with commercial
responsibilities at EMD (Merck) Serono, Pharmasset and DuPont Pharmaceuticals. He received his pharmacy degree from University of the Sciences-Philadelphia College of Pharmacy, a Doctor of Pharmacy from Massachusetts College of Pharmacy&nbsp;&amp;
Sciences and an MBA from The Wharton School of Business at the University of Pennsylvania. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Joseph Kocinsky </I>has been our Corporate
Vice President, Chief Technology Officer since October 2015<I>. </I>Mr.&nbsp;Kocinsky has over 28 years of experience in the pharmaceutical industry in technical operations and product development. Prior to joining us in 2003, he held a variety of
technical and management positions with increased responsibility at Schering-Plough Corp. Mr.&nbsp;Kocinsky holds a bachelor&#146;s degree in chemical engineering and a master&#146;s degree in Biomedical Engineering from New Jersey Institute of
Technology and a master&#146;s degree in business administration from Seton Hall University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>David B. Thomson, Ph.D., J.D. </I>has
been our Corporate Vice President, General Counsel and Corporate Secretary since January 2002. Prior to joining us, he practiced corporate/commercial and securities law at a major Toronto law firm. Earlier in his career, Dr.&nbsp;Thomson was a
post-doctoral fellow at the Rockefeller University. Dr.&nbsp;Thomson obtained his bachelor&#146;s degree, master&#146;s degree and Ph.D. from Queens University and obtained his J.D. from the University of Toronto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stuart A. Tross, Ph.D. </I>has been our Corporate Vice President, Chief People Officer since December 2016, with responsibilities for human
resources, information technology and west coast facilities. From 2006 to 2016 he served in various roles of increasing responsibility at Amgen, Inc., most recently as Senior Vice President and Chief Human Resources Officer responsible for human
resources and security on a global basis. From 1998 to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
2006 he served in a series of leadership roles at Bristol-Myers Squibb Co, most recently as Vice President and Global Head of Human Resources for Mead Johnson Company. Dr.&nbsp;Tross received a
B.S. degree from Cornell University and M.S. and Ph.D. degrees in Industrial-Organizational Psychology from the Georgia Institute of Technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Raymond W. Urbanski, M.D., Ph.D.</I> has been our Chief Medical Officer since August 2015. Prior to joining us, he served as Chief Medical
Officer at Mylan, Inc. from September 2012 to September 2014 and Chief Medical Officer at Metabolex, Inc. from October 2011 to June 2012. From June 2004 to October 2011, Dr.&nbsp;Urbanski held several positions with Pfizer Inc. most recently as Vice
President and Medical Head of the Established Products Business Unit. He also served as Vice President of Research and Development and Chief Medical Officer at Suntory Pharmaceutical, Inc. Dr.&nbsp;Urbanski earned both his M.D. and Ph.D. in
pharmacology and toxicology at the University of Medicine and Dentistry of New Jersey. He completed his residency and fellowship training at Thomas Jefferson University Hospital in Philadelphia. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Rosabel R. Alinaya </I>has been our Senior Vice President, Principal Accounting Officer since January 2016 with responsibility for finance,
accounting, tax, treasury, investor relations and risk management. Previously, she was our Vice President, Finance since March 2011 after serving as our Corporate Controller since June 2003. Ms.&nbsp;Alinaya began her career at Deloitte&nbsp;&amp;
Touche LLP, graduating from California State University, Northridge and is a Certified Public Accountant. She is also a member of the American Institute of Certified Public Accountants and a member of the California Society of Certified Public
Accountants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executive officers serve at the discretion of our Board of Directors. There are no family relationships between any of our
directors and executive officers. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Retainers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our
non-employee directors receives an annual retainer for service on the Board of Directors and an additional retainer for his service on one of our three standing committees, as described below under the subheading &#147;Non-Employee Director
Compensation Program.&#148; Non-employee directors have an option to receive their annual retainer in cash or common stock of the Company pursuant to our director compensation program, as discussed below under the subheading &#147;Non-Employee
Director Compensation Program.&#148; In the fiscal year ended December&nbsp;31, 2016, the total annual retainer earned by non-employee directors was $432,500, of which $67,500 was paid in cash and $365,000 was received in common stock of the
Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Awards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
non-employee director of the Company also receives annual equity awards under our 2013 Equity Incentive Plan (&#147;the 2013 Plan&#148;) pursuant to our non-employee director compensation program, as described below under the subheading
&#147;Non-Employee Director Compensation Program.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning director compensation received for the
fiscal year ended December&nbsp;31, 2016 by our non-employee directors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Director Compensation Table </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>Earned&nbsp;or<BR>Paid in<BR>Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted<BR>Stock<BR>Awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald J. Consiglio</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">451,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael A. Friedman, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kent Kresa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,953</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">545,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David H. MacCallum</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">383,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">383,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James S. Shannon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,078</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">374,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">These amounts reflect the grant date fair value of all option grants to non-employee directors in 2016. The Company uses the Black-Scholes option valuation model to estimate the grant date fair value of non-employee
director stock options. Option valuation models require the input of assumptions, including the expected life of the stock-based awards, the estimated stock price volatility, the risk-free interest rate and the expected dividend yield. The expected
volatility assumption is based on an assessment of the historical volatility, with consideration of implied volatility, derived from an analysis of historical trade activity. Reference Note&nbsp;12 &#147;Stock award plans&#148; in the notes to our
financial statements for the period ended December&nbsp;31, 2016, included in Part&nbsp;IV of our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended December&nbsp;31, 2016 filed with the SEC on
March&nbsp;16, 2017, which identifies the assumptions made in the valuation of option. All non-employee directors received a stock option to purchase 15,680&nbsp;shares of our common stock upon re-election to the Board of Directors on May&nbsp;19,
2016. Options granted to these non-employee directors vest monthly over a period of three years. The exercise price per share represents the fair market value of our common stock on the date of each grant (based on the closing sales price reported
on the Nasdaq Global Market on the date of grant). We have no consulting agreements with any of our directors pursuant to which stock awards were issued. As of December&nbsp;31, 2016, our non-employee directors had option grants outstanding to
purchase 273,478 shares of our common stock as follows: Ronald&nbsp;J. Consiglio, 49,060&nbsp;shares; Michael&nbsp;A. Friedman, M.D.&nbsp;49,060 shares; Kent Kresa, 49,060&nbsp;shares; David&nbsp;H. MacCallum, 49,060&nbsp;shares; Henry&nbsp;L.
Nordhoff, 49,060&nbsp;shares; and James Shannon 28,178&nbsp;shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">These amounts reflect the grant date fair value of all restricted stock awards to non-employee directors in 2016. Restricted stock units are valued based on the market price on the grant date. Reference Note&nbsp;12
&#147;Stock award plans&#148; in the notes to our financial statements for the period ended December&nbsp;31, 2016, included in Part&nbsp;IV of our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the fiscal year ended
December&nbsp;31, 2016 filed with the SEC on March&nbsp;16, 2017, which identifies the assumptions made in the valuation of restricted stock awards. Restricted stock awards granted to non-employee directors vest annually over a period of three
years. As of December&nbsp;31, 2016, our non-employee directors had restricted stock grants outstanding to receive 184,157&nbsp;shares of our common stock as follows: Ronald&nbsp;J. Consiglio, 39,717&nbsp;shares; Michael&nbsp;A. Friedman, M.D.
8,084&nbsp;shares; Kent Kresa, 48,567&nbsp;shares; David&nbsp;H. MacCallum, 32,743&nbsp;shares; Henry&nbsp;L. Nordhoff, 33,241&nbsp;shares; and James Shannon 21,805&nbsp;shares. For 2016, Dr.&nbsp;Friedman elected to receive his annual retainer in
cash. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Employee Director Compensation Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our non-employee director compensation program (the &#147;director compensation plan&#148;), each of our non-employee directors
receives an annual retainer of $50,000 for service on the Board of Directors. The chair of the Nominating and Corporate Governance Committee receives, in addition to the annual retainer, a retainer of $10,000 per year for his or her service as the
Nominating and Corporate Governance Committee chair </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and non-chair Nominating and Corporate Governance Committee members receive an additional retainer of $5,000 per year. The chair of the Compensation Committee receives, in addition to the annual
retainer, a retainer of $20,000 per year for his or her service as the Compensation Committee chair and non-chair Compensation Committee members receive an additional retainer of $7,500 per year. The chair of the Audit Committee receives, in
addition to the annual retainer, a retainer of $25,000 per year for his or her service as the Audit Committee chair and non-chair Audit Committee members receive an additional retainer of $10,000 per year. Our non-employee directors do not receive
fees for attending Board or committee meetings. Additionally, the Chairman receives an additional annual retainer of $32,500. As of a result of Mr.&nbsp;Kresa&#146;s appointment to the position of Chairman of the Board in February 2016, we do not
currently have a lead independent director and expect to keep the lead independent director position vacant for so long as the Chairman and Chief Executive Officer positions continue to be occupied by separate individuals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The members of the Board of Directors are also eligible for reimbursement for their expenses incurred in attending Board of Directors meetings
in accordance with Company policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Non-employee directors have an option to receive their annual retainer in cash or common stock of the
Company. If a non-employee director elects to receive his annual retainer in common stock, two awards of restricted stock units will be granted. One of these awards will consist of that number of shares that equals 100% of the annual retainer, based
on the closing price on the day immediately prior to the grant date. This award will vest (i.e., the shares will be delivered) on the earliest to occur of (i)&nbsp;the retirement or removal of the non-employee director from the Board of Directors;
(ii)&nbsp;his or her death; or (iii)&nbsp;five years from the grant date. The other award will consist of that number of shares that equals 15% of the annual retainer, based on the same closing price. This award will vest upon the earliest to occur
of (i)&nbsp;the retirement or removal of the non-employee director from the Board of Directors, provided that such retirement or removal occurs more than one year after the grant date; (ii)&nbsp;his or her death; or (iii)&nbsp;five years from the
grant date. Non-employee directors who elect not to participate in this program will receive the full annual retainer shortly after the date of the stockholder meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each non-employee director of the Company also receives annual equity awards under the 2013 Plan. Only non-employee directors of the Company
or an affiliate of such directors (as defined in the Code) are eligible to receive equity awards pursuant to the director compensation program. Options granted under the 2013 Plan pursuant to the director compensation program are intended by the
Company not to qualify as incentive stock options under the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the director compensation program, each of our
non-employee directors automatically receives on the date of each of our annual stockholder meetings an equity award determined by dividing $150,000 by the 20-day trailing average closing price of the Company&#146;s common stock reported on Nasdaq
as of the trading day immediately preceding the date of the applicable annual meeting of stockholders (the &#147;Total Award&#148;). An amount equal to 1/3 of the Total Award rounded up to the nearest 100 shares is in the form of a restricted stock
unit, and an amount equal 2/3 of the Total Award rounded up to the nearest 100 shares is in the form of a stock option at an exercise price equal to 100% of fair market value of the Company&#146;s common stock on the date of grant; provided,
however, that a maximum of 150,000 shares of our common stock may be granted to any one non-employee director during any one calendar year pursuant to stock awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each such annual equity award vests in 36 equal monthly installments commencing one month from the date of grant.&nbsp;If a non-employee
director has not been serving as a non-employee director for the entire period beginning from the preceding annual stockholders meeting, then the number of shares subject to such annual equity award shall be reduced proportionately for each full
quarter prior to the date of such annual equity award during which such person did not serve as a non-employee director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
each person who is elected or appointed for the first time to be a non-employee director of the Company will automatically receive, on the date of his or her initial election or appointment to the Board of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Directors, an option to purchase 50,000&nbsp;shares of the Company&#146;s common stock as an initial grant. All initial grant options vest in equal annual installments over three years. No other
options are provided for under the director compensation program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price of options granted pursuant to the director
compensation program cannot be less than 100% of the fair market value of the common stock subject to the option on the date of the option grant. Acceptable consideration for the purchase of the Company&#146;s common stock upon exercise of options
granted pursuant to the director compensation program will be determined by the Board of Directors and may include cash or common stock previously owned by the optionee or may be paid through a broker assisted exercise or net exercise feature. An
optionee whose service relationship with the Company or any of our affiliates, whether as a non-employee director or subsequently as an employee, director or consultant to either the Company or one of our affiliates, ceases for any reason may
exercise options for the term provided in the option agreement to the extent the options were exercisable on the date of termination. The term of options granted pursuant to the director compensation program is 10 years. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMPENSATION</SMALL> D<SMALL>ISCUSSION</SMALL> <SMALL>AND</SMALL> A<SMALL>NALYSIS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are pleased to present our report on executive compensation. The report&#146;s objective is to assist our stockholders in understanding the
objectives and procedures used by the Compensation Committee of our Board of Directors in establishing its recommendations to the Board of Directors regarding the compensation of our executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for
diseases such as diabetes. Our compensation program is designed to attract and retain the individuals needed to support our business strategy and to allow us to compete effectively with pharmaceutical and biotechnology companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is responsible for establishing and administering our policies governing the compensation for our executive
officers. The Compensation Committee is composed entirely of independent directors within the meaning of applicable SEC and Nasdaq rules. The Compensation Committee&#146;s responsibilities and duties are outlined in detail in the Compensation
Committee charter, which is available on our website at <I>www.mannkindcorp.com</I>. A primary responsibility of the Compensation Committee is to make recommendations regarding the compensation for our executive officers, including the determination
and confirmation of annual corporate goal achievement for purposes of awarding bonuses, to the full Board of Directors for its approval. As part of this process, the Compensation Committee has historically invited our Chief Executive Officer to
attend Compensation Committee meetings or portions thereof to obtain his insight and guidance, though the Chief Executive Officer is not a member of the Compensation Committee. The Compensation Committee engages outside consulting firms to assist in
developing compensation levels and practices and to provide external market data. The Compensation Committee engaged Mercer LLC to benchmark the compensation levels of seven executive positions relative to a group of peer companies for fiscal year
2016 compensation. The Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the Compensation Committee, other than in-house legal counsel and certain other types of advisers, only
after taking into consideration six factors, prescribed by the SEC and NASDAQ, that bear upon the adviser&#146;s independence; however, there is no requirement that any adviser be independent. The Compensation Committee conducted an independence
assessment with respect to Mercer&#146;s role in recommending or determining the amount and form of executive compensation for fiscal year ended December&nbsp;31, 2016 and considered the required six factors.&nbsp;After conducting this assessment,
the Compensation Committee concluded that Mercer&#146;s role in recommending or determining the amount and form of execution compensation for the fiscal year ended December&nbsp;31, 2016 did not raise any conflict of interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee meets outside the presence of our Chief Executive Officer in order to
consider the appropriate compensation for our Chief Executive Officer. In 2016, the Compensation Committee met outside the presence of our Chief Executive Officer in order to consider the appropriate compensation for our Chief Executive Officer. The
Compensation Committee consisted (and continues to consist) solely of independent directors. The Compensation Committee relies on compensation data provided by Mercer in setting CEO compensation and met without the CEO in setting his compensation.
The CEO in 2016 did not maintain personal or business relationships (including any interlocking relationships) with any of the Compensation Committee members (outside of their relationship within the Company) that would impair the Compensation
Committee members&#146; ability to remain independent and assess the CEO&#146;s compensation without any conflict of interest. Thus, the determination of the CEO compensation was made without undue influence from the CEO. During 2016, for all other
named executive officers, the Compensation Committee met outside the presence of all executive officers except our Chief Executive Officer. The annual performance reviews of our executive officers are considered by the Compensation Committee when
making decisions regarding base salary, targets for and payments under our bonus plan and grants of equity incentive awards. When making recommendations regarding individual executive officers, the Compensation Committee considers the importance of
the position to us, the past compensation history of the executive officer and the contributions made by the individual in the past and the contributions we expect the executive officer to make in the future towards the success of our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Philosophy and Objectives </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee oversees our executive compensation within the context of a compensation philosophy. This philosophy is to provide
compensation and benefits programs designed to attract, motivate, and retain a high caliber workforce that enables us to compete with companies in the pharmaceutical and biotechnology industries and to reward individual and corporate performance.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that a well-designed compensation program for our executive officers should: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">align the goals of the executive officer with the goals of our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recognize individual initiative, effort and achievement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide total compensation that enables us to compete with companies in the pharmaceutical and biotechnology industries;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">align compensation with our short-term and long-term corporate objectives and strategy, focusing executive officer behavior on the fulfillment of those objectives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In keeping with this philosophy, our executive compensation program is designed to achieve the following objectives: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attract talented and experienced executives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">motivate and reward executives whose knowledge, skills and performance are critical to our success; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">retain executives and employees who are instrumental in accomplishing our corporate objectives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">align the interests of our executives and stockholders by motivating executives to increase stockholder value and rewarding executives when stockholder value increases; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide a competitive compensation package which is weighted towards pay-for-performance, and in which total compensation is primarily determined by the Company&#146;s and the individual&#146;s achievement of results;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">ensure fairness among the executive management team by recognizing the contributions each executive makes to our success; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">foster a shared commitment among executives by aligning the Company&#146;s and their individual goals;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">compensate our executives to manage our business to meet our long-term objectives. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competitive Market Assessment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee periodically reviews competitive market data to determine if our compensation levels remain at targeted levels and
our pay practices are appropriate. These assessments include a review of base salary, annual incentives, and long-term incentives. These components are evaluated against a group of peer companies as well as industry specific and general published
survey compensation data. Specifically, we utilized the Radford Global Life Sciences Executive Survey, the SIRS Executive Compensation Survey and the Kenexa CompAnalyst Executive Survey. For the past eight years, the Compensation Committee has
engaged Mercer to benchmark the compensation levels of six executive positions relative to a group of peer companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Peer Group </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed a peer group for benchmarking purposes, by considering companies in a similar industry and of a similar size in terms of
revenue and number of employees. All companies in the peer group are either biotechnology or pharmaceutical companies. Companies were selected with various revenue sizes because we are recruiting from and competing for executive talent with
companies that are generating revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For compensation considerations in 2016, the peer group consisted of eleven companies.&nbsp;Based
on data compiled and reviewed by the Compensation Committee in late 2015, two of the companies had revenue of less than $7M, three between $21 million and $36 million, and six between $140 million and $830 million.&nbsp;Based on the prospects for
MannKind at that time, the Compensation Committee believed that those peer companies were appropriate and were identical to the companies considered in 2015.&nbsp;The 2016 peer group consisted of the following companies: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arena Pharmaceuticals Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Innoviva Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acadia Pharmaceuticals Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lexicon Pharmaceuticals Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cti Biopharma Corp.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Nektar Therapeutics</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Celldex Therapeutics Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Raptor Pharmaceuticals Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exelixis Inc</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rigel Pharmaceuticals Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Geron Corp.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Market Positioning </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee reviews executive compensation at least annually, establishes competitive compensation levels and designs the
compensation program to provide pay commensurate with individual and corporate performance. With support from Mercer, we have positioned total compensation levels for executives at the 50th&nbsp;percentile of our peer group on the basis that we
believe this target to be an appropriate level of compensation to attract and retain qualified and capable executives. However, compensation may fall above or below this level under a range of circumstances, such as individual performance, tenure
with the Company or retention concerns. We supplement the peer group data with the survey data described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our executive
compensation packages are reasonable when considering our business strategy, the revenue potential of our business, our compensation philosophy and the competitive market pay data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the factors listed above, we also consider, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our business need for the executive officer&#146;s skills; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the contributions that the executive officer has made or we believe will make to our success; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the transferability of the executive officer&#146;s managerial skills to other potential employers;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the relevance of the executive officer&#146;s experience to other potential employers, particularly in the pharmaceutical and biotechnology industries. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pay-for-Performance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive compensation program emphasizes pay-for-performance. As described below, both our short term and long term incentive plans are
now tied to the financial metric of sales generated; however, we also include other metrics such as progress through the FDA approval process and our ability to obtain partnerships and to develop candidates for commercialization. The compensation
package for our commercial organization includes both cash and equity incentives based on performance incentivizing strong sales objectives. The compensation package for our executive officers include both cash and equity incentive plans that align
an executive&#146;s compensation with our short-term and long-term performance goals and objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual cash incentive awards
under our bonus plan are intended to compensate our executive officers for achieving our annual goals at the corporate level and for achieving individual annual performance objectives. The goals for our company and individual measures are
established so that target attainment is not assured. The attainment of payment for performance at or above target levels requires significant effort on the part of our executives. Long-term equity incentives are intended to reward executives for
growth in stockholder value. As described below, our compensation guidelines for executive officers seek to deliver approximately 75% of the award value in stock options and 25% of the award value in restricted stock units. We believe this mix of
equity along with our performance-based bonus plan, places a significant portion of our executive compensation at risk, encouraging corporate performance and stock price growth. Additional details of the plan are described below under &#147;Bonus
Plan&#148; and &#147;Long-Term Incentives.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consideration of Say-on-Pay Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our 2016 Annual Meeting of Stockholders, 96.8% of the votes cast on the proposal approved, on an advisory basis, the compensation of our
named executive officers. The Compensation Committee considered this result and, in light of this support and the continuing success of our compensation programs, the Compensation Committee did not implement significant changes to our executive
compensation program during 2016. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OMPENSATION</SMALL> C<SMALL>OMPONENTS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to provide a total compensation package that is tied to stockholder value creation and the achievement of strategic corporate goals,
our executive compensation package is comprised of several components. These components are designed to work together to create a balanced approach to compensation, rewarding both short-term and long-term performance and fostering sufficient
retentive effect to secure the services of our executive officers while we execute on our plans. Currently, our compensation structure for executive officers includes a combination of base salary, bonus, stock options and restricted stock awards,
401(k), medical and other benefits, severance and change in control and other post termination provisions. Each component is described in further detail below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Base Salary </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Base salaries are designed
to provide compensation for day-to-day management of the Company assuming satisfactory levels of performance. This component is designed to provide consistent and steady cash flow for the executive and represents only a portion of total
compensation. Salary levels are based primarily upon the competitive market for the executive officers&#146; services. Base salaries for our executives are intended to fall at the median of the competitive market. Individual performance,
responsibility, and the importance of each role in our organization can also impact base salary levels. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bonus Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of our executive officers are eligible to receive annual performance-based cash bonuses. The annual cash incentive awards under our bonus
plan are intended to compensate our executive officers for achieving our annual goals at the corporate level. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Performance goals are generally based on any one or more of the following performance criteria:
(i)&nbsp;earnings (including earnings per share and net earnings); (ii)&nbsp;earnings before interest, taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization; (iv)&nbsp;total stockholder return;
(v)&nbsp;return on equity or average stockholder&#146;s equity; (vi)&nbsp;return on assets, investment, or capital employed; (vii)&nbsp;stock price; (viii)&nbsp;margin (including gross margin); (ix)&nbsp;income (before or after taxes);
(x)&nbsp;operating income; (xi)&nbsp;operating income after taxes; (xii)&nbsp;pre-tax profit; (xiii)&nbsp;operating cash flow; (xiv)&nbsp;sales or revenue targets; (xv)&nbsp;increases in revenue or product revenue; (xvi)&nbsp;expenses and cost
reduction goals; (xvii)&nbsp;improvement in or attainment of working capital levels; (xviii)&nbsp;economic value added (or an equivalent metric); (xix)&nbsp;market share; (xx)&nbsp;cash flow; (xxi)&nbsp;cash flow per share; (xxii)&nbsp;share price
performance; (xxiii)&nbsp;debt reduction; (xxiv)&nbsp;implementation or completion of projects or processes; (xxv)&nbsp;customer satisfaction; (xxvi)&nbsp;stockholders&#146; equity; (xxvii)&nbsp;capital expenditures; (xxiii)&nbsp;debt levels;
(xxix)&nbsp;operating profit or net operating profit; (xxx)&nbsp;workforce diversity; (xxxi)&nbsp;growth of net income or operating income; (xxxii)&nbsp;other operational goals; (xxxiii)&nbsp;research and development goals; (xxxiv)&nbsp;regulatory
goals; (xxxv)&nbsp;commercial milestones; and (xxxvi)&nbsp;other company and individual metrics approved by the Board or the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2016, the corporate goals were based on achievement of certain operational goals. Because we were still in the process of supporting the
launch of our first product, the use of traditional performance standards, such as profit levels and return on equity, were not appropriate in our evaluation of executive officer performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each eligible position, including the executive officers, is assigned a target bonus opportunity expressed as a percentage of base salary,
which reflects market competitive levels. Target bonus opportunities are generally positioned at the 50th&nbsp;percentile of the market. For Mr.&nbsp;Mann, the target bonus opportunity for 2016 was 60% of base salary. The target bonuses for the
other named executive officers for 2016 were as follows: Mr.&nbsp;Pfeffer, 60%; Ms.&nbsp;Palumbo, 50%; Dr.&nbsp;Thomson, 50%; Mr.&nbsp;Kocinsky, 50%, Dr.&nbsp;Urbanski, 50% and Dr.&nbsp;Castagna, 50%. Payments of target bonuses are not guaranteed
and are subject to funding and corporate and individual performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bonus plan is funded based on the achievement of overall
corporate goals, based on a careful review by the Compensation Committee of the accomplishments of the Company during the previous year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2016, there were five corporate objectives, as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Initiate sales and marketing of Afrezza in Q2 2016 and grow sales to certain target levels. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Pursue licensing and distribution agreements for the sale of Afrezza in foreign jurisdictions. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Pursue license agreements related to MannKind&#146;s technology (for products other than Afrezza).</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Publish data from completed post-marketing studies at and submit clinical study reports to the FDA. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Extend MannKind&#146;s financial resources. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Board determined that these
objectives were achieved at the level of 60%; accordingly, 60% of the target bonus opportunity for each executive officer was paid as a discretionary bonus for 2016. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Long-Term Incentives </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to provide
a significant retention incentive and to ensure a strong link to the long-term interests of stockholders, we provide a portion of our total compensation in the form of equity compensation &#151; specifically, stock options (both performance-based
and time-based vesting types) and restricted stock units. Executive officers, as well as all full-time employees, are eligible to receive awards. The Company has developed guidelines which target the annual long term incentive award at 200% of base
salary for the CEO and at 80% and 60% of base salary for the other named executive officers. The intended award value is then split between stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
options and restricted stock units. The majority of equity compensation is delivered in stock options, which have no intrinsic value unless the stock price appreciates. Awards of restricted stock
units foster equity ownership and encourage retention. Restricted stock units also require fewer shares than an equivalent grant value in stock options. We target equity compensation at the median of the competitive market. The awards are made at
the discretion of the Compensation Committee, after taking into consideration the grant guidelines. Equity awards are granted under the 2013 Plan, which is administered by the Compensation Committee pursuant to a delegation of concurrent authority
by our Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our policy with regard to the timing of grants of equity compensation is to issue equity awards in the form of
options and restricted stock units in connection with an employee&#146;s hire date or promotion date as well as in connection with an annual grant of equity awards that generally occurs in August of each year. All employee grants are approved by the
Compensation Committee at its regularly scheduled quarterly meeting with the grant date on or after the approval date. The timing of grant dates is not based on any favorable or unfavorable non-public information anticipated to be disclosed at a
later date. All stock option awards are granted with an exercise price equal to the closing sale price of our common stock on the Nasdaq Global Market on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2016, our Compensation Committee awarded stock options that vest based upon the achievement of specified quarterly product sales and which
expire ten years from the date of grant. Our time-based stock options typically vest over a four-year period, with 25% of the award vesting after one year and 1/48 of the award vesting monthly thereafter. As with the performance-based options, the
time-based options also expire ten years from the date of grant. Awards of restricted stock units vest 25%&nbsp;per year over four years. The vesting of all awards ceases when an employee is no longer providing continuous service to the Company.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide a
competitive benefits package to all full-time employees, which includes health and welfare benefits, such as medical, dental, vision care, life insurance benefits, and a 401(k) savings plan. Executives, including the named executive officers,
receive additional benefits, including executive medical reimbursement insurance, additional life insurance, as well as short-term and long-term disability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2016, Messrs. Pfeffer, Castagna, and Thomson, also received an automobile allowance of $1,200 per month. We have no other structured
perquisite benefits (e.g. club memberships or financial planning services) for any executive officer, including the named executive officers, and we currently do not provide any deferred compensation programs or supplemental pensions to any
executive officer, including the named executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to encourage stock ownership and provide greater incentives to contribute to our success at all levels, we provide all employees,
including executive officers, the ability to purchase our common stock at a discount under our Employee Stock Purchase Plan. The Employee Stock Purchase Plan is designed to comply with Section&nbsp;423 of the Code and provides all employees with the
opportunity to purchase up to $25,000 of common stock annually at a purchase price that is the lower of 85% of the fair market value of the common stock on either the date of purchase or the commencement of the offering period. The executives&#146;
rights under the Employee Stock Purchase Plan are identical to those of all other employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Severance Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, we have severance agreements with two of our executives, Mr.&nbsp;Pfeffer and Dr.&nbsp;Thomson in order to ensure that we have the
continued dedication of these executives and in order to provide them with reasonable compensation and benefit arrangements in the event of termination of their employment. We believe that it is imperative to diminish any distraction of our
executives arising from the personal uncertainty and insecurity that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
arises in the absence of any assurance of job security, thereby allowing executives to focus on corporate objectives and strategy. The terms of these agreements and amounts that may be realized
are detailed under the heading &#147;Potential Payments Upon Termination or Change of Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Change of Control Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into change of control agreements with each of our executive officers in order to ensure that we have the continued dedication
of these executives and in order to provide them with reasonable compensation and benefit arrangements in the event of termination of their employment following a change of control. We believe that it is imperative to diminish any distraction of our
executives arising from the personal uncertainty and insecurity that arises in the absence of any assurance of job security, thereby allowing executives to focus on corporate objectives and strategy. The terms of these agreements and amounts that
may be realized are detailed under the heading &#147;Potential Payments Upon Termination or Change of Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>S<SMALL>UMMARY</SMALL>
C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows for the year ended December&nbsp;31, 2016 compensation
awarded to, or earned by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the individuals who served as our principal executive officer or principal financial officer for any portion of 2016; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our three most highly compensated executive officers in 2016, other than the individuals listed above, who were serving as executive officers as of December&nbsp;31, 2016. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These individuals constitute our named executive officers for the year ended December&nbsp;31, 2016.&nbsp;The following table also includes compensation
awarded to, or earned by, the aforementioned named executive officers for the fiscals year ended December&nbsp;31, 2015 and 2014 to the extent such individuals were also deemed to be named executive officers for such years. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:97.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Restricted<BR>Stock<BR>Awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Non-Equity<BR>Incentive&nbsp;Plan<BR>Compensation<BR>($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alfred E. Mann(5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Former Chairman and Chief</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">280,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">299,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">858,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,076,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,343,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">490,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,703,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,392</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,227,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer and</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,220,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">466,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,110,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, Pharm.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">315,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,800</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,209,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,028</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,660,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Corporate Vice President,</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Commercial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David&nbsp;Thomson,&nbsp;Ph.D.,&nbsp;J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,915</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,226,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Corporate Vice President,</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>General&nbsp;Counsel&nbsp;and&nbsp;Secretary</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">440,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,951</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">282,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,122,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">409,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,007,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Urbanski, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,320</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,269,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Corporate&nbsp;Vice&nbsp;President,&nbsp;Chief</I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes amounts earned but deferred at the election of the named executive officer, such as salary deferrals under our 401(k) Plan established under Section&nbsp;401(k) of the Code. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Restricted stock awards are valued based on the market price of the stock on the grant date. Reference
Note&nbsp;12 &#147;Stock award plans&#148; in the notes to our financial statements for the period ended December&nbsp;31, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
2016, included in Part&nbsp;IV, Item&nbsp;15 of our Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2016 filed with the SEC on March&nbsp;16, 2017, which identifies
the assumptions made in the valuation of equity awards. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Non-equity incentive plan compensation is based on individual performance in the achievement of corporate objectives. Performance is compared to these objectives annually. No bonus payments were paid in 2016.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Amounts include employer contributions credited under our 401(k) Plan and the incremental cost of perquisites received by the named executive officers. Under the 401(k) Plan, which is open to substantially all of our
employees, we make matching contributions based on each participant&#146;s voluntary salary deferrals, subject to the provisions of the 401(k) Plan and limits of the Code. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">On January&nbsp;10, 2016, Mr.&nbsp;Alfred&nbsp;E. Mann ceased to be the Chief Executive Officer upon the appointment of Matthew J. Pfeffer as the Chief Executive Officer and member of the Board of Directors.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Includes $14,400 in auto allowance, $4,903 in contributions under the 401(k) Plan, $13,539 in medical benefits, and $450 in airline club membership fees and travel benefits. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Includes $11,354 in auto allowance, and $1,674 in medical benefits. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Includes $14,400 in auto allowance, $4,595 in contributions under the 401(k) Plan, $13,594 in medical benefits, and $450 in airline club membership fees and travel benefits. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Includes $4,724 in contributions under the 401(k) Plan and $96,596 in relocation benefits. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>G<SMALL>RANTS</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>-B<SMALL>ASED</SMALL> A<SMALL>WARDS</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;1, 2017, we filed with the Secretary of State of the State of Delaware a Certificate of Amendment to our Amended and Restated
Certificate of Incorporation (the &#147;Charter Amendment&#148;) to (i)&nbsp;implement a one-for-five reverse stock split of our outstanding common stock (the &#147;Reverse Stock Split&#148;), without any change in par value per share, and
(ii)&nbsp;reduce the authorized number of shares of our common stock from 700,000,000 to 140,000,000 shares, as previously authorized and approved at a special meeting of stockholders on March&nbsp;1, 2017. The Charter Amendment became effective at
5:01 p.m. Eastern Time on March&nbsp;2, 2017 (the &#147;Effective Time&#148;). No fractional shares were issued in connection with the Reverse Stock Split. Instead, we issued one full share of the post-Reverse Stock Split common stock to any
stockholder of record who was entitled to receive a fractional share as a result of the process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the Reverse Stock Split,
proportionate adjustments were made to the per share exercise price and the number of shares issuable upon the exercise or vesting of all stock options, restricted stock units and warrants issued by us and outstanding immediately prior to the
Effective Time, which resulted in a proportionate decrease in the number of shares of our common stock reserved for issuance upon exercise or vesting of such stock options, restricted stock units and warrants, and, in the case of stock options and
warrants, a proportionate increase in the exercise price of all such stock options and warrants. In addition, the number of shares authorized for future grant under our equity incentive/compensation plans immediately prior to the Effective Time were
reduced proportionately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We grant options and restricted stock units to our employees, including the named executive officers, under the
2013 Plan. All options granted to our named executive officers are nonstatutory stock options that do not qualify as incentive stock options within the meaning of Section&nbsp;422 of the Code. As of December&nbsp;31, 2016, 2,052,345 options and
14,203 restricted stock units were outstanding under the 2004 Plan, 3,399,245 options and 723,763 restricted stock units were outstanding under the 2013 Plan and an additional 3,840,587&nbsp;shares of common stock were available for issuance under
the 2013 Plan. Options generally expire ten years from date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exercise price per&nbsp;share of each option granted to our
named executive officers was equal to the fair market value on the date of the grant. The exercise price is payable in cash, shares of our common stock previously owned by the optionee or pursuant to the net exercise of the option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;3, 2017, our common stock began trading on The NASDAQ Global Market on a split-adjusted basis. All references to shares of
common stock, all per share data, and all warrant, stock option and restricted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock unit activity for all periods presented in this proxy statement have been adjusted to reflect the Reverse Stock Split on a retroactive basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2004 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors adopted and our stockholders approved the 2004 Plan, effective July 2004. The terms of the equity awards granted under
the 2004 plan, including vesting requirements, were determined by our Board of Directors, subject to the provisions of the 2004 Plan. Following the adoption of the 2013 Plan in May 2013, no additional awards have been granted under the 2004 Plan,
and all awards granted under the 2004 Plan that are repurchased, forfeited, expire or are cancelled become available for grant under the 2013 Plan in accordance with its terms. However, all stock options granted under the 2004 Plan continue to be
governed by the terms of the 2004 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2013 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors, or a duly authorized committee thereof, has the authority to administer the 2013 Plan. Our Board of Directors has
delegated concurrent authority to administer the 2013 Plan to the Compensation Committee, but may, at any time, revert in itself some or all of the power previously delegated to the Compensation Committee. Our Board of Directors or its authorized
committee is referred to herein as the &#147;Plan Administrator.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options vest at the rate specified by the Plan Administrator
and may have a term up to a maximum of ten years or, in some cases, five years. Unless the terms of an optionee&#146;s stock option agreement provide otherwise, if an optionee&#146;s service terminates for any reason other than disability, death,
retirement or cause, the optionee may generally exercise any vested options for a period of three months following the cessation of service. The option term may be extended in the event that exercise of the stock option following such a termination
of service is prohibited by applicable securities laws or our insider trading policy. If an optionee&#146;s service terminates due to disability or death, or an optionee dies within a certain period following cessation of service, the optionee or a
beneficiary may generally exercise any vested options for a period of 12 months in the event of disability and 18 months in the event of death. If the cessation of service is due to retirement, the optionee may generally exercise any vested options
for a period of 24 months. In the event of a termination for cause, options generally terminate immediately upon the termination of the individual for cause. In no event may an option be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, an optionholder may not transfer a stock option other than by will or the laws of descent and distribution or a domestic relations
order with the approval of the Plan Administrator or a duly authorized officer. Additionally, an optionholder may, with the approval of the Plan Administrator or a duly authorized officer, designate a beneficiary who may exercise the stock option
following the optionholder&#146;s death. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Transactions.</I> In the event of a transaction (as defined in the 2013 Plan and described
below), the Board of Directors will have the discretion to take one or more of the following actions with respect to outstanding stock awards (contingent upon the closing or completion of such transaction), unless otherwise provided in the stock
award agreement or other written agreement with the participant or unless otherwise provided by the Board of Directors at the time of grant: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the surviving or acquiring corporation (or its parent company) to assume or continue the award or to substitute a similar stock award for the award (including an award to acquire the same consideration paid
to our stockholders pursuant to the transaction); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the assignment of any reacquisition or repurchase rights held by us with respect to the stock award to the surviving or acquiring corporation (or its parent company); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">accelerate the vesting (and, if applicable, the exercisability) of the stock award and provide for its termination prior to the effective time of the transaction; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us with respect to the award; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">cancel or arrange for the cancellation of the stock award, to the extent not vested or exercised prior to the effective time of the transaction, in exchange for such cash consideration, if any, as the Board of Directors
may consider appropriate; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">make a payment, in such form as may be determined by the Board of Directors, equal to the excess, if any, of (i)&nbsp;the value of the property the participant would have received upon the exercise of the stock award
immediately prior to the effective time of the transaction, over (B)&nbsp;any exercise price payable in connection with such exercise. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors is not obligated to treat all stock awards or portions of stock awards in the same manner. The Board of Directors may
take different actions with respect to the vested and unvested portions of a stock award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the 2013 Plan, a transaction
will be deemed to occur in the event of a corporate transaction or a change in control. A corporate transaction generally means the consummation of (i)&nbsp;a sale or other disposition of all or substantially all of our consolidated assets,
(ii)&nbsp;a sale or other disposition of at least 90% of our outstanding securities, (iii)&nbsp;a merger, consolidation or similar transaction following which we are not the surviving corporation, or (iv)&nbsp;a merger, consolidation or similar
transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A change of control generally means (i)&nbsp;the acquisition by a person or entity of more than 50% of our combined voting power other than by
merger, consolidation or similar transaction; (ii)&nbsp;a consummated merger, consolidation or similar transaction immediately after which our stockholders cease to own more than 50% of the combined voting power of the surviving entity; (iii)&nbsp;a
consummated sale, lease or exclusive license or other disposition of all or substantially of our consolidated assets; (iv)&nbsp;the complete dissolution or liquidation of the Company; or (v)&nbsp;when a majority of the board of directors becomes
comprised of individuals whose nomination, appointment, or election was not approved by a majority of the board members or their approved successors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Change in Control. </I>Under the 2013 Plan, a stock award may be subject to additional acceleration of vesting and exercisability upon or
after a change in control, as may be provided in the stock award agreement or other written agreement with the participant. In the absence of such provision, no such acceleration will occur. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the equity awards granted to the named executive officers during
the fiscal year ended December&nbsp;31, 2016. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Grants of Plan-Based Awards in Fiscal 2016(1) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other<BR>Stock&nbsp;Awards:<BR>Number of<BR>Shares of<BR>Stock&nbsp;or&nbsp;Units<BR>(#)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Option&nbsp;Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Options<BR>(#)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise<BR>or Base<BR>Price of<BR>Options<BR>Awards<BR>Options<BR>($/Sh)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date&nbsp;Fair<BR>Value of<BR>Stock and<BR>Option<BR>Awards<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alfred E.&nbsp;Mann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">389,913</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,793,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/19/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">910,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna, Pharm.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/19/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">72,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/19/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,209,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson, Ph.D., J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">403,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/19/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">364,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Urbanski, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">403,788</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/19/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">364,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">All equity awards were granted under the 2013 Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The shares subject to these restricted stock units vest annually over a four-year period. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">The shares subject to these options have exercise prices equal to the fair market value of our common stock on the date of grant and vest over a four-year period with a one-year 25% cliff vesting and monthly thereafter
over the following three years. These options expire ten years from the date of grant. Vesting ceases should the executive officer no longer provide continuous service to us. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Outstanding Equity Awards at Fiscal Year End </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth summary information regarding the outstanding equity awards at December&nbsp;31, 2016 granted to each of our
named executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:17.50pt; font-size:7pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options <BR>(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options <BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of&nbsp;Shares<BR>or Units<BR>of Stock<BR>That<BR>Have&nbsp;Not<BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value<BR>of&nbsp;Shares<BR>or Units<BR>of Stock<BR>That<BR>Have&nbsp;Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan&nbsp;Awards:<BR>Number of<BR>Unearned<BR>Shares,<BR>Units or<BR>Other<BR>Rights That<BR>Have Not <BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan&nbsp;Awards:<BR>Market or<BR>Payout&nbsp;Value&nbsp;of<BR>Unearned<BR>Shares,<BR>Units or Other<BR>Rights That<BR>Have
Not<BR>Vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Alfred E. Mann</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,060</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,000</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,000</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,280</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,325</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,624</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">(17)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">(24)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,060</TD>
<TD NOWRAP VALIGN="bottom">(7)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,480</TD>
<TD NOWRAP VALIGN="bottom">(11)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/28/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/13/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,600</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,380</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/2/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,700</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">(24)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,400</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,000</TD>
<TD NOWRAP VALIGN="bottom">(17)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/23/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,667</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">(14)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,063</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,617</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">970</TD>
<TD NOWRAP VALIGN="bottom">(12)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,820</TD>
<TD NOWRAP VALIGN="bottom">(15)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,640</TD>
<TD NOWRAP VALIGN="bottom">(15)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,415</TD>
<TD NOWRAP VALIGN="bottom">(16)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,853</TD>
<TD NOWRAP VALIGN="bottom">(18)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269,060</TD>
<TD NOWRAP VALIGN="bottom">(19)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">(20)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Michael Castagna</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,840</TD>
<TD NOWRAP VALIGN="bottom">(21)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">(20)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">(22)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">David Thomson</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/13/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,400</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/19/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,380</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/2/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,320</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/17/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">(10)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000</TD>
<TD NOWRAP VALIGN="bottom">(24)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/17/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">(9)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,000</TD>
<TD NOWRAP VALIGN="bottom">(17)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/23/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,333</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,667</TD>
<TD NOWRAP VALIGN="bottom">(13)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/22/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450</TD>
<TD NOWRAP VALIGN="bottom">(14)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,063</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,617</TD>
<TD NOWRAP VALIGN="bottom">(8)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">970</TD>
<TD NOWRAP VALIGN="bottom">(12)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,820</TD>
<TD NOWRAP VALIGN="bottom">(15)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,640</TD>
<TD NOWRAP VALIGN="bottom">(15)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/26/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,415</TD>
<TD NOWRAP VALIGN="bottom">(16)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,780</TD>
<TD NOWRAP VALIGN="bottom">(19)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">(20)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Raymond Urbanski</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,820</TD>
<TD NOWRAP VALIGN="bottom">(23)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,640</TD>
<TD NOWRAP VALIGN="bottom">(23)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/10/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,415</TD>
<TD NOWRAP VALIGN="bottom">(16)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,780</TD>
<TD NOWRAP VALIGN="bottom">(19)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">(20)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5/18/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;15, 2007. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth&nbsp;anniversary of the vesting determination date. The vesting commencement date
is August&nbsp;13, 2008. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;19, 2009. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;19, 2010. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 25% each anniversary thereafter; being fully vested on the second anniversary of the vesting determination date. The vesting commencement date is
March&nbsp;3, 2011. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;18, 2011. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
April&nbsp;21, 2008. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;21, 2014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;16, 2012. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of four vesting determination dates over two years; being fully vested on the second year anniversary of the vesting determination date. The vesting commencement date is May&nbsp;17, 2012.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Performance based non-qualified option grant on April&nbsp;28, 2008, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is August&nbsp;21, 2014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;22, 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(14)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is August&nbsp;22, 2013. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(15)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;27, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(16)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is August&nbsp;27, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(17)</TD>
<TD ALIGN="left" VALIGN="top">Performance based non-qualified option grant on May&nbsp;23, 2013, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(18)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
January&nbsp;10, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(19)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
February&nbsp;18, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(20)</TD>
<TD ALIGN="left" VALIGN="top">Performance based non-qualified option grant on May&nbsp;18, 2016, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(21)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
March&nbsp;14, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(22)</TD>
<TD ALIGN="left" VALIGN="top">Restricted Stock Unit Award: 25% vest on each year anniversary of the vesting determination date; shares shall fully vest on the fourth year anniversary of the vesting determination date. The vesting commencement date
is May&nbsp;19, 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(23)</TD>
<TD ALIGN="left" VALIGN="top">25% vesting on the anniversary of the vesting determination date and 1/48th&nbsp;per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. The vesting commencement date is
August&nbsp;10, 2015. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(24)</TD>
<TD ALIGN="left" VALIGN="top">Performance based non-qualified option grant on May&nbsp;17, 2012, which shall vest upon the achievement of certain corporate objectives. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>O<SMALL>PTION</SMALL> E<SMALL>XERCISES</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> V<SMALL>ESTED</SMALL> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table contains information relating to the exercise of options and vesting of stock by the named executive officers during the
fiscal year ended December&nbsp;31, 2016. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Option Exercises and Stock Vested in Fiscal 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares&nbsp;Acquired<BR>on Exercise<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized&nbsp;on<BR>Exercise<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares&nbsp;Acquired<BR>on Vesting<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized&nbsp;on<BR>Vesting<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alfred E. Mann</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew J. Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael E. Castagna</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Thomson,&nbsp;Ph.D.,&nbsp;J.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Urbanski, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,703</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Stock awards acquired on vesting represent restricted stock awards that vest annually over a four-year period. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>P<SMALL>OTENTIAL</SMALL> P<SMALL>AYMENTS</SMALL> <SMALL>UPON</SMALL> T<SMALL>ERMINATION</SMALL>
<SMALL>OR</SMALL> C<SMALL>HANGE</SMALL> <SMALL>OF</SMALL> C<SMALL>ONTROL</SMALL> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Estimated Potential Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into severance agreements with Mr.&nbsp;Pfeffer and Dr.&nbsp;Thomson, and change of control agreements with each named
executive officer. The table below sets forth the estimated current value of payments and benefits to each of the named executive officers upon termination or change of control. The amounts shown assume that the triggering event occurred on
December&nbsp;31, 2016 and do not include other benefits earned during the term of the named executive officer&#146;s employment that are available to all salaried employees, such as accrued vacation and benefits paid by insurance providers under
life and disability policies. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Triggering Event</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Termination<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change&nbsp;in<BR>Control<BR>($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew&nbsp;J.&nbsp;Pfeffer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,082,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,168,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,261,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,218,873</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael&nbsp;E.&nbsp;Castagna,&nbsp;Pharm.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">709,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">791,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David&nbsp;Thomson, Ph.D.,&nbsp;J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">905,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">975,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,730</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,209</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,019,569</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,032,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond Urbanski, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lump sum cash payment</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continuing health and welfare benefits(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Value of extending exercisability term of stock options(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intrinsic value of accelerated unvested stock options(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,688</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">922,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents the estimated cost of providing or paying for continuing medical and dental coverage for 18&nbsp;months. The amounts for medical and dental insurance coverage are based on rates charged to our employees for
post-employment coverage provided in accordance with the Consolidated Omnibus Reconciliation Act of 1985, or COBRA. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents the fair value of the stock options held by the named executive officer that would be exercisable for a period ending on the earlier of 18&nbsp;months following the triggering event or the end of the original
term of the option. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Per SEC rules, the intrinsic value of accelerated unvested stock options shown in the table above was calculated using the closing price of our common stock of $0.64 on December&nbsp;31, 2016. The intrinsic value is the
aggregate spread between $0.64 and the exercise price of the accelerated options, if less than $0.64. Accelerated options with exercise prices equal or greater than $0.64 have no intrinsic value. Each of the named executive officer also has an
extended exercise period ending on the earlier of 18&nbsp;months following the triggering event or the end of the original term of the option. There is no fair value calculated for this extended exercise period. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Represents estimated current value of payments and benefits payable upon termination without cause or resignation for good reason following a change of control. The terms of change of control agreements with our named
executive officers are detailed under the heading &#147;Change of Control Agreements&#148; below. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Severance
Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into executive severance agreements with Mr.&nbsp;Pfeffer and Dr.&nbsp;Thomson. Each agreement is for a
period of two years and will be automatically renewed for additional one-year periods unless either party gives notice to terminate the agreement at least 90&nbsp;days prior to the end of its initial term or any subsequent term. In addition, we
entered into a severance agreement with Mr.&nbsp;Kocinsky in January 2013, which was terminated in December 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agreements provide
that each executive is an &#147;at will&#148; employee and that his or her employment with us may be terminated at any time by the employee or us. Under the agreements, in the event we terminate an executive&#146;s employment without cause (as
defined below) or the employee terminates his or her employment with us for good reason (as defined below), the employee is generally entitled to receive the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the portion of the employee&#146;s annual base salary earned through the termination date that was not paid prior to his or her termination, if any; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any compensation previously deferred by the employee and any accrued paid time-off that the employee is entitled to under our policy; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on the condition the employee executes and does not revoke a general release and settlement agreement, or release, in favor of us, then the employee will become entitled to receive: </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the employee&#146;s annual base salary on the date of termination for a period of 18&nbsp;months following his or her termination, subject to certain limitations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an amount equal to the average annual bonus received by the employee for the three years prior to his termination (or the prior period up to three years during which the employee was one of our executive officers and
received a bonus); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event the employee met the performance criteria for earning an annual bonus prior to his or her termination, a portion of the annual bonus earned for the year based on the number of days worked during the year;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event that the employee did not meet the performance criteria for earning an annual bonus prior to his or her termination, but the Board determines that all such criteria could have been satisfied if the employee
remained employed for the full fiscal year, then a portion of his or her average annual bonus for the three years prior to his or her termination, based on the number of days worked during the year; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">health insurance and, under certain circumstances, life, disability and other insurance benefits for a period expiring on the earlier of 18&nbsp;months following his or her termination or until he qualifies for related
benefits from another employer. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the executive severance agreements provide that, on the condition the employee
executes and does not revoke a release, each vested stock option held by the employee on the date of termination will be exercisable for a period ending on the earlier of 18&nbsp;months following that date or the end of the original term of the
option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, an employee may be terminated for cause if he or she, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuses to carry out or satisfactorily perform any of his lawful duties or any lawful instruction of our Board of Directors or senior management; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">violates any local, state or federal law involving the commission of a crime other than a minor traffic offense; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">is grossly negligent, engages in willful misconduct or breaches a fiduciary obligation to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">engages in any act that materially compromises his or her reputation or ability to represent us with investors, customers or the public;&nbsp;or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reaches a mandatory retirement age established by us. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, good reason
includes, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a reduction of the executive&#146;s annual base salary to a level below his or her salary as of October&nbsp;10, 2007 (April&nbsp;21, 2008 in the case of Mr.&nbsp;Pfeffer); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a material diminution in the executive&#146;s position, authority, duties or responsibilities with us, subject to certain limitations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an order by us to relocate the executive to an office located more than 50&nbsp;miles from the executive&#146;s current residence and worksite; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any non-renewal of the executive severance agreement by us, on the condition that the executive may terminate the agreement for good reason only during the 30-day period after he or she receives notice from us that we
intend to terminate the agreement;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any material violation of the executive severance agreement by us. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, an
employee must inform us if he intends to terminate his or her agreement for good reason. We have 30&nbsp;days from the date we receive notice of the employee&#146;s intent to terminate the agreement for good reason to cure the default. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Change of Control Agreements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into change of control agreements with each named executive officer. Each agreement is for a period of two years and will be
automatically renewed for additional one-year periods unless either party gives notice to terminate the agreement at least 90&nbsp;days prior to the end of its initial term or any subsequent term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, a change of control will be deemed to occur upon: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction that results in a person or group acquiring beneficial ownership of 50% or more of our voting stock, other than us or one of our employee benefit plans; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any merger, consolidation or reorganization of us in which our stockholders immediately prior to the transaction hold less than 50% of the voting power of the surviving entity following the transaction, subject to
certain limitations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction in which we sell all or substantially all of our assets, subject to certain limitations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our liquidation;&nbsp;or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any reorganization of our Board of Directors in which our incumbent directors (as defined in the agreements) cease for any reason to constitute a majority of the members of our Board. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agreements provide that in the event of a change of control, the employee is generally entitled to maintain the same position, authority
and responsibilities held before the change of control, as well as the following compensation and benefits during the period ending on the earlier of two&nbsp;years following the change of control or the termination of his or her employment with us:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">his or her annual base salary in an amount equal or greater to his or her annual salary as of the date the change of control occurs; </TD></TR></TABLE>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an annual bonus in an amount equal to the average annual bonus received by him or her for the three years prior to his or her termination (or the prior period up to three years during which he was one of our executive
officers and received a bonus); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">medical, dental and other insurance, and any other benefits we may offer to our executives;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">prompt reimbursement for all reasonable employment expenses incurred by him or her in accordance with our policies and procedures. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the change of control agreements, we may terminate an executive with or without cause (as defined below) and the executive may terminate
his or her employment with us for good reason (as defined below) or any reason at any time during the two-year period following a change of control. In the event we terminate an executive without cause or an executive terminates his or her
employment with us for good reason, he or she is generally entitled to receive the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the portion of his or her annual base salary earned through the termination date that was not paid prior to his termination, if any; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any compensation previously deferred by the employee and any accrued paid time-off that the employee is entitled to under our policy; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on the condition the employee executes and does not revoke a release, then the employee will become entitled to received: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">continuation of the employee&#146;s annual base salary on the date of termination for a period of 18&nbsp;months following his or her termination, subject to certain limitations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an amount equal to 150% of his or her average annual bonus received by the employee for the three years prior to his or her termination (or the prior period up to three years during which the employee was one of our
executive officers and received a bonus); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event the employee met the performance criteria for earning an annual bonus prior to his or her termination, a portion of the annual bonus earned for the year based on the number of days worked during the year;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event that the employee did not meet the performance criteria for earning an annual bonus prior to his or her termination, but the Board determines that all such criteria could have been satisfied if the employee
remained employed for the full fiscal year, then a portion of his or her average annual bonus for the three years prior to his or her termination, based on the number of days worked during the year; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on the condition the employee executes a release, health insurance and, under certain circumstances, life, disability and other insurance benefits for a period expiring on the earlier of 18&nbsp;months following his or
her termination or until he qualifies for related benefits from another employer. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the agreements provide that,
on the condition the employee executes and does not revoke a release, each equity award held by him or her as of the termination date will become fully vested and exercisable at any point during the term of the option, subject to certain
limitations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the agreements, in the event we terminate an employee with cause or an employee terminates his or her employment with
us without good reason, his or her agreement will terminate without any further obligation to either party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The change of control
agreements provide that an employee may be terminated for cause if he or she, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refuses to carry out or satisfactorily perform any of his or her lawful duties or any lawful instruction of our Board of Directors or senior management; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">violates any local, state or federal law involving the commission of a crime other than a minor traffic offense; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">is grossly negligent, engages in willful misconduct or breaches a fiduciary obligation to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">engages in any act that materially compromises his reputation or ability to represent us with investors, customers or the public;&nbsp;or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reaches a mandatory retirement age established by us before a change of control occurs. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under
the agreements, good reason includes, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a material diminution in the employee&#146;s position, authority, duties or responsibilities with us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an order by us to relocate the employee to an office located more than 50&nbsp;miles from the employee&#146;s current residence and worksite; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any non-renewal of the change of control agreement by us, on the condition that the employee may terminate the agreement for good reason only during the 30-day period after he receives notice from us that we intend to
terminate the agreement;&nbsp;and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any material violation of the change of control agreement by us. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the change of control
agreements, an employee must inform us if he or she intends to terminate his or her agreement for good reason. We have 30&nbsp;days from the date we receive notice of the employee&#146;s intent to terminate the agreement for good reason to cure the
default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The executive severance agreements and the change of control agreements with Mr.&nbsp;Pfeffer and Dr.&nbsp;Thomson provide that
in the event such executive becomes entitled to benefits under both agreements, compensation payments and other benefits will be coordinated to ensure the executive is entitled to receive the benefits described above without duplicating coverage.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain information with respect to all of our equity compensation plans in effect as of December&nbsp;31, 2016.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Equity Compensation Plan Information </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities&nbsp;to&nbsp;be<BR>Issued Upon Exercise of<BR>Outstanding Options,<BR>Warrants and Rights<BR>(#)(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-Average<BR>Exercise Price of<BR>Outstanding&nbsp;Options,<BR>Warrants and Rights<BR>($)(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities<BR>Remaining&nbsp;Available&nbsp;for<BR>Issuance Under Equity<BR>Compensation Plans<BR>(Excluding Securities<BR>Reflected in
Column (a)<BR>(#)(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,973,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,286,370</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes 3,743,013 shares available for issuance under the 2013 Plan and 445,783 shares available for purchase under our Employee Stock Purchase Plan </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2016, we did not have any equity compensation plans that were not approved by our security holders. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and shall not be
incorporated by reference into any filing of MannKind under the Securities Act or the Exchange Act, except to the extent MannKind specifically incorporates this report by reference. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis contained in this proxy
statement. Based on this review and discussion, the Compensation Committee has recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement and incorporated into our Annual Report on
Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2016. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:52%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:52%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Kent Kresa, Compensation Committee Chairman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:52%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Michael&nbsp;A.&nbsp;Friedman,&nbsp;Compensation&nbsp;Committee Member </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:52%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">James&nbsp;S.&nbsp;Shannon,&nbsp;Compensation&nbsp;Committee Member </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC and shall not be
incorporated by reference by any general statement incorporating by reference this proxy statement into any filing of MannKind under the Securities Act or the Exchange Act, except to the extent MannKind specifically incorporates this report by
reference. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In discharging its oversight responsibility as to the audit process, the Audit Committee obtained from Deloitte&nbsp;&amp;
Touche LLP the written disclosures and the letter describing all relationships between MannKind and its independent auditors that might bear on the auditors&#146; independence consistent with applicable requirements of the Public Company Accounting
Oversight Board (&#147;PCAOB&#148;) regarding the independent accountant&#146;s communications with the Audit Committee concerning independence, and has discussed Deloitte&#146;s independence with Deloitte. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee discussed with Deloitte the matters required to be discussed by the applicable Public Company Accounting Oversight Board
(&#147;PCAOB&#148;) standards. In addition, with and without management present, the Audit Committee discussed and reviewed MannKind&#146;s financial statements and the results of Deloitte&#146;s audit of MannKind&#146;s financial statements. Based
upon the Audit Committee&#146;s discussion with management and Deloitte and the Audit Committee&#146;s review of MannKind&#146;s financial statements, the representations of MannKind&#146;s management and the independent auditors&#146; report to the
Audit Committee, the Audit Committee recommended to the Board of Directors that MannKind include the audited financial statements in its Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2016, for filing with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee Charter provides that one duty of the Audit Committee is to determine whether to retain or to terminate MannKind&#146;s
existing auditors or to appoint and engage new auditors for the ensuing year. In performing that duty, the Audit Committee evaluated the performance of Deloitte in performing the examination of MannKind&#146;s financial statements for the fiscal
year ended December&nbsp;31, 2016, and determined to engage Deloitte as MannKind&#146;s independent auditors for the fiscal year ending December&nbsp;31, 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Audit Committee</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Ronald J. Consiglio, Audit Committee Chair </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">David H. MacCallum, Audit Committee Member </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Henry L. Nordhoff, Audit Committee Member </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires our directors, executive officers and any persons beneficially holding more than 10% of our
common stock to report their initial ownership of our common stock and any subsequent changes in that ownership to the SEC. Our executive officers, directors and greater than 10% stockholders are required by SEC regulation to furnish us with copies
of all Section&nbsp;16(a) forms they file. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specific due dates for these reports have been established and we are required to identify
those persons who failed to timely file these reports. To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations from our directors and officers that no other reports were required, during
the fiscal year ended December&nbsp;31, 2016, all of our directors, officers and greater than 10% stockholders complied with the Section&nbsp;16(a) filing requirements. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RELATED-PERSON TRANSACTIONS POLICY AND PROCEDURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Related-Person Transactions Policy sets forth the policies and procedures regarding the identification, review,
consideration and approval or ratification of &#147;related-persons transactions.&#148; For purposes of the Company&#146;s policy only, a &#147;related-person transaction&#148; is a transaction, arrangement or relationship (or any series of similar
transactions, arrangements or relationships) in which the Company and any &#147;related person&#148; are, were or will be participants involving an amount that exceeds $120,000. Transactions involving compensation for services provided to the
Company as an employee, consultant or director are not covered by this policy. A related person is any executive officer, director, or more than 5% beneficial stockholder of the Company, including any of their immediate family members, and any
entity owned or controlled by such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, where a transaction has been identified as a related-person transaction,
management must present information regarding the proposed related-person transaction to the Audit Committee (or, where Audit Committee approval would be inappropriate, to another independent body of the Board) for consideration and approval or
ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to the Company of the transaction and whether any alternative transactions
were available. To identify related-person transactions in advance, the Company relies on information supplied by its executive officers, directors and significant stockholders. In considering related-person transactions, the Audit Committee takes
into account the relevant available facts and circumstances including, but not limited to (a)&nbsp;the risks, costs and benefits to the Company, (b)&nbsp;the impact on a director&#146;s independence in the event the related person is a director,
immediate family member of a director or an entity with which a director is affiliated, (c)&nbsp;the terms of the transaction, (d)&nbsp;the availability of other sources for comparable services or products and (e)&nbsp;the terms available to or
from, as the case may be, unrelated third parties or to or from employees generally. In the event a director has an interest in the proposed transaction, the director must recuse himself or herself form the deliberations and approval. The policy
requires that, in determining whether to approve, ratify or reject a related-person transaction, the Audit Committee consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, the best interests of the
Company and its stockholders, as the Audit Committee determines in the good faith exercise of its discretion. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN TRANSACTIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of transactions or series of transactions since January&nbsp;1, 2016 to which we have been a party, in
which the amount involved in the transaction or series of transactions exceeded $120,000, and in which any of our directors, executive officers or persons who we knew held more than five percent of any class of our capital stock, including their
immediate family members, had or will have a direct or indirect material interest, other than compensation arrangements, which are described under &#147;Management.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>RANSACTIONS</SMALL> <SMALL>WITH</SMALL> <SMALL>THE</SMALL> M<SMALL>ANN</SMALL> G<SMALL>ROUP</SMALL>
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are the borrower under a loan arrangement with The Mann Group, which is one of our principal stockholders and of which
Mr.&nbsp;Mann was the sole member and manager.&nbsp;Outstanding principal amounts bear interest at a fixed rate of 5.84%, are due and payable quarterly in arrears on the first day of each calendar quarter for the preceding quarter, or at such other
time as the Company and The Mann Group mutually agree. All or any portion of accrued and unpaid interest that becomes due and payable may be paid-in-kind and capitalized as additional borrowings at any time upon agreement of the parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2016, the largest outstanding principal amount under the Loan Arrangement was $49,520,906. As of March&nbsp;31, 2017,
the outstanding principal amount under the Loan Arrangement was $49,520,906. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2016, we have not repaid any of
outstanding principal under the Loan Arrangement or the accrued interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional details regarding the terms of the Loan
Arrangement, please refer to Note 7 to our consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2016, as filed with the SEC on March&nbsp;16, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2015, we entered into a sublease agreement with the Alfred Mann Foundation for Scientific Research (the &#147;Mann Foundation&#148;), a
California Not For Profit Corporation. The lease is for approximately 12,500 square feet of office space in Valencia, California and expires in April 2017. The office space contains our principal executive offices. Lease payments to the Mann
Foundation for the year ended December&nbsp;31, 2016 were $290,458. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of
Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials
addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This year, a number of brokers with account holders who are MannKind stockholders will be &#147;householding&#148; our proxy materials. A
single Notice of Internet Availability of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker
that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in
&#147;householding&#148; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials, please notify your broker, direct your written request to MannKind Corporation, Investor Relations, 25134 Rye Canyon Loop, Suite 300,
Valencia, CA 91355 or contact David Thomson at (661)&nbsp;775-5300. Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials at their address and would like to request &#147;householding&#148; of
their communications should contact their broker. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNUAL REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A COPY OF OUR ANNUAL REPORT ON FORM&nbsp;10-K FOR THE FISCAL YEAR ENDED DECEMBER&nbsp;31, 2016, FILED WITH THE SEC ON MARCH&nbsp;16, 2017, IS
AVAILABLE WITHOUT CHARGE UPON WRITTEN REQUEST TO: MANNKIND CORPORATION, INVESTOR RELATIONS, 25134 RYE CANYON LOOP, SUITE 300, VALENCIA, CA 91355. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER MATTERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board
of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on
such matters in accordance with their best judgment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:54%; text-indent:-2%">


<IMG SRC="g366702g09k79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">David Thomson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Vice President, General Counsel and Secretary</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Valencia, California 91355 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;7, 2017 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:1px" ALIGN="center">


<IMG SRC="g366702r1.jpg" ALT="LOGO">
</P></TD></TR></TABLE> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ANNUAL MEETINg OF STOCKHOLDERS OF MANNKIND CORPORATION </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Date: May&nbsp;18, 2017 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Time: 10:00 A.M. (Eastern
Daylight Time) </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Place: MannKind Corporation, 40 Taylor Street, Danbury, CT 06810 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please make your marks like this: Use dark black pencil or pen only </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Board of Directors Recommends a Vote FOR all nominees in proposal 1, One Year for proposal 3 and FOR proposals 2 and 4.
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1: To elect the seven nominees named herein as directors to serve for the ensuing year and until their
successors are elected; </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">01 Matthew J. Pfeffer 02 James S. Shannon, MD, MRCP (UK) 03 Ronald J. Consiglio 04
Michael A. Friedman, MD 05 Kent Kresa 06 David H. MacCallum 07 Henry L. Nordhoff Recommend Directors For Withhold For For For For For For For 2: To compensation approve, on of an the advisory named basis, executive the officers proxy of MannKind,
statement as for disclosed the Annual in MannKind&#146;s Meeting; 3: To preferred indicate, frequency on an advisory of stockholder basis, the advisory vote executive on the officers compensation of MannKind; of the and named 4: To of the ratify
Board the selection of Directors by the of Deloitte Audit Committee&nbsp;&amp; Touche accounting LLP as the independent firm of MannKind registered for its public fiscal year ending December&nbsp;31, 2017. For Against Abstain 1 year 2 years 3 years
Abstain 1 Year For Against Abstain For Authorized Signatures&#151;This section must be completed for your Instructions to be executed. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please Sign Here Please Date Above Please Sign Here Please Date Above Please sign exactly as your name(s) appears on your stock certificate. If held in joint tenancy, all persons should
sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the proxy. EVENT # CLIENT # Please separate carefully at the perforation and
return just this portion in the envelope provided. Annual Meeting of MannKind Corporation to be held on Thursday, May&nbsp;18, 2017 for Holders as of March&nbsp;27, 2017 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">This proxy is being solicited on behalf of the Board of Directors VOTE BY: INTERNET TELEPHONE Call Go www. To proxypush.com/mnkd <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">866-437-3716</FONT></FONT> Cast your vote online. &#149; Use any touch-tone telephone. &#149; OR View Documents. &#149; Have your Proxy Card/Voting Instruction Form ready. &#149; Meeting &#149; Follow the simple recorded
instructions. MAIL OR &#149; Mark, sign and date your Proxy Card/Voting Instruction Form. &#149; Detach your Proxy Card/Voting Instruction Form. &#149; Return your Proxy Card/Voting Instruction Form in the postage-paid envelope provided. The
undersigned hereby appoints David Thomson and Rosabel R. Alinaya, and each of them, with power to act without the other and with power of substitution, as proxies and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and hereby authorizes them to represent and vote, as provided on the other side, all the shares of MannKind Corporation Common Stock which the
undersigned is entitled to vote, and, in their discretion, to vote upon such other business as may properly come before the Annual Meeting of Stockholders of the MannKind Corporation to be held May&nbsp;18, 2017 or at any adjournment or postponement
thereof, with all powers which the undersigned would possess if present at the Meeting. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE
VOTED FOR ALL NOMINEES IN PROPOSAL 1, ONE YEAR FOR PROPOSAL 3 AND FOR PROPOSALS 2 AND 4. All votes must be received by 5:00 P.M., Eastern Daylight Time, May&nbsp;17, 2017. PROXY TABULATOR FOR MANNKIND CORPORATION c/o MEDIANT COMMUNICATIONS P.O. BOX
8016 CARY, NC 27512-9903 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:1px" ALIGN="center">


<IMG SRC="g366702r2.jpg" ALT="LOGO">
</P></TD></TR></TABLE> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please separate carefully at the perforation and return just this portion in the envelope provided. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Proxy &#151; MannKind Corporation </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Annual Meeting
of Stockholders </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">May&nbsp;18, 2017, 10:00 a.m. (Eastern Daylight Time) </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">This Proxy is Solicited on Behalf of the Board of Directors </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The undersigned hereby appoints David Thomson and Rosabel R. Alinaya, and each of them, with power to act without the
other and with power of substitution, as proxies and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and hereby authorizes them to represent and vote, as provided on the other side, all the shares of
MannKind Corporation Common Stock which the undersigned is entitled to vote, and, in their discretion, to vote upon such other business as may properly come before the Annual Meeting of Stockholders of the MannKind Corporation to be held
May&nbsp;18, 2017 or at any adjournment or postponement thereof, with all powers which the undersigned would possess if present at the Meeting. The purpose of the Annual Meeting is to take action on the following: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1. To elect the seven nominees named herein as directors to serve for the ensuing year and until their successors are
elected; </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">01 Matthew J. Pfeffer 04 Michael A. Friedman, MD 07 Henry L. Nordhoff </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">02 James S. Shannon, MD, MRCP (UK) 05 Kent Kresa </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">03 Ronald J. Consiglio 06 David H. MacCallum </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2.
To approve, on an advisory basis, the compensation of the named executive officers of MannKind, as disclosed in MannKind&#146;s proxy statement for the Annual Meeting; </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">3. To indicate, on an advisory basis, the preferred frequency of stockholder advisory vote on the compensation of the named executive officers of MannKind; and </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">4. To ratify the selection by the Audit Committee of the Board of Directors of Deloitte&nbsp;&amp; Touche LLP as the
independent registered public accounting firm of MannKind for its fiscal year ending December&nbsp;31, 2017. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. IF NO
DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED FOR ALL NOMINEES IN PROPOSAL 1, ONE YEAR FOR PROPOSAL 3 AND FOR PROPOSALS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2 AND 4. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">To attend the meeting and vote your
shares in person, please mark this box. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g366702g09k79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g366702g09k79.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[17D4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@     !=0   !     !       +<')I;G1/=71P=70    '
M     $-L<E-E;G5M     $-L<E,     4D="0P    !.;2 @5$585    !$
M00!D &\ 8@!E "  4@!' $( (  H #$ .0 Y #@ *0       $EN=&5E;G5M
M     $EN=&4     0VQR;0    !-<$)L8F]O; $    /<')I;G13:7AT965N
M0FET8F]O;      +<')I;G1E<DYA;65415A4    (@!< %P 4 !( %@ 1@!"
M %4 +0!- %< 10 M $8 4  Q #  7 !! %H ,  Q #4 ,0 M %@ 10!2 $\
M6  M #$ .       #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\
M9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M
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M9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$"+6
M"G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M    3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M        4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN
M9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,
M969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!2
M96-T5&]P;&]N9P      .$))30/M       0 \     !  $#P     $  3A"
M24T$)@      #@             _@   .$))300-       $    'CA"24T$
M&0      !    !XX0DE- _,       D           $ .$))32<0       *
M  $          3A"24T$"       $     $   )    "0      X0DE-!!X
M      0     .$))300:      ,U    !@             !G@  !M@
M     0                         !              ;8   !G@
M               !                         !     !        ;G5L
M;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !G@    !2
M9VAT;&]N9P  !M@    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L
M:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M    !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T
M960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   9X     4F=H=&QO;F<   ;8
M W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M   !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O
M;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M
M#T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M   /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E
M;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T
M;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E
M=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M     C_P        .$))3004       $     SA"24T$#      +NP    $
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MU67.8RY\X]K&.:6TY%[*FT4?9Z'M9=D44_:LI_Z2FFS_  M7A"22GW>WK_\
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M &( 90 @ %  : !O '0 ;P!S &@ ;P!P "  0P!3 #8    ! #A"24T$(@
M   !?DU- "H    (  P!   #     0<,   ! 0 #     0*O   ! @ #
M P   )X!!@ #     0 "   !$@ #     0 !   !%0 #     0 #   !&@ %
M     0   *0!&P %     0   *P!*  #     0 "   !,0 "    '@   +0!
M,@ "    %    -*':0 $     0   .@   $@  @ "  ( (6#L   )Q  A8.P
M   G$$%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,38Z,#0Z,C$@
M,3$Z,3 Z,#D     !)    <    $,#(R,: !  ,    !__\  * "  0    !
M   &V* #  0    !   !G@         & 0,  P    $ !@   1H !0    $
M  %N 1L !0    $   %V 2@  P    $  @   @$ !     $   %^ @( !
M  $              $@    !    2     $X0DE- _T       @      0
M /_A 8!-30 J    "  , 0   P    $'#    0$  P    $"KP   0(  P
M  ,   "> 08  P    $  @   1(  P    $      14  P    $  P   1H
M!0    $   "D 1L !0    $   "L 2@  P    $  @   3$  @   !X   "T
M 3(  @   !0   #2AVD !     $   #H   !(  (  @ "    \     !   #
MP     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$V.C T.C(Q
M(#$Q.C$P.C Y      20   '    !# R,C&@ 0 #     ?__  "@ @ $
M 0  !MB@ P $     0   9X         !@$#  ,    !  8   $:  4    !
M   !;@$;  4    !   !=@$H  ,    !  (   (!  0    !   !?@("  0
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M 0$! 0$! 0$!_\  $0@ +0#  P$1  (1 0,1 ?_$ !T  0 " @,! 0
M       )"@<(! 4& 0O_Q  M$  !! ,  @$$ @(!!0$    $ @,%!@$'"  )
M"A$2%!43%B$B,A<9(S%"0?_$ !0! 0                    #_Q  4$0$
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M+B:Z(R@@R;DS:C2=RQHH:$.,H8<,EP6"%$,_Q$J=6T,\$(7&O1WNU]H/L.Z
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M=3PPQY_GG8FTB11VVG9*^]"[H",/>;Q],F&,ZUN&O(O\AU7^[C8D<*%G/^J
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MG 9"E8F*GHTR'G(R/F8B186+(14J$-(QIXSG^'!S 3&WA2F%X_YLOM+;5_\
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M3^J>@(7H7\QDT:7ZHM-;VGK^W"M#+'<A+ ?2=:T^[5HM:L!N"6T5RXH '$?
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%$MD/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g366702r1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g366702r1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@">@,J P$1  (1 0,1 ?_$ ,@  0 " @,! 0$
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MA,<DU4UCEMW[\7+\M]099<>SM9X^*<IWSMRSG'#V5E$5C><7E$XZWK,7MJ>
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M/=E$U,XS,S,5ENF=E1IE>40V]X/T#H/1Z7(-]+YQ(YA98Q?4'8%YXH^S*@2
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M9=WGEQ]KS<?)GA_=&.493C]\1,UTGKY)YGKGEF P& P& P& P& P& P& P&
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MOGAS9\?-'/AIR8Y1E'WQ-Q_%TRX,<^.>'*;PG&8G[JU26!^2UJA].X)Y /\
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MT_ELJ35>L$.4"*S9WNJ<^;ZNQ+ZWYR$^CA9LIYPU(5T)OGU6"E-B#M@CO28
MXG'>^/SM-.+22<*BR)^6<C=^#63O'&?+5EOHRI^FA'G@Q6K)U>G<V-.".DVO
MGE9\^=C$++BBC!.A]PC=7 %8/Z-NPA<MQYS;GT%IV-FM3/@[Q;\JQYA71AU:
M\EW>Y6;@ _L%Q])@1'3J/%US/FG%+.NHV0_6292/#B]*MU@+B3:@@*/J#][&
M!25NS(RW(K3XV>O5/>$_E+Y=WWML3A]8H5G&GIOH'KW%HA(H3'-Q"55YOS2T
M=&K?:@L;Z")):B=&53"H>,E'RR(!<;*9D:_PM;6)PF(OT>HN&# 8# 8# 8#
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MHY,=8\LHTRC\,HF(]%IYZ5[0P& P& P& P& P& P& P& P& P& P& P& P&
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M^RU:M'8<R2/!NID3--MK2[L>W6J\?Y,IY8XKZ=\]>D_;?3+3R?JU@JGKT/\
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ML[7\?GVTWM?QU\-_-M&OF^.OT^&_CAX[EP& P& P& P& P& P& P& P& P&
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MNA1.%%%,2OHOJ<_<F5*-S$*OL_HWM%9_G@L5UI^FB!<N]$2C86M\U8@\IZR
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MJ[/!-.[:0XZD9I3NMN[7O9F5XX0P& P& P& P& P& P& P& P& P& P& P&
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MRCP\BJ2_%BZ3J.7;:;'_ ,@,FMRCLPMQF.JJ@U728Y(@]*ARKH0&UCI?5^7
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M;!SFRU"O>D.D<GOB/;_7O?U/ZL&8H4FQ\UZ)W95^!V(+""GQ$@'.JC +HI:
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M=%\A5<<7BPX2-%&VY$4G)AR)+C&UEK"_#K^C9[GC/>^/_B1X )JJ?1?-]/\
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MKVE6MIWO6!%^=<RYQR"ICZ'RB@TSF=($KE.#*A0:R&J-9@.S9"Y<UZ(# 0H
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M& P& P& P& P& P& P& P& P& P& P&!KWVSS70^[S \ZTE[N!>@ +)23?\
M"+(JNIO'-KI("2KCS2X_"',7/J-E>KL3;_VRHA%E+:TQI;"7Y&G2Q-*YM'A3
MAEGWJ1\+B"+1YUG("3H*P,MD@$FY7WI_0+*L(DF,*C8:B,_L=@A)5N.MR*/F
M(3&4R]'COM%W2V#,\IIYTAS$B0C3W7>1S2<^GM;)S'64NEZ*?YU,08^Y<?>-
M-KK-EE(_UA:U[>4EW:MKU\=DMJ3%_&_P*'NI;C&NIM)I"Q+->:3;X/T( 6L'
M^<6.FUN)'_C_ -$<*JD_E(;3;D1,>>3;:=T6DD-ONJ47=*^C_F+DMHYGS7D1
MT44(47E5=DU2L"W#4YMYP',XY;^$R8A>>PMJ804YS^[SVOJ?.AQ,M3<A*M.-
MIWA+F[?/*_--$Y1:9=\'%[K:KZ7%&Q5DN=U/,EC=HT>*@R<H@;1 '"!*R,9F
MLCH4=<>+'0S!AMMZ1\?F6H3-Q7@IGC?@KFO.ZS5A]V/VCJEDKK,R"HQ82;K
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MY];WKYWDZ_TX6<<L>L-P,,F P& P& P& P& P& P& P& P& P& P& P& P&
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M()_,.G?;$H>F$;?91]5&$F*;&X0P& P& P& P& P& P& P& P& P& P& P&
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M28L,<N*E15PH[SDE$F,ZUM&EMK3H5*W=)1O6MZ2C>MZ^.MZUK>MZW_9O6_\
M3K>$?6DIU^NDZUO_ -S6M8'[@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#4CT1YV
M)]>Z_P"-^H -4^#*\Z=]*]+M9(S%<39B5((\&[=S)5;JY*(+F2-O/6GI Z8]
M%??C0UL17'-J4\AI"C4343'F[<3BE@<XIPF@0JKR[ED[FUXY%:BU&YS,*R.:
M5X70;9 /%:Y1)3]8KT^3"^UBJ1"^X&P4J<WKYTMZ_7"7JHX5Y>[4/Y5W>I/6
MX:/-WMVE?93X-X-D4WB15[^=M5[N5FF66I$X%..]EII2-7B41 \S!B,0$;7]
MTQ\&=&MT7$J81X7[^MUE8;L,:.E5=L0]HE Z(:W("V2=Q:O<X<*&"3'/T';;
M,.RA;<:6]&E E,Q(,>7MM][Z<5@;L?):\7QB?E\\]75B13.4UMWT-RD!5 M?
M@6VYV8*&G@-=#CB*N?-'J_HH[7A$,\.^E)BL[984M]B*/8BQHS;@W=/1#"7A
M?K<:7%>J%M#U<22Z1KH-FKE9NQT&W).3>F>A+;JQ_N4^DV-'[I6@G2*VRC4.
M+ DS5AU-HE1$QXKBQNA*O0?DKN'2ND]5LU)M(P+6;U%I^GHCU_*0#AUL' JP
M[]@AOO\ .[&-H@2%*#R23K3C%B:<FHCR!Z1DF85<>$3$0QYWQCW65911*/UJ
M5-!@.JARE=&MWJP"YT6@L2)U[42,DBM4M:IUN!=0NE@:8:BHBNR@#8YK1&+M
MM;*27"PZ+Y%N%>XN4Y*<L 8C#/=%\X6X['18KC*@%!?/A7#F^TP94N:WHFZ[
MT<US\Y(4UM7T"/[GK<S:-OR-:$Y:VJ(3XK[+')51B[7NM$:^/@\:%W0M*Z!?
M'Y'11%8:\[#B7."@>2*B,_L8HIRRPRQSSDMQ91ZTJ;>995)(*<+NAW@WA7J4
M434ZL7O ,C3X*:FNV@';AT*1&L,J)7/+;5U?D;?8T^0W9[AR"SD'MON:W+4;
MTM_^_*F)2CU-T?;\4*C^'?2JYK;Q'L;Y>1'/\\D'G8W3YL+][37*@;&P"&T2
M>4%B(LCSPH9AOPG9$F:3*LPD+:EBEI92D;H;!TWRST5GDMNYA;R->=&V'T+1
M^A[B_P NM1V47YV#N5&/W():+&D-77C)"U1:[/:0WN$VJ5%DM-%94Z2N7-?)
M<6H*%X6]&$Y!*#;[Y4)@650*96)"H=[O^MG;#1^-VBD@[.79_CK)B469MY^/
M,<DR"DA&M#VW8T6*O_#67='\66/^(NXR"4B'5NH0X(0>#Z&. "(?0;(,A59Z
MWC[DN4+E-;J)FR3(M^>MT74[<<H.1 T.1,TU.?3&0T-T+%+^,[:>XESGG[4>
MB54O1;_Z:Z*%%#K+;)H:G%.MN]MG\O;KUD9""C$F;02'21RG9&XL=#*X;BXZ
M%?39ULF[7\D)3XB[E+$7)LITY<D[+E]I+ "[]\,N;E6N[QJ,/K]L_:X-(% 0
MK\\,#*0Y3,Z-85C]S_KZ=G.;4E)=T,Y3_%W71IZD'#EY@R6J2;I1NOP9E[MY
MJ97TA[/Y6EG(+$N-7JX'GN.4KD5K#M+1 B1W(YI#6F6&)4M+8W0]0,,& P&
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MB2X1;A,0WG\+LFK2?C'Y/>&^C/6-;\T\.AG;P!-<<[-U=[L<D)=*C4Y6^/\
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ML>JS%7!KFCT45$8,?Q^$[\'8@3]P0Y]HTK^\VQ\J=_KK#C*3X# 8# 8# 8#
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M5T#2"3,,BM(>X7!H[58'3I*B4,9*(35;C+;WJ+$;;:@1!<7Z+!\Z\T]"0KM
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M*$FKQO6'9*T+W@4L0BUB/>/'7SI6Q]&K029%]" FZ]8Q)R[T$I2%!*5#Y-'
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ME/YD(\*AEND^BZ+/CBC/3NO5*EUKCO+^FQIM;I'"[;TD7TKHUNOG8GZ3SSI
M"NU6F1"4I5%E&9,=^4J'J,[)^5O19PUJ%QS/S)<';+BPXKAOJ$^Z=N1ZE5^7
M!IW,QT$]-">@8OEJ.7$.V/K@1V77;!W2:@+!E?(G6TH=E/I8BM*=PFR?18]U
M_*GYVHW,>&]>(5+MA2D=V\R=)]<"2 "CB"#M$XQRFK4JT6TOTMERV1=5^>WO
MH0D=':C*G-O$Y:6OJI;_ ,7";)N8\I5:K\UWE"'"H!4Y5>R@0W0:?VJU#BLD
M/SLDQ&?X(*[(:O@5F& Z87+69K0[A9I<(X$C$ZO*W)&IT3TJ>WI)?V\NCG\T
M_EEI_8;F)Y?T+DW0>>]/Z#W&]<YY94XP\$6V0J-<N_2JXV8M!*';IXV'8*<$
MYJ^0M;4!Z;#@-SH>XCLK3^]($X5K'1Z\X8,!@,!@,!@,!@,!@,!@,!@4_P!7
M[A1N-;KFKC^_N?R.1+5K8  0/:!5\2^+C6&[67[%M?[/2ZP^=@I(3E_-J/\
M>-;^7:=JVDL1,H3:/6G&JGRCKO:2!"S/43B%L)4J_28M,LJ2\0\'G@1I-H6
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M1WEEL?*TFC1N.6MX';7UO#*WMHP\Y/7IV9]=8F<H_)>'2.'^-_5OJ2NWRZ]
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M<J,Z2)SZ>2!TSEOXI[K5?ZCMU6U<]$=1ATJ96%3+CVP':J=JR4_RYU^#:X0
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M5,QX0YK;T1[2(LAY6G$.M.%G+\UOTOPI0*1SST?S058944%Z(!6>K3I8FJ5
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ML[T:BD,X-UB55Z#WWIELM/9+-2X/2(PD8+N%>O-DZ-56E3(U8/7HD!=JXV4
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M*UH>4B2W4[4,DR%ZD?%<E2=(;:.>53/MZ-M,,F P& P& P& P& P& P& P&
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M5+BM;=5I'QPW&-3>O\/ZOZD,.1@,!@,!@55TBB<ULIGE=UZ"['B3^-WV5?\
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M;><>.=M@0S6[ P*'<^&TCE\%E;J86T1561MM[:$1F-R!$Z>KM[\ZU>[W:Y=
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MT_!,C&]C2<@!YD#G(T26T\I"G8DJ/(;^/S-K2K6MX7&8F:F/Y_U>[V&# 8#
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MB'LF.9L4M^5*/-09OSM)FNNN.2M)^JI2MJWO9E*L!@,!@,!@,!@,!@,!@,"
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M3K)82;9DH3JC\)J37%N$VX0_4R*R&>9;CK4TES<="/GVI7Q5LDZRM#"& P&
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M>+*.<[]>3+K3(UR1T$F%E]<X5T G)J4KG T-+,A2?F,]T9SICK#L$C.I]3%
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M9Z>5LMC;%6QSH("0W<+I2B!X-4HG.Z3=Z"\,7(M?6-RB%TZS"L5..MD#9!#
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MOBH+K#KLE7U(LLS<6UJ,^./2KWC^Z44I-.V'NUU]-/=FN4RH]/CUW^7H,Q8
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MAY/IG%4\[IU>GSW"TLBQ_3VQV11MF!I<F*F"XF8^V\QM"RQ&-IF#L7Y%Z).
MTF0F^7$:#!\C:HMAF\]Y\0;Z%<R=:XY)Z93>TV"$RTY2.>5#1"QZA'(VHA)Z
M4R\A^?.D1(\<F3V.I7[3[X D^=C3Z>N_RB[6'EUMO=RA<BI)JC?M;/&^:%[Q
MSBQB!HXN[4'R749\NKP9@]P8R)'-$BD^9,D0XS<T3M8[E_6OR8RSO)7.AU6V
M*#S^@ 1]W##>:@X$Q]J?OF"+U!G6@G0!0\;1:,_-L2H"UPPFB,1KYHMI,2(L
M=DF68PKU3KIP/VO#]6=WN'.+;V1RE5>A'[-RZJO@*@7Y98RKU9\P-">?BOW8
M=_B-V*Q5VW*G;;<27@[0\N/*A:F[7))[:J>J#1+Y^4JQCKTVJ"6IQ,.!ZK88
M&X'.Z<:UOI%<I=V)4[EH%ZUU&L0S7-"]IB@8[$^/HO*FH>DH;L*ENZ4/+[%Y
M=>7[88X4WNG$[R8ZY0O5<UBO$!X*GC9W4>2#2YZ/3$W\6%&PP.J0=D$AS1A^
M!&&K2/C[D.;8TE]["1MO7I2:5FQ>K[#P^^:@$;]#M;_9^/5OF]ZO?+J37>HI
MY8?L7&H/9K2;YFB$/J##U+28N*1CCT-&G8 YA_;4S26Y4TFEM)RWH+\BX2Q0
M*K<X]QK$^W72]@JW'IG):O<SLJUUR@=PL(&K5O1FD5X//Y=+EUVI.SS2-&=-
M)E/_ /7<=#[J1)JL?!:<F^?DZ&66CHEAER=6,I>9Y(; HM:*5D,_&[+<JVFH
MS=P K;BJP XP'$&P,\E;*Q)-DR3GU)DE*=#&R>Q"1G8/RC+CU!IBE6.<I(TH
MEHN=H8B(F_'FYF]V%=C"(Y75IM'!  :DJK[1%51?DDM.-[D6)AIE4TM8-D."
M)]BL>F R>VV?II[FD'C5FB1'7:C1@--L%Z+5GS+;7W+(U4Q,:..,UZUEKD*"
M.*5'_P!3A/1W'93J')$@D[:TZM?:?TW\FEMGWAJ8'Z#3X 'F=RZ75]%^5T!R
M<>Z(/ Q7:[P^<0(U"N#5AW+7#D1'?V^/)EO1W%*BV"6RN,0P>QM-Y+F>DCG:
MNK'^Z-]*CQ-\HYB&4.L]9$5;G0#ID/I7=Y=UKW)/V=3:+?51E9G5[Z)V2F7+
MFQ%Q_JSGW-+CPR35:/0S#)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#1GUS;N%T4G24]0X-SOJ1&X-62=
M",W]GF8D*-_B+ .*Y&DV7H*-L[-S8]A1J'%:TI;D:/)7\R4M?!1J+\&U7,JW
M3JM1J^-H57!4RK28238ZM5EF!' C%6%2C<QL8R*2@6F,[-GN.?&,E+"U+VI&
MO@K#,^J4'-&E!3&JVL8U8MBR&@+AIJ5(#MFMQ'M"UEF(3\:8\,1.^GM]#+C;
MJFOFTE25;UO0>37^<SUK8HXR3$X_$Y]+M;%:@\^I%@Y1TTU=;W8';7&Y=UN
MP52:%U^F*Y#8A1BTL.DX[C)VJN#74?185(G8;VP^_(?M/OMOM=4J/H&MCA]7
MUS7G\4GT)V@6:F%2M^LH_C .K6:9#45,P8,/KE^Z&4A,#78 I(UX;\C;TCZ4
MY,03C%:)-Z8]E]_Y3W"P\\YQST.=KPT%(B19UHYYTE^$P>D\CM'11%L?L]+G
MG)12G*/@V0;OTPD:*F:I]G9#3S+NF1&,3#+W;V#U6O>>O./0=HK%/N'8N@WJ
MD'"-SY%?#4%A-3YWW"WU^6!YQ2+^1-247POS$8Q"ELFYT%^ 4^ZC+=T[&3LE
M1=(,[Z[]F)6*61Y72ZH7M)T[ H]!(\MZP9(V L,Z6'YVKFQ"XCK2T(#GA@:7
M*M$@Z_#CBY MM&V&/MHQ":T6L?P1@AZ_]92RC%@*\\WR"I&*O) 3K-8N8=7M
MXKG]BI\>T K<2+4@,1'DBZ[IV^IR %8EL/M?,!FCR6T2T2F$O"L:1#CWN#V+
M)#U.O=#YU&IL:!7^?B^@])O/+;Z?,\R8_:Z]&3T2^UFLV(7.M:^PR9#KL:.B
M/6= G);;CB9L>--4T)QA?;GHOT12_+_D^P$ 6RU\OW %6Z^SKORSH-B)6[KX
MBHT8A7>'IK-;57B="NG92QXFF+/+,+;%[$NM.07Y"TMI)43,^5IOR_N/JJ^4
M3LCMRIP:G6S?GZ9T[EB@G.;A&>JET(V+M=3'4(Y#L5A+1K^>",T (4<^VV-W
M(454C4?4=R,ZH3$7HU'J?K;V_1..5BWGQ([J[713%]D?S"=QRVUQSE((!TSF
M%>3<;,.EW>OBS%8-!+].=&#UNA-PFQS;JYDN.B6ILLQC>C;7IOJ'OM6XQP2]
MQ.>"JY;^B<K/W6V!R-!Z3>8:^H"*Q5R]1X&%%U]X)8*K8>NEC$Y@<3*I>T.2
M,<97$DRG6T82(BY:AU+U)[^IT#L=Y)U=?:UA+M::6.Y>OCENK18<3$CO2AP>
MH(8$G=C%CJYOG];@SU)CS4&$3DJ9DQWWHZGS58S.C<[R5Z#]&=L-VE[HM2JE
M=HU3H<(F',CJ/<Q<_J1XO?\ J@"";!3I5J/@1 0?6Z##7)'0MGG7Y)%,AF=J
M,XPVLS,1'1J?2?;?JFR$@A"U5(;216FB8:[]+3QWKYKD=%TZNHE&I<:K1K*W
M9;O-8.2U5I,A]P 2&2)WS$1D=R))967;"<^-_97H:QV"DT?T71GZI7X_*>9P
MC%MLM2M .X2;]90O$@M4LAY]QYV*E'8KYT0E&9'R1 1P8[!TW]20XP13%&6,
M>#(>OO6'HBF]9L7'>754PD([&#!(UD#\YM$RT#RY6B%K[#M0"QQR)H.7!22H
M5%?WIT(Q$U,>D,IFKEL[90,<8JY8WM?4_7P;@7B.;0K0;!WGH@6N#NKNF>5%
MK2:*VV8)I9&(P=2,T+E4Y2'FRKT]O;+/W,=#S6E,*3I6D$1C<WT33G?K/U05
M],U7B5SY('8J:;/=:B;N<:E6VO)NHBJV/M )?6ZJN?:3::S7V%\]!)6.DQR,
M9U1Q2]%4:>&HDB8BKA%[?Z']<6CTE-Y-2!X2HC:SV4K$CVJ-Q^]VJM_T["\O
M[!)'C^GDI-IJLV9.LQV,-EP(S+ 6"X^EIZ 3)QMN)6*BK1.@>\/6G1;M5:E"
MX\)JKEY72FUZM/(^GMO\TDJN5!!WT>>91;8BB[RZW:)A,4]/W7=Z898DK8>A
M.;=V)QB&.IWOOUV98HLZQ\6# HAN_P!?!V,?#YKT$M:X<@U&I[IOEXH.W;F
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M1AEW*@! .@\%NUN@30(]I%"-F7^H'*Y!B,NQB$AN"Q-;T]\[33NVM%VPW/\
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M+.W;T;Q;G1DG7KE>(P4V)BBY<D8H189TN2DR2 "!\4,V-$3/Y"5<(VH6VN%
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MXW"BV2O\*$UEW84'$-U\.^'+TZ%UUJ(Y79;+:8FY\F.G;OPEH:%91XJZJ'Y
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MH(/PXBA+4UY432R;<G+;)?FFO=WH?F(-Y5Y_8&^NDX4ZQ&8U,@P1M5$VFF=
MZ0X9/PY%.UJ/(G3N!CH\",S*2I#L9MQS</["*W($75VZ#_J?P.]4*[3S/,&X
M5"$ 2=;IM8.^?WVJI#Y".AV^T66T @CP!T8)XV$:\\DI,U]34=A*P$5:65_6
M&JD"LD#->A?QPWZ8HHL"-IEUL(?IILGTH1S>MQ+GS!0,1835MNSMB0-L$-NQ
M["7:=.<ECVC$B/%+K412RT^XG9:RZ)W5/:'C2-RD%RNE4>V'^><VJ="JR:)"
MYR[8:Y0!XTI#I_&ZM9)J7B=:ASS]A$"H@9*9,I3<B1&=?VPE#SC!)QRN_%V7
MNR>-ZO$X-UD_QR1SVY^FE<^[.$9@TH>,M2[M:]Q(U/AV^4&E0UF+.1MO1_M]
ML1MSDJ(3G)LQ+;*GI6%K+6/)5]S[MY='!N%7>3X@+'IWNVC +]88[?.:JX7:
M8OO2>! 9(Z^:8;E[-71X_P!6%$FE(^.GI QMU4IC>VWVQ4^?1L-S3TAXG[1<
M@O%J>"K$XM9.9L4R-7"7/A8T>S61-?CW*1Q(F(E14R1ZJU6INIKXAV+H2PG2
MVT.*?0MK1)C*(N6L1?\ (9YR[%3//)CO?G\.NOVXCW.S7R)=Y(&[1O/K7&*[
M8RU<.RX[U;4Y9Y79A42.D+'BM1=RH)%SZGU$-N-.%VS$S4IG?O>'@8GSLE6W
MJ8/Z+'KP:^=68Y)#I5:F.QNA5?\ J9;IE;1"^Z=#1N@VPK2[&XU,B+DP)&UK
M<?F::(QMRQ&.5O@'Z4\#CZ0=IYWBL.DTI\C&_F 2)QLC(HHNR\\B70=S:N%7
M(M;'QU=(8JO"7V!L.%%D;@/C(T%F2K2ARY0K+S;)4'FWF3OW$;G2.?\ +M<I
MJ?\ (NA<\LP"#S@#SBVTZTO E<]Z)!@CY@*=!%SB=,FN!5SX:'6GP[_R17ML
M[:7HFL2ONS^?^(7:MU:GW'D] M=7I 9=<J0*QU<2:&U^ONBHH1X(,C$8TA$<
M2^+@QVG(^O\ "<U&94I.U,M*02Y5V5\8^:2MNA7)7):6/FH<L[]@&B:S7AX6
M]O6H,9!2E7V(R)^O9V1L2S%7(4=YW[5B84DR?IJD+TXDN[))]^6/-2Y0F:YP
M7D;TH$ 55P[[] K,AP< 7&.0W!L7;PUSZ;+T.SDV5[_Y:VB,I"M[3(>TLERG
M;W)^72" TL_SJD/% Q*T&!!%VKA5SAA:[3'B-R)P)2H6WXD^U$)#CY%UM27)
MCJU+=VM6][P7*.S_ #SP8H\#D$.-\REO5J6+F@7'J375*%R @<'7PZHO_5^M
M(;%!:N+C1V]_%MEH9$TA.OM6/IBY9R!Q_E0DS7;$*YQ219^HQ(\"L&1U:$02
M8$?%KBJA%'BIL6(U(AP(U65^WML(5II$326])TE*=:)<NG6>(<;IAR79JERR
M@5NQSC<ZQRCH6IA!Q=PX3BD(1 GHA%A-RFY4V*7F)<VA2=+^\D;WKXON[66Y
M5X)\@^<QR^FOS.55&RS>P7 S=K^2M0,2<)'"YFPIL_TG)TF#J0W $EV67(+>
ME?-&^V8WI6U,MJ2+EV+/Y&\UVL);P<WB_.H#5V PJZ9G ZC7Q!1J$*CCF ;X
MF9$')_:9X'84>Y#>92E33@Z)O]=1F=(%R[%9\G^;JF H5;$\4YK^W\S?1-IB
MY5-K\F8'*Z8%,.F&I*QVE[*2=@8+CCO]NW8,5>M:W&C_ $Q<I(1\]\)+K N$
M^/<UF+JVZ[_'E/4P I0=NHPV1U7C0=Z@Z^C"K\*,TU$8U_@L(9;TA.OIH^47
M+ORN'\9G#M!YO*.=2Q6H \5H;(IE>>@Z&B09^L"H&HK@]3.H@RN6LG!CM_#Y
M68A"2TC6D/.:4+ETH/G[A@P%NLP>/\VC@%L1(SPE-,KZH<IJ#_(MQ=S6G("]
M3GFE6\LKZCWSN;63E*VK:I#NUBY9C7'N5:+TL_OG=.6<YR%8KE#,.U\:\4J(
M**VPU%% )[L=<H;#BMQTZ:0VI.F]?'Y?A\ROB+EA _GG@]>+_OX/CG,Q!G3-
M:8;)#Z57HLJ.W39 B75M0W&8"/LE I5>'.1U-?(IM8Z+OX_&,Q\@N6*<\O><
M'8K\%WA?*G8<FT(NC\5VC5YQAVT(:?8274TN I'U]1I3K7R_#Z7T7G&_E^1Q
M:5"Y6#6N<4BG&3)ZK5L8 ('QPP64_:8Z8$.1"$G+=98B$CHWTX#+JK!?"\QY
MU#:79$B<XMQ2M_#X$3; 8# 8# 8# 8# 8# 8# UGZ]YA =>[+P/N$OHO3:9:
M_.\BZNU$73Y5'<JQMOH3%?'VE%G$7.BW!W4V8! J%M$13XHM%&DB$=F4VB8]
M\2Q-1,>;ZZ.QS"BT#DU,[%TVU3DB;ES:0!M]C6Q.N%PMO,RXRX0#=O?J]68%
M-1'Y==3).34P!PV.PI:EKBH4G>A%^#2]^)XJ=YM8^=+[MT0D$Z1+H]>A-0ZR
M4+&H5)H)VLRN?<ZBU^#RF7',\\+2>N#(@YPT.(_RAFR14,RIWUXV\->[R5 )
MY]Y6:$Q/A[ /NAZG;C:]$6:TPAR)QGH?/>C#B5&K$QZ@.0BTF>&Z?%)6DUIL
M@D(RQ];Y!"/D4V6Y\EVQ*_X=GE0U:@==M\D4-18*;(HB1!26*._MM@Z^D>?G
M2I'.73":Q1#W<K##A&H<R.!<F.Q69,B2_&;3LEY>+ \T/^2.1=*:(<NZ=?0T
M]BK<_C7.SV2ACM-'!(8?:JP;#%CA[G@F^G>D6Z1Y?W$+AF7%S8Y!>Y4*"V_+
MDJT)W3K*;"N;>/.IWFSA877KJ9.6<!U4K!#+957QE+K'2075'NF5T<6F\_&1
MHY2/*]!&"TD<7F2C8I[49#C;<:&MC8]T(Q89_E+H?H67V:#:>S6XL#Y%9^SD
MI0(#MJL5NI\=D\//ZKT1DY2(UW4];&Q@,V*#1Y.H<YF;*(QT_ JV\Z-:I#7=
M^)>CO4*PFNL=;YQ+X'6:)SCG\2U!F84F%$I04LFK7\:DYSLU_BPV#29UD5%=
M8@,N"(:SL9IB(A.Q[H_%95FY7XRH1X]2+3U+I#=YJ=+JH^P/I&$#I/6ZW-=M
M+AIIH/S(E5R]U.Q>EAWC$*+'?4Z('B]KAMQ8SJG*7DB=>K/ANMDQ(;7H:\RA
MU<-"KO'AR(*H=(9NU8E(DPKB,LL'F40"*@1@=._C4$8/(,U^+"80/A1&YGT,
MA[O),>>;X8?'!>#U[IMD>NO5NJW/TZF[\Y"J&#.?6.F7(3? ];E+Z+72@H=N
MJCH T0X (17"+4*-O[B+$;<;VD3?7P5: Y1X%@OM%J[Z-N\=7UJ40&P/J#'[
M1L3R?5RGUA%>ESN8+Z8O8.,9ELCR<"5]]$&S!L.$^W%G06I=+R\EP<=>\I<E
MM*;9S;T@=9&HK558.C28V JKV2C4CCIVP0QDDG"H8-HX=K]5ALF)DUR3,-A8
M\-L<M46-(3$5$FY5Q'K7BCHS'0A!SH/0 L49;[9=%.W^($'IBEJCV'L]$DOC
MJL>I#[!JK@.@6:8X/_=(DQHM&<BZ=^Z0Q-;T7W-X*AWCSGS_ (]0Y8GHL97/
M!6D<V %G@Q1,U4BD@7WB:B@4/6H#P6&&KH1TE/F*'P14(:C[S:F86T+PS4VK
MBF_D X_;;">#R MZJ(VOSIH]^P6VM$!4<I*:LO5:R-B5@5J.\<M1,U)Y/)<C
M0QT>3+<U.BMI;4_MUIHNV5H/>R/,T?;FGNLA&_IZ'*7\PZQ:U](C6+#<M2$[
M_9O@N(,K53)RB3R?BT(3!?1-5'<;4C1*E>%*NE<Z%6Q]MJDR5.!%-RM0Y$T0
M9 S-K@S) ^4W)#V$>*,P'69<5:=H?CM*WK7S:UM.];V3H\AZ9ZP\W^9_R ?D
MB&=^['2N23[E9?*QJJ1KL16&581 _P V5<5.)"''V/HSXD0FTN.XIM2OD=1M
M*OAO#=3.,4F(SU)YY],_D5\D;X!URF]:31O/'M%RX.4H@HNS6T6.P>46@.S#
M[3.F(6S#@:7J/I:M*=W'<^76_D5\!4QA-^<?J]82VM[%$]:UO>]CYNM:U^N]
M[W&<^&M:_P!.]X8CJ\0?QQ?D1\/\N\$^0><]#].\HIM[I'GSF%9M]3L)_8L[
M6[$(J\"&6"&!TN,U)A$ALQI;3S:TZVA:=ZPZ98Y;IT\6T_X[^ATCK=E]]],Y
MI9AETY_<?;#LZJV\&MU\'8(<#REY8!SI0F8XTTF=&B&A4J(MQOYD:D1W$:WO
M:=X9RTB(GK7ZRS?Y/#X:I>9 %NLI%@-6*CZK\/6JT'):7MP -:KWL/B)8\=)
M+CM/.,"PPJ([)DN_+M+3+:EJ^&D[W@PUR^WDA_6_R>_CY+<JZ:*'>N>+3"!/
MGUS'P(D>TMO2)4V;7"4:+&89;86XZ\^^XE*4IUM2E;UK6OC@VY>39'PE'?B^
M(/&T64P]%E1O*GGF/)C26G&)$=]GD=0;>8?8=2AUEYEQ.TK0K6E)5K>MZUO"
M9?W3][:O"& P& P-'/=/F2S^IJYY]J5>+: P*'Z@YYU:YFXTH&P=%4ZKU>_C
M"$NK,V>JW.N$;!HA88B6X\V ZRMA3N_BE:4[PUCEMO[FBG-/$WMJ)ZE3;KYT
MRSM\+&>J$]--0!WHWHFGNE4T"Y["+T @FH!_VL550 0+T;E=8)4YG[8*4U4'
MGWF'6&VON#6[&JCK3W.PYF!YL?D(=@0/Z8FIP[HAA@.,Z ].'UNNTX]2H@F9
M-Y^/F66Y*O/0N>B!DNOR)+&X\EI^0]'&/DWW$(BLR'$FL6^/-)Z"O..?E&X<
MH<V2I-4GMCYT-0^; 1,!0)"8<R K^]!E14N?(XSO]6EIVG_1AF>J:[UK>MZW
MK6];U\-ZW^NMZW_;K>O].MX&H\7P?Y*@ I=;'<7!#0\T"*K,B..+VJ"]L,"K
M/3*<'C(G1CS<YEX=7.Q62.T^AS3^OW+:_GVXQ&6R:W2FB?*O M54_2U\^BOU
MZTT"5S"PQ))NS2I):DS;)9+A*%22<@TX4^X>M-N(S]S4O)G:DRMJT]KY4?*3
M=-VZ'._(GGSEEO:O],HK\6[,S2Y)%H+W"\VDQN>?T?V;E.2K193&WG2K]J)/
M/?/I6E/S77/T6K6]"<IF*\%94?\ 'QYSJG.ZY0BX:SW.2#KT>KRKB9O_ $&+
M:"]<T-(B25.<(C+7&?&\T-PS,U,NIQ5M5IW[IS>X7S;TK1=TW:=S_%'EPA//
MEG.0 8QBRNVR24,#)]@%%$SKM;J+?CY(7/&F(L@&47<^: B463"5'>'2AZ%1
M%,?.[IPFZ7P2\5>;"U2F4B;09JJX6=AN'XK-\Z)&E6E$4#,J[T2W%(]L:)VL
M>8 $9$<C&(/26"/U=N24NO:2XDNZ4VM_FCA-]NH?HMOYL".74 USQ@,?DN$F
MY(YGE%OGWSGK<=F-.8AI16K84?F-:VWOZNW-MO?4:UI&B7*(D_&/FHKNNO.\
MU:AD*?4:C1Z>;#VBZ [#4:_0=0M4M%9/B+'#+@RU:_;F?M2,=YL@GY=ZV]O2
MUZ4-TIK1?.G%^:2PD^DT>*%G5U-M2(E_NM@)28^[W&J<2WNO/%RT]R=(/LT8
M5]P[(VZXI<32]*TMQU2Q<J[B^'O+\*H"Z/&YDE $%/>+@=KMMY?,@C"Q=-"Q
M3 >QR+*]8!Q4.,YZ#9'R&I*7A^A;&XZFU)WO8W3=L[9_(O ;C3J=0C]-)2:O
M10UEK@.%%OG0A4U^NW3[55RK]C.";5!/6\);I,"/()Q2LF8S/DQVG7TK<0E6
MA<L/9_$GF.W#(PDOS534:)3)'.67@5SO]7)_T_G/7!XM2G3%:M0DL_6#N[\6
M20AK?4S/1*TE]+FF(_TB[I9$%XZ\Y5LM,-!N=-Q)<HH4,1V/Y-<GA028<%7@
M.9U5P;]A<#56(6B]*.KD,#F(S+LDDX^I.WD,K:)NE1O4OQO\5N-/*U_GTHUR
MJR663(:MW2(YFXW"_P!B!$JQ;J<7'2K><NC-K3/E5^YRHZ9>R#FG64-1IK,V
M$G<398RGQ7)+\5^;IU;JM9D4!U$>DPR\2JEAMKN *S 56*S3+C8IHBR #PLP
M+(G;$2E/27HSK*UM2WHVOEBNK9V3=*6<_P#,7$>6W!-YHE.?!'F:X>J8]O5J
MN)"O! -K(U@Q;(==IY6P3JE7G;8:I@V:4D0H3$DA,C?7D...N.J6)F9ZH.,\
M,>6  QL75^6,T]+$&I#8A.F6V]U*R#X5'%74#7&!EJKUG'609]N Z,<@/KCR
MFW)T(F\Q)4\WM*4C=+JN>"O)C\K;TGD4&5#;CEX8ZNR;-=GJ;7XE@V(<L$:K
M4A=EW4:NR>E 8DB;H?"C_=2F=/.?,YO:MC=+Z/\ BKCY6MU6IB9%^K(D%W#7
M?C9 ;TWI$B[W&]KI)VCRIICI<^W2.AQGI@TLSMQV,3:7M$-#&O@RMQ"B[I_@
M[;WA_P S+VK[+G\\$VW%W%$1:O?NC5:!5?KM XY:521M?M@X?29]FCUJ V9?
M%-1'#3<?Y9VY&G'OJ$W2Q6_ OE+2(Z8_,Y4!0P</#UE\9?ND#9E$##V'8V@_
M.9T*W,3>=B9\:0ZW-C!7(+,Y#SFGTN:6KXC=+ME_"?F XZ3>(T$NM942JNN_
M;])ZA!3"JLAIUDM3@J(5RCI TVQMR'/W03#^@/(J7\\AIQ>DJ27=*X8W"N2P
MKH Z'#I0V+<*L,!A:\8CR"3.Q(JMU^W54%!B0&YR1B8XVO7LM%;UMC?^',5O
M?Q4AO:"7/11W,O"/G[GU6B5\K7)?1I[4:SP)=@O9NPG),D1;H/2!!JN1!DXS
M*$ ZC(#=:L$?0>"RP+1LH^\EA+RM+26<IEDGO"WF"; '"C'/B-E$P)$B6\)M
MG0>DVL4>F/(VU'F6X;8K<3A7"8':WI YTFW*<&MZTF-MI.M:PFZ4C >0//-<
M'%1D.@N3VSJZ@X=F6.W7>TF#2Z#;M7JF[*F['9"A:<FO6=*7XZ7'E)TVA#"M
M*CI2UH7+J$_&GG<PWSYLC2RS^N7U:BTNG+1T'H\5^-6N868;<N=C3,B';8[]
ML13;0)9FP%%E35M/:5O>]Z6O2ANEG_\ *WP[<7B\)RH2WXWGR%$&\E:DVVYR
M-5@8.+4\Z+&R%/6%:[) $E^? Y$5HIN:F.X+8^3X:3O6Q<N*B>5.#<RN4:^4
M2C?QNP0V)B(^H5EMJP:9A& V(GG'*O*/2*W(L\P*PW!<*.1%D-PFD,?6TTG2
M<$S,]475X;\H*B$H2N+UW<8N*K 0BG]PL?SR1U,H-JYA5FMO_O?UVGP='NQ*
M&P^A27TJ?3(^?<EB.\T7=EYNLCPMY@TXIU[GD^8[* ':X:=G] Z1-<M<.Q1;
M=!)3KHN1;G%7 ^F'?C+<4D2W)G04$%ZC.M:0S](;I#/B/SW-H5FHX>E1A"K%
M]^0T<GSCEMG1K;*!7P%&M\YJTF"39XM$:Z69=5J7MQ+[LU:U_P"(EI;9-TVD
M_FOS@'\ZU4F)9MEIO-GLU@LMJN%KL1VT3$&CEHLI>S39,8,>LUG^RVS(+J83
M(?E32;T=II$B8_IIO2!,VV1PA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,#5WTNUQYA'/#?4[Y;.?2A)PXFOE:7LCLK-%2J]+<OHPNH77;)+%
M4ARK0W'C)728'[7%9T]]_$_Y>RQ?@T/I4KS34'N V2:)[HQ$ZU=[[3Z_:;I,
MKPI=2">3#5-LM0W<!3 2NO,UN6ORZ#&BOI19$Z0W.WJ:\X_*<DI6UK*J.15W
MQ=8^4U6T="O'7 6R44/T;FO/+/1=62S\MK5FK5?KI6KBH8KG-[$WBQS1PEE%
MAG0U$UB9"VWHNQ<A"7<+.ZT_ZU-\,BFJZP/OG7RI!ZYAZ'7X5'(:K1LY=94S
MM)?GHCGEPMU8"RG[#:^B#2]5@D:F6CRM3)FH,N6W =FZ74]S) .9^)JWI%.,
M=#ZC6K4!.$VM5\="BE6Q'0P_0N\PJ]H--HO)$4V9T35ULUIDAP4-+CL]^,G6
MQ\I+'P5#7JO_ )O6O-%<XW5_3Q:;T:+4+8$/W(K*M<::=*S?ZHUB"$N!FUUZ
MD5E;\604'BUD)^XT:-%'N.2'-HCLH^FT2;NGQS.K>4 53Z)<0G1^A7@3% 3^
M%VJWDQAJ5*.0;<[1>/A:_545V@!8]V*0GN:"ZX-D XTUQZ='=2\J1-==<V)O
MQ:Y5B%X7Z=7*18;);>C!S  'J_C%GA\&VFAH2UTL+:B!"TQ1O-[!5*N8L@@N
M\/B-[8B$ES$K2)VB=IC:"^Z%D]1F^*NSV#H,KH-\Z!35NVYLB8GN0R$('+AN
M<MX8B;+LX@W2#@NL5*=%@"@+H^V1HNIQQF7&0RX]MI*21<,9-I_@ C3(7.#'
M0>A$81>I0&HM<*!KFFUGH$B]%&Q@UNN+YW'($+.3M-L5] 2W#W-EPUM/HC+B
M;^LI2^[JS%&E^5.6ZX_UTK:NC@0EWXDSU -6)X\<4@S==+HC'[U82]$Y7SS]
MRA'&.=5)6I>QNHE>&PQCBFXC&]+<4-9T4#UZI>0.(/W;G12M]GLSO&.+\R)4
MUX!-Y;'$V.D][Z5#IQ.F5*O+ ":84=$FZ533UBV8%O)GM @\IUV4MF<F0(N=
M?.5P&JCXD:$%><R.\=DK8K9<\-FU^&)*BA]1.NT !R6[V2;"7R+]JK3=^J?6
MQ45LE/;0-4Z<84"5%^OO6Q[NJ*%;#XJF= BA0TGIM_/F94SOT *0(,4UEFK5
M.R=^NO0MF MJ!U6V#N<TB7TF61GZF1G'9CA>O-QW7_F:^ ]S/6$EXFJ7!6*
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M\29=>=ARTEO&]'H5W_G?9>J<S\J5L((DACJK_72?7A%CN5R("@8F/Y]ZR@C
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MEC #E]AD0$DIT$I>K\+E.F;%8-H8EFIDIO2VV6(L9AHS,QX-Q<(8# 8# 8#
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M[FJV8MY@N85.9GUNS#T"X^V],,#Y8FOP?M'ZA[4;YEUKH4TSTJ?T/C;-.NO
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MA8C2_5I:U[]]3#@[Q&]U\%3G^B]&@A^:Q4TLB\Y1S 'R3!Z]TSB-ZW*?5_\
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M,%@+96CA,=]7]P'!SHLG.@?0?U&?^\B0I3\B+]&3O3:_G2GY5[^7?Z_I@27
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M\-M"G=_,WOXZ+MEOLRZT^TT^RM+K+S:'6G$;TI#C3B=+;6A6OTVE:=ZWK?\
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M+HW/3]:ISE/@S?+R#/)J+:B0\L5B5IA(B+,TEY*'=MN&HF+UGRO\I>S'Y#_
MEH]V_D/I](D[A4?EDSP#;0-I[,9X:GI\JO$6_3_-CR*]Q^[E#($#R3N<H9"7
M)'&];)3H$)M]UJ"O>M.MG/'+;CZVB7Y@*_TKM]L\L=.\Z\FZM>K]XKMGKSJE
M7U)Y7?(NG>S^<:1S_H%,$CI16O,:,B^JS:Q( A"47;T&P.S'&83LA7S)PN$Q
M%W,5-+F_#MSDAXNY/UG@?0Z1TD(?M_L;J1(,4_IG=Y86Q$HWFKB=ZZ!>B=CA
M GPPP#9[@,.MP2DQ]J(5+IW"C..RU):V3/W3<>3E_*\1@^HO%OD/IG+ 5FMO
M/[%[ \F==D3G_.%V[C(K?,4D#)0G<[OYRCA-V^S!:_ EH62#28C#WZ_2=TA?
MZ8,-,IB>M-/;+T?UT+]4<SI_ "_K:M\4&\#<KKRN?^6+51>330)CQ#W&W ^A
M\>\WF.;UWGG.S@;T)6@[+(*TV55J>M.V@S3,(1OYIA8B*N:O[_5JZ#)>]#5*
MYQV4'OVT=]#T?R=^5#G/(KK<:KT0U#LO1$"O+5AHQ2LP+?R6H72*%N,0=9R%
M:'7@=HNBP@E#(4HHT.'+DFJQC32KC]6P-1-_D?L/+5$X/;?8$R#SSQG^4CJ7
M/20CF5YKTKJ_1Z;<JB \FU.TIZ]0'.M6>7#'V0K,JNR,8):+/'',/.QE,H<0
MZ3V7X=8_U7S=JCZEN'XH?RX<BZ.GT)V6W-0NEUCB,;IE=)6+I]RJUL\K\-N$
MD+5V!E5"S+F+;ZO:K)#@HB0WM,.M.0&]_P"J_303V[\9BJ_U:2]5_K]S3G/K
MR^>)>6^L//O->Y>DJT_PN!QOA73>/,OW+EGX[D0SUM,\8#\>(=0&4?HGHJL0
MA0U# BNB++:8J'#$](G[C4LL5-1E,:?U2'T39_;7<CGL_P XV>;V'HM8YUPK
MSSZ'CT6/7G",P\:]673QI+JM+>K <+LKN-Q6V<3Z]+B0DMI4/9G[4[KZ;*--
MB-L5/J^O6/;/6O!6S<R+<^]\/ E?6_Y%#55E4*ENU05<+'_G=\M@.,.=$<&T
MEV*1YR=X;;KFZ/+$_HPBS[J7MSGYNHGS#&,9_*/Y2A'3^->H0E-]*TML?ZXA
M\8N':>O=X)4>MU6Y/@*Y8J7^=.K%P]IYF, TF2?ARCGGLR6MCK,5<UTU!8;*
MH0XQ':VEXK$Q-3I?^CVV]K^=*MT[WM^+:_D.#U_HL*N=,] M='NY+E@NW,@*
MX/\ ,O2I?/47BR3 ,](D/!Z',9>#ZG/-LM&W&UQM)E;3O#GC-8S#R=I$'\@T
MZM^<:U$.^O>3!1]:\_-V41S"EO<\&:)]4_*WTSFG:B5B#Q><."FS WRL;23<
MVXPV@:/^W..M[VA$G#?M]/M"1<EZ#^3N1WK\<8>Y7KTZ+J&ZUSP7=8M@Y3T8
MY_4M\=ZD]$U3M*>PRQ5-'4081@^>*_3I<HS<)PU^&Q)C$0K$R;*E:428QJ>E
MO3#\DX^N^ZOQP6&M\[K%OOU0ZOWCSS030'^!VF-8]UZL^U^;4;K$DC3R8>/8
M80ZK0ZX7DRY#T9#+4"(N7M7V^M.89Q]N6O6GAGQ?E?L3C$[T-W:^\_\ 2E/[
M!VCBGF+F5UOW*ZK=X%J%U_DWLPKY8'R)-BKG.^@71BN,<(Y+ M9Q-9%3+3JM
MG-R1NXRI+4YHW,XSI%5']&ZOB?L?O^Q^I_!'%.X=#[2B'TSR[7_579X%V"?Q
M(W!?X"%[?Y\OM LH(D%@&0S'0^@="YC92$=]#<B3.A..;5_?=TLF48[9F/-N
M@?\ .56 ?E6]%=0L7';CTOD?4OQJ,/=+;N8ZY=;YS<;D#[R3E.\RKP:[NV>E
MC)DNJ!8TA%4$LQHSRUZE;AJ=>6ZLE^R/.UB?C)#5+S+Y@\L<RNE#7RCM_L9/
M4/2EFH8#F1.I@ /3+ZRGLEWI)@<'"1*US9_G53/P:\/&2TP%JB@M1V6U.,.Z
MT3/69\H>.GM3@>NU]O\ R>%..\&Z]0.G53@7IZE<X@A>+]\FWWV?TSK/+^81
MNOW\OWDE6GN<.\=JM.J$2K\[Y^/-KV0,,$9S$5M2XL=PW$U$7/C'X)7SWR[+
M.5OSIURB\.[#5JB _/0_T?A5,C4WK',:I4/*MP*LOSK[/\ZOQJZ"IU/;.@GW
MHA$Y7HKXI#[CD=R.U-7MX3/6/^EZ9^?N=<[X[ZW_ "*>P)OG=SEM;JASE/F'
MFR>8>?B(^RW^K0Q-9ZEUGJ JM<[J?[_TW70>V=@U$FFFXT[XQZ@A:GDHBO[2
M8F?;$/8S#!@,!@,!@,!@,!@,!@,!@,!@,!@:T=I\E<9[]?\ E/2.C#K/+L7(
M"#4VOL@[I9ZT"/1XEQI/1A@:^  A*&+NP(+T?FM?/PXL]MU$<H(8<3_=^JAP
ML3,=&)ZZ8X_Q;G?)JCTV7TBR@0UDJK]=,295MZ!;/O\ C$!WJ&KI?;0M^8<)
M0J\+HCQ,M/GNNKF:94E6GG74MK$7,Z-*+#UKR'2:);J53ZUU#HQFZO4FQ@*"
M4)6$(2F :!V9P%SH+7"91&R5>YE7;:%*SANTQGV7QL24I*GM/QFWC53>KIQR
M7X_KD]J;6F^Q'HTQ@37R@ZE(OQ,18-:!5?S?S99M0E<F+*F20_8XL8$GZZ'=
M+,ORI+:7HKRH@]T,*[(\-7NQ4B-2(?7^DRD]2'<]@#(-LM6J?SFO= OE&%M2
MT/./31]9HCI.TL.CV(FV99!;KT64M.FOEC#W0G?/.R>=_/QSJ,F6QVCFP_G7
M0[2-,0BDV=8ZST >--G>=CSA&4]#A@8<JY]$FV$K"@?<N$9C\5<E3NF4-0V!
M4R[]2)^%JV0))@.]/F*JB(,D.?-LWJ=!(53GYB-=:\/J!!3:4%J?1BOC10^(
MTI/UD*#/,N;=_<-NR1[OM]O5$I=F_'B2MO2+G(F=%+*NAGHXGH9Z"Y;)U2KL
M$ON53K%82,T0M;8T&8E^F7(\![:GYK.RR6TMLL#VVX8]W1:I&F^2^V]4.6PP
MWVBC]9N4&8\0CE$7+GIZNBH]'#H+6B*W(B);&@9]0YTP.W/0Z_ ^=YUJ,I#\
MUY3@]T1X4@E?=\G=!M\NLU&@=6$!B/,[9V&XW]Z7:Q!"K#^=\SXO3*N.8J4N
M*:D6%F]\EN\ LB Y'<B3FY4G[R+)F3IL= UCJP-&O'CNFG Q.K5/MHL95*74
M.E<K+&X]BMM. P# [KL*W&P 2$>?E2Z\.%<MEG[1(^Z=B$_FCJANK?VEM0J:
M\&)LU^\N5'CW*N+3AO3;.%I%"] =$YV1B2;'SR;VJ=2:O*:Z1$K<;44@JR\P
MZ)2.H6"1+GI?DQQ V/O:]ZD_:N8*F[\6",P?#(6N%&(E3[7)DL'3;AR@68Q9
MJX'#W\F//<\U4K&5>:FQ*[<T5'FY5V(_'7M^? '+^]E/_N'R3*M9>BT>:>A/
M)W,KU?S*3'5:K$MQBTNNQ;3+,&D]4KDKEG+>BC>@O 7XO\@6%% K9'%@'_C+
M)O-3]IDKTVVEN'$J:9&]4_Q-SFM<C!789UZO?R2KD+#SF>2<M:+>VMNFUA"J
M\C[EU1-J[%:/R>,/1'0PN5$;UM+KD23-8<=%Y+Y%>\>5;J0XL:#6>HFMW Q5
M25,-AK))-@15>MT2L2CL_0:OEWG5.1YT?Z+"&U(=+.*':?\ J-N.Z)MEG$^\
M.$?M8\RY_/T#R0\4_%D,40R49?,V%15VLU&)("I)12MGM D'+(CFX3DF-*'M
M:>0_\'6=.#;*^N9]CI?64E=U!TNMX R)_?XI8+/#R0A,K^XZ77"3<UIO3%D#
MK&+3/A_';D3:V_G_ $<1O9)BEIX1XJ ?6'$/*?OK\B,;O!JZTS^HUA\NGZ1+
M@\:[3=Q-D$!/.E: EI@XYS_GMI"KT/,L+C/-JD)=;=1O2DZPZ;9RQBDQK/J7
MB_JK\AGE6=PHS<;>.YOY\]C)NY0GR+L%"$@'+B?\M-UB/(+=%H=3&R)9I5;G
M_198===VF*XK:=:U\<)4XXS?G'ZO6LJE2A9)*=;4I4"8E*4ZWO:E;CN:UK6M
M?KO>]X8AX6?CV_(UY(XOX:\G<EZ==>B5/HG.>#<VIUVK$WSAZ7D3 %F UJ"/
M,")+X_D$R \_ FLK;4MEUUI6T_%"E)^&]G3+#*<IF.E^<-O/QV7VN=8->[.K
MTC9^70NA^SWS=+.'Z;<J*[81 [RWY@J\TG "7L!6K!N Q80$V'IY<1+;CT5S
M2%*TGXX9RTJ/&OUEG_R;EHU<\QA[81CF'@=*]/\ BJ[V=T#7;!:R(RIT_P!=
M<6L=H-I 546:L)&,# C9$M],6*^ZEAE:M)WK6\&']RK.J_E2\.G>7](""NFW
MV84,4*X"AL1OS7ZATY*GD*\1B0XS>U<92GYWY#R4Z^.]:^.\+LR^TPVV\.#B
M CQ3X^$EH$T45%^6_/PXF,)17X)$<0A<FJ4:; GP93;4J'-AR6E-NM.)2XVM
M.TJUK>MZPSE_=/WM'^K^CN3>7/R>=%N/;R=OJM6O7A7SY6JH?$<IZST 06/U
MGO?IPF?$:G\XI%MC0B(H?8(+SC,E3+GTY3:DZWK?QT:B)RQT\V/N_L?S_P"I
M_4OX^*KPJQ7:YFJ=Z5OUVM#<OB?<:8.!51KR%Z8K:S1(_>^<5BOQ8W[]8H$1
M"52M.N/RVTH2KX[^!8QG'&;\GLIAS,!@:Z_Y6N1_TA[KP_\ ;C>J!Z,*]Q,]
M.B:L!'1*?.]$23TOIBQ!;ZGW@1N>]9)7VB6-IU"TI.FOA\NL+<W;7[IOXQ?+
MW5KMT*_V*+T*"?Z;4Z55K3_'[V1%#Y+W/WN<;K5G^P^C(8EV"..Y*!@.)E_=
M#7H41:%1-JE2UOEC*87WYN\I\@\I5\O6./CSHX2<B\[AD&SMB)6)Y;/+N64S
MCE2^F^2<<<:<8H]"&M/JU^LF0VMY?Q<<5O9)F9ZMD,(U)]3]SZ'Q!'/)U.KM
M0,!K"9(CK3.LMCJXF<,;0@<W 4&&6CH'.8Q%#*)DB;+=1,>VTS!TQMI.Y29#
M!8B)ZME*@4)G*G5S1N#!&&2]="%"XT848.#1Y,@-C2Y\$<:BZU%,08DIY;;,
MIO\ PY#:=.)_16L(D6 P& P& P& P& P& P& P& P& P&!^;UK>MZWKXZWK>
MMZW_ &;UO]-ZW_[^!#>?<ZH/)J>&Y]S"F5CGU&KS<IH%4*:#'5RN"4SITHI/
M^P$"H\6#&7/)SGI+ZDHTIZ0\MQ>U+6I6Q,S.LIG@,!@,#Y6A#B%MN(2XVXE2
M%H6G2D+0K6TJ0M*M;2I*D[^&];_3>L#AB1(L"+&@P8T>%!A1V8D.'$9;C18D
M6.VEF/&C1V4H98CL-(TE"$ZTE*=:UK6M:P.Q@,!@,!@0P!SF@56TWF\5JEU<
M!<^FRP<_HMK$ QT"Q7F96 [=?K;]K,QH[9 ZL $:U%A?<N.:C,?%#?RZ4KXA
MB;WQKD742M+.]+Y;SSH1OG!G=BY\7NU,KMI)T@\I49>S-3G&QTZ37R>W83"_
MKQ5-.?4CM+^/S--[26)F.BR<(8# 8'4@P((R*S &PH@^#'TI,>'!CLQ(K"5+
M4XI+,>.AMEK2G%[5O2=:^.][W_IP.W@0MCG'/XW02'68]*JS74"M3'T,CT-
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M P& P& P& P& P& P& P& P-6O3]ZX14&.01.W")=A<*]=K,WFHD>E;LUOH
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MC;+JT#;DL/SY[4\\>GS):M<EM%J=M :G5?HS]6O_ "GK''K).YW=7R,.JW\
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M&,:7M7R?J+ED^<<!Y+R0P3.\]JNZ\0*A1E;?TD[9","(!$S)Y.(*#B"YB>)
MQ'"Y:7-D:A,,*F3I3LA_;CSBE[%RN/"& P& P& P& P& P& P& P& P& P&
MP/-_VEUR8%M=4IU=OYKEAP!"?L<ZX@.F\0"%OLS&VV84.!S_ *GZ4Y4 L"OG
M%.[6_9J\:&,_%/VC:UJD?*:QAN]RMJT-4&N;N%L3>#+\/<S5IV+ !YA87.=<
MF!'BT2IRYM3<--"'V6YCXI2!LF0A;L9MME:$),SZ+"P& P& P& P& P& P&
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M"2^S[?<RPRS_ )KR%$C6M%2-B.ER*\J.Z@D)Y!)<EQ !?UI8Z^)+5-XY"H<
MT;TSSL63(P!8^6_%F?W5M;2M49K^"^S[?@_HCPY& P& P& P& P//;U[9R!&
MT@J!5(W6:_9XP$R>F6FJ\U]&E*\2$O)%P(;46W\0YET 81+"2$S:OVZ>IIUG
MYMK2WM*];6:Q;O42,1A4>FPS!62=+Q*I7HQ0Y,%RP<PR18$0VIQ64%GH:G!Y
M)&2A3RXKZ4O1U+VVO6E)WK#*5X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X9
M$AB)'?E2GV8T6,R[(DR9#B&6([#*%.//OO.;2VTRTVG:E*5O6DZUO>_TS6..
M6>4881,YS-1$:S,STB(\9E,LL<<9RRF(QB+F9Z1#K"R,<N/B$XFGM1)S*9,5
M3[2F''8SO]Z/(^BOX.-HD,_!Q.EZ2O25:^9*=_'6M<O%EP\F7%G6_&:FM=8Z
MQ?I.GDSQ\F/+A')C>V8N/N\)_%UA!T<:43;A.[W)"DWQ!:&ZG3<L?/9:9DI9
ME,_%6T:DP93,EE7ZI=COMN)WM*M;S?-V_+P;)Y(]G)A&6,^&43<7$^DQ.,^6
M43$ZPG'RX<NZ,9]V.53'C$]=?OB8F/.)B6FO;_R#^??/G<BOG[I"[M"NPCRU
MT#UT].'5E$^KR>9\VDGF#X6"8_<V79'09+%8GR80KZ&ONH\5Q27=;3M.<':,
M9F+CSI":_P#E'\L6 EX<#HEWX24_(#5I%NXI",U'45RNB]"84\2WUMQ@I*8H
M,VTE2#084VM<G4XUO<5"OFUM6ALG7T1>/^77R'-J%RM\"3T><US_ *_Z5XC<
M0#%-919P=U\M<KZAV:]N2A,DW'TNNV:A\D*R*T0;<7'+O;:9^+3FG],%V3]O
M5DD?EG\<NU*CWYNT635%O=%\U=$BW"6$@BJ_7*[ZA[-:>#5#=WGF#0]-2(47
MH5+)L7!B9I"J^U#<4[\ZT+;239E=>/\ 1&[Y^8#RUS?F WL=JJ_?(7/K+SSK
M/7Z*5URMS1#H7)>1]%Y#S.=T>H5F0<CVB36KR7[8%FUC4J'$F&A&W)C<=+>X
M_P!P6,,IFHZIS:_R=<$$F8M=H-0[+WD^9OG-Z!4!7%*E7;&Y>IW4_.1;U36#
MU1FV&YU05/JVN.A)$V1+=D,;;?1IE+:][TK";)\=$\E_D"\_L>6ZWZQA:Z":
MIEQM8_F=3Y^*HI5SM1_LY'H<GDK7$(7-IBH1%GJ47IL"2%E09#K,>)(BO.O2
M$1&ER-#;-TKE?Y-N8.Q*D'$<"]<'NUVDCTV&_P"9H'%V(7<ZH.XZJL(Z%;;.
M.L%M"<^;HXIR\ VX9B#8IT Y(+QF!;DV1MQIL;9]*0@[^8;R^+$(N02F>@;Y
MRL=Q_E?=;[UVE\T@S:1R?G77;)=*E7I_1X9BUA+X)+B#W.S4<N-B!)T\:X/=
M0XU]1/R879/I;+S?RX^6J[=;Y6K^&[-S2HT2T^D*0KM-SH$5KD-KM_E 38+!
MVFNU$W7[%8+'-)@P%4)3(B)0F'HDB&MN-MR1M#*QLFKAV9?Y5.-! -PDW3B?
MJ;GE]JXWBMA$<4O'+003K71:IZ!ZF'XMS*T\^#ZO<JME!T_I1Z*+(QIA6 4!
MR'D)(Q(NW&M+)LGTI^W+\LOF3FWGSI/H7I5?[701_(.WC?//1>76#G;+O8:Y
MU D'KMNT)_BX.P&0QB! YW96;/*F#R<N/'!,R7U*^I'=9279-U%+%O7O^ET?
MT/3?./\ 0OTC;SO0JQ,OM*Z'2:;1C/)['SL$BA;N=_'6F1TH<175Z&_TL0R4
M6H>F3]23_JS,E&OFV3;I=PIU'Y@O,$RIBNB@:9Z#M7,(O).2=OZ]TJL\N9*U
M#SASSM@=%EHY/MSZ+*V5'3M5->C!2& B6"4%#[3-G(8C+0XHNR>FEK2H_P"3
M+R]T2\'><5<I;Y=SK/L"5XH.!'JVVQ(@]314K]<Q=H^*B>T2^3V83S(TV-/,
M;=;DS(3L?Z276GDMDG&8U]+>@F&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# \Y/<GN1SRUT[QIR:NJYX]:/2?H:BTFSM7TVV+6'XZ0MM:I%N.U&$DR)DE[
MLJTWP'%@-?!^.RP[+DO-J1&^79K'&XF?*%\=7ZKV:L<SY9<*S0:C6[==+IRR
MHVVB]0L+\M^G2^FV,'4U04&^<[L80P4K!8YI3ZH\AR%);87IE_\ O)5@B(MU
MP_KOGYNI'[:/JW1I#08KRJ ,#I!!4&[H/[;=(U"YA:*K'59MP?X]:; \O2=D
MI(^9$8CN.2H[&M)^<E*//_D3JR2I,73N:6PZFOJM<"PSY9>DMQH5IK![C(V)
M3V=A;2;9>GV@?V6&XU*^M]$7):4Q/0RXEY+)=J:5[VM!,\*M'3&N:VDA?>=\
MRK-WZ!S:+* C=BSYXR= +J4.PD#+HM<K[FLRY\=Q:_D>#N1)/QUN4VW@VZTZ
M%*]]4(N7J%,N=+NU2Z#<KHJJB0+,8$:B2ADN\RZ((NL27 L+LJ16G2Z&&Y:-
M,?N4+ZBY#D34%I<O0G&>O@DYOW3QZN7F=STP(OD6PP^H0^4MQ_VD N1.,R)3
MD5\S&"ZL_P#)VZ]$UIJ2A;T!J60'2F9P^/,AKV^D;90WEGY"N;]+CUT.,I70
M370R,"M?NU6I@L0>B1R\^K$K+<(XDG,/"5S8E"T%DLRT/M12,OXLKA1)2'D*
MV)QG\'5I'Y":4;',3K?0;I59*P=+LYX9 0$L6J !O,:E1*].M1>*;CQ"C1ZT
M7B'"A_L[<YU*%[=DM1VV7W$"<93$I[6 ,T"G])$<TZ%)#E.DE*1<*Z09K$.Y
M50.)X;<.ZS+0W$C6F=7"K#%2 1)*F&R?U_H2EMI3N:WJ(H;?!()7K^I$>?%K
M]0*9<;LT#N7':63$[2&K4F*6ZST0%0W82Y1LHU$T7I;)UH@1B;5I7TG6&T+V
MIW:FR4A')/?/.NBDN34H[4;M4.G],&U^4[5W8@0K""[L'/:?T(:940%GY<N7
M4C ZZ16XLIN-N3'7M6B,>#\N]X6<9C[F+ _D'YI)Z%Z"I9V(QMGC=R+  [E.
M,CK8<-AZK1>JG+>1LH)MZ$Y4"0VW<$MXQB(ZXXJ0VP/>^*$S/\,;9J&,+^_F
M6+1+'5_DEH.@W3_/@]3<=G@A!>\"[M=H-)D7$/J656)'5T7(F[E,-SWXY":T
MWM&X\=6];P;5GE?35F WZ^-S:2')\RK%X'<< M K&QKKEIZT41R_]JA#*N?V
M#K#U;-3^G)A[?648T,T.W+E.?;R?]5%?FC8[\@O(2NXLR#3>LNUN0B*MRVJK
M]89#1-.R>9"YJ9,-ZY(LNG!%A[  &R$H@+5N5*=4UIV/%D/MC;*)7+\BM3!4
M\S9 _)^EJ*"1)@U K=H9J(=ZV(!U 9<)X4,4#W"QP1A- VTA5J>(?1BH004E
M*G'X[[+8C&V0U^1KE0:=8P?0:5?*19JZ8N8U\&Z]2S6_H@.E6KF56=FDQ]LT
M+#O7PU4):8SDEUL9">1IF7.:V[&5(&V9UCHWBI%M%WZFU.\A&B+ :Y5L):13
M!>"Z,*L#CXV,4ALDQS_^- (-1Y24O,J^.VW-;3\=_##+1,WZP].63T5Z#X9Y
M^\P<MZ(+\[2N7"[-=>C^FB_)Y1@OT_G8WHL1@15P_GSJ&M0A0\FEAQ]V>A3K
MJ=[2WK6&JBKF>K.T#TWZ0;]'<UX!Z"\W<SY>CK/..OWZHV_G'HTMV#Y'N.$N
M70388V!+\'Y2J DDUU*,Y'DM2Y/ZQW$J;U\4JP5%7$M[Y;^HL63*VGY]1H[S
M^T:W\NUZ9;4Y\NE?#?P^;Y?A\?AO#+RZX3Z]]W^B>,\P[MS_ ,4>?X]'ZY2:
M_P! J;%E]MV4=8&J_9A[)06@T/@>0RT*"3U#D)^LTU*D(;<^*=.*^'QPU,8Q
M-3/\&SWE/T#?NZ1^X!^I<KK_ "/H/".U2.-V:OU/I;_5ZV2D?TPYAU*">$6R
M70N;RULR1'3X[#D=T6VIE^,Y_?7K>O@28KIXLWZR[P?\Y\?_ *A5.A0.F6LG
MTGC'+:O32UR5S\02L?:NN4KD@207N"*S<G0@H41N;<N0X@9+7MEE24H^;>MZ
M$1<TH*S]V_(E5*W8;00\5^:W8%;!EC\YN-[FMJI#D,/ D$9*(Z7?&S3>WELQ
ME:1I2DI^;>OCO6OUPM8^?\&WG">GM]MXAQOL[(9RN,]=Y5SSI[5>=G))N@F[
M]41%K0&=)(C0D$'!:2VF%/Z9:T[M'S:0GX_+HDQ4TM7"& P& P*B[-W?EOGZ
MNA;3UBQRJ\)LEL$T6N(&UBVW(U8+@<C$9@FN@ZS1P5DLI8I-B"9+J6X\1S>F
MV%JW\-:^.%B)GHF$"^THFE7V=J K=;FC1<F&\3B1"4 N7@-%!@0H+EN,$11V
M8.>2\B%)::E_3W\?IX1+<!@></O^#6URN*%K;/GAP@@E<I*#,#J/G:C/12S;
M58E1X&Z]Z6EPJ79XQP3%G194B&YHC!B+<9WI42=)3LUCZ-[>=QQL3G]%BAY,
MZ:(C4ZL1Q4PH9C6(G+&LA(+<&21L$.3-B'9S\5*5O3&GG6Y3F]N)6I*M*V93
M' 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&GWN6XEJ5P6:1&-NNQ9UPI8JQ(9
M^;2W:P\;9EF(&U)^&TLFF86H#FO[%-RE)W_RL^^_QM\=P?)?5&/!S3$9X]OS
M9<=__J1A,89??A,[X]<8E\E]:]YR]C\%ER\<3.,\W'CG_P#1.43E'_W1&V?2
M6LGHJO>FNC]LYE>N(DK,0YJ7"5 K23-<-['UH'N4M,LO,L\5$QAG:93#J7'%
M2&GDOQMZ83I2D[;S['Z2[OZ,^(^F^]^,^I,.'#YG#DY<>7#DPW<F=16&/'-3
M,5,3$;9B<<O=.DQ+YOZA[?ZE^1^:[7OOA<^3+XW/#CRX\L,JPQO7*<XN.L5.
ML3>/MC6*3_FG:-VW\DW=.=5)_4VI5G@51'WMV,I*H.NEU6UK<8?TI.MZ^^AA
MKRX-?_7Y]KB?35\?M]:UZ3Y;X#_PO\4_'?*][&WO>;Y+EGAOK^QR<>L?=.?%
M&>/A65Q_=K[OL?E/_)^N.[[+MYOM^/L\(Y*Z?NX9_P XQSG&?NK_ &L+ZV_&
M92?6O=JSW&Q]2M=/G 1'$:O)KP$,(DQ3M.Y7T'JUPN-0($9KVI7[)V*M]8F@
M2[:4_%F&PAUO:E[WK7Y6^XC*HIIS2OQ"<7ZW2ZE<:;['[!8"O*J5PCB7"[_1
MGFJW4Z09\/=DL-BV5+4:#.;KW4IRO0(\C,FZ(;5%8>82S%7I"$NJ-;YCPC_B
MJ_O?B?\ 'Z"-=*;OGMX=R?H?EKE_KJP>HI*F0<!$+EWY!=^CM<YLO4JT])W%
M:7QJ;Z7L#5.(MJ<D/QY;T-_^Y+3IL;LOPT_A_P '1LODW\8M[[[V;G,CU:'.
M/]7)^0+!U?SL2J*+3S7<_P M'=^HKG'DQW!O\;!!_1E4))+6H<X_IK3D^211
MI;\]Q*A>4:NE3>'>#.U4*CAZ-^2R-=.;\%VGCW'X9""-*6B@<T]1>G_,O0_/
M/+II:P2HUBN%:%7'@T2FTPQ(C?+-&$4Q7'WWAZ7%EO*/!8I7RCY4X9>?5U]X
MI^0*N<)L/ECTV ]@=3%V2J5+I]9\B#KWY?O_ ">+S@O621<.V(YL5JO1"YP(
MRI;?[*G;<5A/T(Z$Z)NFM8TI8W8@7@KAGD6G^>+E[CB\VN/(NL\]]3 O2Q9D
M!9[' ]%= OUO]'5WLUJ #0#O/B-<ZO8Y)]_8I;<<7*"27849UK>F74B-TY73
M\M=!JU#Y3RWW^5_*85KG1%1^F4UOU)T'D]2-\^Z)0^^66G2M<4HWGB8D1-#0
M*W:N5"Y=1'C)<LPS,C379>R;4N2C8B;G;6C4Z^>2?Q"5OC]*L-B]E<WW_5'@
MG%J]YM[^>8JMWOM$?\\]GZ)U&_>BP=A#LMZ .V[JO37TVZ;*8#A0DZ,F(XN.
MI.V$%W9WT\6S1_SG^)"CU?\ )(UV7KO')5UM<OIM\]2]ND_QX)U+@_-O>9IV
MRT03 N#3!A88-.CFH38">SI>B268^WVW-;^FHEYZ5T_H@M]XUY&ZO#ZO9/8O
MY':3WNRU;I7E+QK;2YB@T6BUBI/4GT!S_P!$"//MHH865-AG.B^C+*"'QSY%
MQU++T/Z>H,*&TRXVL7,:8Q1:O#WX\!@,:P;]?S.<^6QOI7W7U:H\@Y<;WR:N
M5_HX?C$WF_H.D![95I22\:N\*I?..DR20]AIE#V["4T]\R([:5EW9>6M0V2Y
M!SWR]S,SX2V1]L"NBGN/>/6/-O(YQ"."1)[1SGV/8**%X#>5S1DB3'D$347S
M@L6)<C*4R8>9DO.;;5K2=F9N;T\6HO"_)/DOH0#I/CGS'^3."0J$[S[RSB'M
MCFU8K=!-6+K-*\_5.-P:Q7_GUP*R$M<[>LU+%M5.VE0J+(*B*9:2U]@1U]=9
MJ<LO[IC[F9G\Z_&+S\EY#]T*]P P5,;]3>D.]<MOX*,B5SOMH#H5QOC+W$3<
MP-$GLDAW'>@](<:KD]]:2#$QZ7'9;VHC(3A/?/MKP>O)C\@?C(!2IO02_H2A
MPZO L=2ISS^WBCQ=ZW7JA"NI5.JCJM'&.VDM9#7.#<8XW!BPGI2!CFY"T);0
MXI)G;EY)"-]M^1S+,60']$\I+,3N#G_3\%X9;1T]N=Y_JA&2(M/582XCCR9=
M4K1:&[%(.M_,N%);4T\A"];3A-N7D5_VSY0M781_ :]W>@E>O%H[3PJF1B+W
MW922[4XM\T#&DG(R DZV-4>:T9=#-2EEF12]2G(R6/BYH;9JZT;280P& P&
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M+K<<U4ZGSXM*YR2G#+G9&(L@*W6:I'CQFVUCM1QR=BE.MP7/D=#W.IR#M?)
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M^"#MY,=>:50.T<SD4.Z\8IO$[&[=?Y;'L5Y!<*\:\7Y?Y[(V5@6 *0![]?\
M3W*WK#-9;>F(8 3?E84[)^9G#4<D?;[TNOWX6O0MKZ5T>S#^G\:C4WHG;7/0
M9:M3'KI]U-ZA2.KB9_%S\M]FJN1T+ <;N=V'SM:TXK130C32ELI>=9&^*\5C
M]#_%SZMOT.[\L5;> BN55ZX?D\ZKQZ\-G^A/]"M5O_(#2.\5VJU'HE-51DUV
ME@.6D^\35DBPXN:D%&!T7;$%A;CZ4DC..OW?P?(?\.W6J9VJ"6IG3N?1O/\
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M4V>]K;\AZ7*D2R!*1,)$9\V9(<?D29#SLB0^XMQQ:EJ4K9$AP& P& P& P&
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M#Y^J/1*YT =W69)Y7TVE$%-JEQQR1J!#D]J6ITTXJ0)RBM%2P_#_ +4 -_C
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MBO&PI:OS)==)C"03HLAJ5J*Y+BQ'H+3$9]2&W=828TN7H+ADP& P& P& P&
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M6B7_ ,[5,_- <_8-U6OQB$:JCI<7_7&M$'Y$@L[>L1%_\&SGCKL_JVR>H_#
MWI=_]0D[[9N5Z:]8<KZ!7;A6*I7 B?)XZR4>\QZ9_3L1R9NEG^C[8>-VE9C5
MT:Z%-<KZ(K8QF1&C&<HBIJJ?TD8<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M2EU3#>U:WM"?@&0P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M#X81XLAO_P 8.Q?_ %2'I?\ _3QT#/(Q_MAC/K^"0Y63 8# 8# 8# 8# 8#
M8# 8%R>(O_IF/1W_ - [S-_^7/I[.7)U=8_LC[Y_1ZFYS# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'GE[O($(LGD;
M(2V=:KY],JUE PFA#B$^L6UP:[5$E0UL<@]-Y6P.ELUZ9,DHG3IST 8#9,35
MMH=CL.H-8MUN9/ZD\VY])U+M,_4BD5-_4Z]1]1+M-TZ!@.:EW&+I*-1K3)^;
MYR#?RZ^26IS7PU\,,M#R?A7I.K+>2U8]#5T.%N'1>@]!BAB_#56">'=Z%<#-
MSG"G#;'6 39-D?/-NM,N_:,*4RE/S)VK6][W&<Q%:$Q$ZNO_ )'.S_\ J6I7
M_#K(_P!]V/W,O1-N/J?Y'.S_ /J6I7_#K(_WW8_<R]#;CZG^1SL__J6I7_#K
M(_WW8_<R]#;CZG^1SL__ *EJ5_PZR/\ ?=C]S+T-N/J?Y'.S_P#J6I7_  ZR
M/]]V/W,O0VX^I_D<[/\ ^I:E?\.LC_?=C]S+T-N/J?Y'.S_^I:E?\.LC_?=C
M]S+T-N/J?Y'.S_\ J6I7_#K(_P!]V/W,O0VX^I_D<[/_ .I:E?\ #K(_WW8_
M<R]#;CZG^1SL_P#ZEJ5_PZR/]]V/W,O0VX^I_D<[/_ZEJ5_PZR/]]V/W,O0V
MX^I_D<[/_P"I:E?\.LC_ 'W8_<R]#;CZG^1SL_\ ZEJ5_P .LC_?=C]S+T-N
M/J?Y'.S_ /J6I7_#K(_WW8_<R]#;CZG^1SL__J6I7_#K(_WW8_<R]#;CZKL\
MV>7;#PV\=+O]KZC"Z*9Z%5N<U!N.*Y^FA#0@OG93HIB,[]!5ON$@E.*2^BOZ
M<7MUE#;<9O24;WM2LS,SEU72(J&X>0,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>='Y &I#\3ET;;W=(D(A..C$D^5
M%+T/JH8Y)(T]P"1OL3GDB*=/Z>>CNPVX+CC+"Q$LJ\EYF2S'5AK%NWRN,N'S
M#G$1QJR,.1:'3XSC-RCLQ+>RMBO#FE-6N)'4J/%LC:D_"<VC>T(E:7I._AK6
M$GJGF$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#S.]!\PZM9O1\*V?Y;FNQ<MC0:
MJ"GMBWN.09IRM.@[F_99#YV\=1I5Q'VVOVUX0@?%892&>&KE;>4Z^XA4<W$Q
M775Z.@V&HP4/&8%NA&(XL>PR%>7%<>$--1&6VQ;KD*5.A..P$)TTI3+[S6]H
M^*%K3\%;,,I@,!@,!@,!@,!@,!@,!@,!@:9>P/;W/?&:..QK?S?NG6K/W>]E
MN=<UH7G[GC?2KR<L8.FG;\40BOJ.@WMQ(=8K<R0MQM;BDI9WO:=)UO>C48[F
MM7_UUQ'_ /K<_+%_P:R/_P _\+L]8_--^:?DF1TKH5+Y]KP3^2N@[N=A'U[^
M;=+\JOU3GM5_<'-M_O=TLRKK-T"KT+X?-(E;9=^DG]?EWA)QJ+N'I7ADP& P
M& P& P& P& P& P& P& P& P& P& P& P/-OOGY1^$>=.KVCCMRY'[.L]CJ2
M0RB!SE'C?O\ U6@S=' @\]%T#OE)I9:LF]QXA)#<G4:0Y]M*0XRY\KC:DZ-Q
MA,Q>GYJ=_P#KV?F'_P !/R)?_P#/3U3_ +N<'[<^<?FW8\A>R^-^W*#;NB<7
M9Z%!%4/I)WDMN"]1YS:N5W,!>JV(KQPN'*4ZYCQA^ N,/M$-7Q>81\5+WKX?
M%.\,S$X]6UV$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@>8W7?;/6J9[F!>9*[Y\Z><I ;D<CJL
MHT %<PDG^_S9[KHAZM<<E]$[/R\1$"\@>=8E6R0E)0O]S/@,ZAPX2_OY)J(C
M;=ZO2L9,=(#1\]\?.$O3H,28\*)_9_N0QV2PV\X/(?M\LA ^^A+7MMWZ#[[/
MU$[^1Q:?@K9EWL!@,!@,!@,!@,!@,!@,!@,#R7_(!_\ 3K?AK_\ JP>U?_J7
M>@<-X_VY?A_-ZT88,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#
MR;_%IOXVW\IOQ_7_ /NK>@M?_!RO@>M?_!K6&\^D?=_5ZR88,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@8J<""%)H<F3#BB)*NRY$^OD)P^)+F@YTN#)&2IH>7(9<?&2Y(V8]'<
M<84A:V'5M[WM"E:V&5P& P& P& P& P& P& P& P&!YQ>R^.=-Z-ZI_&!>Z1
M49]AJ/$/3/5+KU<Y%E"V(U+JQWRUV:BB#)!F=/B3)<>=;;)!A)1$;D.Z<D)4
MI&F]*6DU$QMF/MU>CN&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MG3>];3%T3;%^BJK[^9SOM)&6$1)Y?P^/>*I235F-/E"-U@!W(]9Z<KFQ2R#
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M] L,F P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P&!^;3K?Z[UK>_AO7ZZUO]-_#XZ_\
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MTA/=<<<TTC:M[_L_3!,W-RM;"& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P&!A;)9*[3@!JV6\^%JM6K@R::L-ELA6"#  0PUA<H
MB6-&2;\4<+&0(K2G'GWW&VFFT[4I6M:WO J:A^GO-_4H%!*<U[WQV_#NJ%+*
M#YI,I_2*C8F+\;IHQ\U;@U06*+RM6$M5@\9R41C1?JO0HR-N/)0C7QPM3#JW
M_P!6>8N4Q[/+Z?Z'XESN+2;6#H=QD7;J%*J[-5N]FK2KG7*A8G#1J$@-9CU0
M3LI#@R-MR9(_6Y#:%-?W\&V9Z0Y8_J;S/+%S3<7T'Q60'&TVB]%(%&>GTMR!
M!H'4"2PW-KO+EH-;8CU*_%VU10Q%:M1"4C6VX[CB_P!,&V?)BZA[ \G]!Z9(
MXM1/2_!KGV")/L8J5RVK=:HI[H48G3MR]6P>_3A9V58&IM9W ?\ OVE1]+B?
M17]72?E5\!MF(N8FEOHOU%<MSG/V[I4W+XS#60>I2+&'5;6H#;,22Y-<KB9F
MS"(C<8@PXIS;.D:0^VK>_@M.]D2W 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$!Z
M!TVG<O'02MSF%H<(E.V.B+$52V6UY<O4=Z5\CL.H@SLR*U]%A6_JNMH:^.M)
M^;YMZULL1:J/\W/"O]N7;_R8[7_N\P;9/\W/"O\ ;EV_\F.U_P"[S!MD_P W
M/"O]N7;_ ,F.U_[O,&V3_-SPK_;EV_\ )CM?^[S!MES:]8\2VWI[16^;9W\W
MP=UQ/MVV]_+I6U?!?]._EW\ND[^/Z_I\-X-LN'_-SPK_ &Y=O_)CM?\ N\P;
M9?2/6W#7%:0V9O"UJW\$H1Q;MBE*W_[-)3SS>][P;9?J_6O#FU?*X9O+:OU_
MNKXMVQ*OTWM._P!%<\UO]%:WK_W]8-LB?6W#5_\ (,WA?][2?[O%NV*_O*TK
M:4_ISS?]Y6D[^&O]/PW@VR^/\W/"O]N7;_R8[7_N\P;9/\W/"O\ ;EV_\F.U
M_P"[S!MD_P W/"O]N7;_ ,F.U_[O,&V3_-SPK_;EV_\ )CM?^[S!MD_S<\*_
MVY=O_)CM?^[S!ME*:9Z&Y5T"PQ*M5REGE&IK,M^.R3YITVMPU-06%R9.W"]E
MIX@.PI+*-[2EQ]*G-_W4:4K>M8)B879A&*.FAU;#%; 7<D-"PH^63(.Q8$\I
M);APF5R)"XXT5&FDI[R6F][2TPRZ\YO]$)4K>M8&O_\ FYX5_MR[?^3':_\
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M!@6!8**-JI2-$16)"W(<8AMF(_#UME;S45A;Y9G'9$1U?T+X<S 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M_<OT/_PM>CM?_MY?@J3_ #-43_N7Z'_X6?1_^Z[!1_F:HG_<OT/_ ,+/H_\
MW78*/\S5$_[E^A_^%GT?_NNP4?YFJ)_W+]#_ /"SZ/\ ]UV"C_,U1/\ N7Z'
M_P"%GT?_ +KL%)+4.WU2ZGHU=%UKL0V;+:E/-R[?P?L]& H3$85(<3)LEQH@
M.OPW7$(WII#LE"WE_!"-*5O6L%+BPC&&BT<"()FI;!.5%%09)"1&"ARE@+OL
MQ&5O.-# 8.&0,%YSB4;TU&BL//O+^"4(4K>M;"B_\S5$_P"Y?H?_ (6?1_\
MNNPM/S?INAZUO>Z9Z&3K6M[WM7EKT<E.M:_7>]J5R_6M:UK_ $[P5)KTW0E)
M2I--]"J2K6E)4CRWZ-4E2=Z^.E)4GE^];3O6_P!-_P"G!4OW_,U1/^Y?H?\
MX6?1_P#NNP4^?\SE!^;Y/X=Z$^?Y?G^G_E<]&?4^36_E^?Z?]+_G^3YM_#X_
M#X?'!4OK_,U1/^Y?H?\ X6?1_P#NNP4?YF:)_P!R_0__  M>CO\ V_#^S^E_
MQP5)_F:HG_<OT/\ \+/H_P#W78*/\S5$_P"Y?H?_ (6?1_\ NNP4?YFJ)_W+
M]#_\+/H__==@I/Z'U*O]%>)L!0?2!"Q3<5V0J^<FZ9S5E],M3Z&TC'^@52ML
MEW&]QU?51%4\IG6T[<TG2T_$4LC"& P& P& P& P& P& P& P& P& P& P&
MP*YM/7.:TB]<PYG;+B'!7WM$^U#.5U><ZZ@I=R%'K4FXVR*$;0TMMYT%6(;L
MU_2U(^#*-[U\=_IA:GJL;"& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P&!$*GT"BWQZV1Z3<*S;7Z';2-!NS-<-CC+M2O >(.GE:A8T#Y#Z@UD&P
M2\5Y^%(TW(:;D-J4C6EIWL5,)?@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M>:W7OQ]/=*ZKU7MX?K).E],M-\Y=:N<%AP$$Y HD6B!^,C"&S.VAL2U7:2^_
MS.7*@C9AC=<C2IC4C8_<IM<A9J,JBO!1B_#WY!?LH47?N0Q(TW4"869_\\NI
MPI;LZ68DEXR/W9J3)?=^WDL1])+I:8,-PGWX/SK9;:<V7=CY+J8\>>BS?/O1
M-*ZSZ':ZZUU7^G;E-'G-VL36:^NH69-H+-,0&21.=4D$V&HPEM+#Y>$^W 9G
M$X9)Q^;$DDN+T:XO^)O==/W0^=\\[XX-K)+]S78;W2BLCF5=Y7%8H<*LQQ\+
MGU3*U^->R!9X?%0R^L5]O"5"1(AM"%OOIV7=C/6&TW2_$?0^D5"GUN7Z'ND*
M93JMZ*J31I4XD8)V8%U?L_.[]SVOW<M9'SANR@Z+1J R$FJ7);)D7--O:F-_
MXJ7"1E'DJ25XA]NR:];VW/>%Y=LTZ6G59>9-W(0*CQGK)"FFYDI0V:A\7+/C
M827V8S+4N,$>^I!@[U ?=UA=V/EH]80<*<-"AQQ,H\;)0!8^$0-2&6(\@O.B
MQ&6)91^/&0W&8>GOMJ=4AM*4)4O>DZUK6M8893 8# 8# 8# H_TGR*5WKA73
M..0SK=9?Z%6W:[H\[!:)MC6I,J*Y)?4.D)<B3OC&96G33Z'6%[5\'6W&]J0H
ML34V\^BGX[NYT6T3I7FKU,;YE3"4J<2E5TC&F,J=-R!B74$I\:D_Q>O20NB[
MLZ&P!'0@HH2.);>'ICRX<;>&MT>,(^GQ#^0'8:; 1[D,09#H)P6TI-KZ<2?4
MTUT:79 PV*9DS(LL-)%U22W!E'=L3BQ7[5MA>F(SC^G1NQ\EI]7\0=DN/4C?
M3J?U>E5ZW2*=3(H;J,NO6&)UJ/9*?RJ^\YF@]6&KE@N@M#NY*ZI+D4PEZ6Q*
MC:VU&4[IE]DD9152B7,?#OKVDW2DVPK[ /$FV[]4;5U& W8;^17=!=4AUH%&
M&OKL!">/(MN5&I[&OQW(D://6<E3I'S384-U9=V-53KW[P#Z.,])OG4:OZ6A
M,%NC]3)=1GB'(UXI2:<<$4'K/'^6RZG::)9X9R5NG<TZ..;GQ):-0C<FL16G
MT)CR'M)$91TF$T@>0/9;3)%MSW%:8$J=)ML.838BGSKA=J7724BK7F.+/''!
M5&LO]1&!$F>!$(36F <69 A-,[(..MDN/)NMYUH70N9<?J=+ZG?IO2[P)V;<
M+VR>0(F'WVR=@*%1@I!DRVT;,QJZ*FL#V9<[6YDAJ,E;N]KWO>$F8F=%VX0P
M& P& P& P& P& P& P& P& P& P& P& P&!Y.>TO_P#))^&__P"B7[4__5$M
MN&\?[,OP>L>&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# \FOQ
M9ZUJV_E-^&M:^/Y5_0>]_#_3O^EG _UW_P"[AO/I'W?U>LN&# 8# 8# 8# 8
M# 8# 8# 8# 8# UN[M$]!$[!S43PXU"K4*0[:)EV/%$B%B8;<%H%^P,D8Y"E
MW&<68DN29?\ U?"6&?F?)O7[I$^36UEBJU:F1?2/NH9';AE/,*R4@>>YP&>G
MZ"'),DJ,GCI6[J5E. R2!3$IY,=J<S)A,O01KCRQ\AI3Z4+66L4[Y=WWV+:;
M-%$77SE"K(C^GES,2#ST"SBH<VZ!I!]L#"'_ 'D\E(@")[\&#%U%G-,%)J)2
MIS*&V$::4)B%52/77K<2Y20YCB@L5>NA_N#-6J!>JVC:[,1$A&5%5B&8)]HI
M1Z\&E?">X\>^X?FL/?0^6"[K6M"H7A?>S>O*HOGP\!PH-<IA*%U=%S,#AYYH
M7LK3S1H91MBA[1^<Y585W&0(I-O1*9*2IN9]LA[3K:E[%0@POT=[/(V%L,3\
MW;JT-\=2G7S$BFVRRQ0EB)!?N;/5W%";9#B6& W99+0UD['D1XD!EMV=*CN,
M_P!U K%(.0]P]22WR]7Z+S:(6L@GCYGJS\N""E5Z:LNC[T/7.=HK+A5W0\K:
M+"/??'?<S-J<@1GTN.?42ES8J'7YWZ.]3DQ=]*]-X<-H\*J\:N-X%%" 2V5\
M//M]3.$HT049EGRFW!4*V@(K<R+$CHFRH;?SKE/(_P )MP5#D'>D/5*F7"Q3
MS<3W ("4D!P,96[*^8 RCU+*GZ&**E%%%C[%)+'%PAYQR)'AL59]I]$M;B7F
M7FQ4>::VWJ'K4!4*?8!?)JU8"[E'G6*]5L8%.2R,>Q$2FH@2JUY&[C%^616!
MLE,HDIS[E13[9QN,B*IU&VR5"M0O=?=A"MZM<CSQ5M*:#'-[HK@JS!;*1-B
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M<($EE,;]W1]NU97=/+2Z*^9"1[:7+T^?Z:E\Z"B>7P8@GJ@F;1II:<9)T63
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M:3;+8"ER),$(%WFRI$EUPC!GC)A)554N#)A.OQ429<D+%^HXSK>UMQ+C\'.
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MD"U:DN*6@7"%N^5/2>C$5IGOYV4S_%Y#A2XD+]U-N4\?=22@?QD53(MH6!C
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MQ<5ZJ]-^7_6$(5$GU3T04B'(%?6#&UN)9K^0!1;06N5=DZZ(1+6ZTS9QN.
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=!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g366702r2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g366702r2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"8 ,J P$1  (1 0,1 ?_$ )P  0 " @,! 0$
M       &!P4( 00) P(* 0$! 0$                  0(#$  !! ,!  $$
M 0(#!0<#  L% @,$!@ !!P@1$A,4"14A%C$B%_!!46$C<8&1H3(D&+'!,]'A
M\30E&4,F-B='$0$!  (" @(!! $$ P$!     1$"(1(Q05%A(O!Q@9&AL<'A
M$]%" S+Q_]H # ,!  (1 Q$ /P#^_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X^?\
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M\IZ,%!/SGGD:7$5K9=?_ )Y]XX6J7_9W<?/4?FA/TLY1.B.V3R?1_0MC$>6
M!.W "Y3LWIWGG"^<0>57BPV,?%M8*'KIPUI;K[$=13:%S&E,M*2SHDUE]_+M
MW_\ <O7!_/KF/H7FSN)CTQ5)7IX!8>$3AU1<)<W)^9:!7;Q;+;=C46W( D:1
MJ-T"M;9V+ER9LS9-3337W&%X.G/GX_RF_1_=W==^;/USSN45+F2?2G[#RG-J
MH (7IX^CCO,")SAUC[GT"SE8PUQJQ6!H-7:=-CAQ*'X\@A-<90MU"$N*T)KS
M?B.O/_9%TG@ E/-O1W&8O9O2E6$=CZ-?@?C(T/N-6%>=.*E@8L_W(Y&OABMS
MZ:8EN6*,SJFKD3S&YVG6VUK;TE>$FN;B.2'[EN(+7=25)XWW?I5(JE^\\\P#
MW^H@:TH!T.]^HZ=SV]\?K]&8+V886GOE*WTH=(G.26(K(].U?<7O>OC!UOUX
M=.5^YKDJ0+:A/GWT/9.CU*+WTYZ$Y #"TU^Y>=*=Y?N86B=IM5XD2;?% 'X@
M<[8H2A3 25/D&8KJGF4I2VO6AUOGTR\_]PO'G:SV.]5+D/6+7SSDW2*;R"'T
M9R7SVITGH71+S'&&!(>H$[;<1$Y^'!JIJ(1FON1$N-ID)899??TM""]*UO)_
MNL)7QJR'.2\:,USE*O/OFCME/ZM>(:"Q5PUVCUW&\P'Z#8.9CBT"=%>@FH<^
M+%F(F[TF0PJ2M"F-)2X7_K^;[7_8/W/\!JD2\6D]RON$/E H7Z)E\FZ[_;]>
M=J7H0GY0(&Q7<P7-8K-C<.Q"(696":A7\O&'MFHXY]UE2=:1IPDTM]QMYY)]
MGUOU?/[+6X_,ND\@O7#;/405SI/3(H%LIH;T2@ .G\^LD"9631X4^/LU+LL:
M1MK;VI$1[ZV7D:4G^IFS#<W"& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P&!QO6MZWK?\ 76]?&_\ LW@>=%%$_KPM]3]3
M_KAI4NF3ZKSV+:&?4'$4VVW,.UV)ZCGV/I-JT<LL\XT;A(NY"Z3IKFX9-'\?
MN<EMK<=/V6]&LWC9W.D^/_UY]6N5%[5T"O\ /C!<*.H]+#ET]<L(>E7P;QNQ
MN$^<5SH=6#WH=0.UM\QMQ!3XEBRP32A<Y]7VM(4XK2A-MD)Z#^N7R:FE>D(G
M&6*/QSKGI#F'6N/]/ZU:"-MZU_=@CH)\O>.ES>J4ZS=4"PNK600Y8RC\*8:F
M+FUUB7MJ.ZT.TJ&X6;[9E^*OGS:GS-P6D\!\0<MN82P?V9P:#,YZ,U*C6"7;
M>?\ .9(FF';Y-,#FG0A(K/M$Q+Q)U+FEND);B_I_KOX)<VW9%:[^P;PI9VZ)
M(KW8*.0WT?TM8_(=(3&#3]2C/HNGZDN6'G,9G8A+S)04U%VXM]S2(NT*;4EW
M>G$?),6OOUGRWX*[=;YW=>M5OFEQLD6Y<+;(7@GT8E&%Q+QYIMESM'%ADG0^
MWPJY%,TNT=*,JW!4TE1'1%4>>U*9TVTDLNTXC5YGR'^I+73:_3@=8"/WKG][
MK-.F *CU[LBQU4Z'P@^0]8TIOK X%T!(#5BH!H[)L V79D/.,LRU1T+W&7]C
M"YWD^ESD?"WZUYW-ZN (4KG2^:4@#T'C=:6OL%K9"BA?3^IA.S7ZE:.HZ"A3
MY,YTZNPR:T/2')\=;/V65-QU+943MMY6Z0\K^-*U>(/>#51IHFUE.SV?M,"Y
MG;R;9$ENP]6XE#\Y6,XU#+6G^UBK]NXL-:!I&?CN#ULHV^S&U*VI_8S;,>FF
MH/S9^H2&QW+E8RM5.)7O$=(#B^R0)71>LHI_ Z!!Z8,]FC:NX8EW/8>NUZI]
M I46S[&1'M-!X\9,/[;,!6XBB]M_[1U'.?TZ^MG)\PI"A0;'U'O=GF3(EAO'
M>N ]%OO6O27*!@.Q XL9^TT"X'*EVWD_.XWU XWUULM&%Z>3%4\A2\IG?6?3
M=OH_FWQ'U+SM7N%7D91IW"N 3J:.J?X/3C-;(\2LG,HL8129U?ZM7K@)OG/+
MQ5(RT1V)[)B*52EY2%NJTZO2XF=LV_+3^X^4/U"1>7=!IUCJ]?!4CQV*Z@_U
M(F(ZCV6LVV.!Z7SX;WKM(KH70:[>!O0>WA.FT%$4_91Y4B>CF64H<E-NJ3KX
M+VW3'N_A7Q=W3B4H?0[I1>-<[Z)Z3\[]PZ'9JO8W7 %T.\,@4NMU.AB9#=\K
M\3FLV31:4)#0OX%\>^)U%:>8C;DI^K9)MM+SZ1BU>/OU'.\[NM;MM=!BJIY+
MMW5J3U$Q/[)V:MVE=EZ]6Z;Z+[32>L7[70QUW[NQU8&?"V \*L)"P1C2ML[=
M9=6UI*#7;_Z9SGE>['D_]>/3*/IH17JK$KAOIM-]O1UU7JMYY[8*YT,O2HU?
MJ'7 \RM7BN6KF\0A0"&AK4>$X-&+'R7&/L?2XYK9GMM+GVQ5?_79^MIZ/7J%
M5N=U)UH9RX)3PM5K_:.B+?F\K =P1Z'J[$P6-Z1^19 U>[:SLT-GS$2G(;ZW
M8[#Z(KKL=1>VWE*YWZM/"!0WT\Z2X/&FO==%]/$6P5)OW47*J.C=M):,=ED\
M[IW][:JO(BW52FOR+!.JD,-,*.K<4^ZO;KOUD[;?+:/G? ^2\HN'2[]S^H,U
MZV]@=HCW1B[94[/79'.9T8/S:CJ<B%2DZ ._@J4 B04ZB-1]/)9^X]]QY2W%
M$S5P80P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MB!&)0CA9Z3\299 Y1&!LMU]WZG)"WMNKWM2M[V8VXMQX;LX0P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M?COG>I/U6Z6@H;Y\FVM1XAFR2B<]\?38[[S$B7)=9UIPG66\7CTS47]S /\
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M.1<,ZS.LEKJY'J78ZO%Z83A=J90*"";229(P6FY,AX<Y^0PS%_Z[;QX6B/\
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M:SM*L@C^=#[U"F.C;!7)+*T[0S(86C;4AEE]#C2(Q9BX;'80P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MF[6[28$%_P!83KTJ<\7M)2-9U*EOUMY;J5[C?E[95.FS$)&9G%3![]?WI\]
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M8('?:-?57SM&XH8%%WBNFI\J4/BBG9GU1&5[DUK\?X7#VOW#Z6JG>^]\^X\
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MLWC/?O1G9.K>L9J;.0 4E?!"I/S+75<C-#&G)H'K/H:EB.G"'K*_&)6Z>7#
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MZ(4ZK4^$%(MUOG'I'G:;26<5'0S#)/0?1TR2XI.M)2H6RW\_;==UD3L@0_\
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M9:24.48@]-H_/+/PL] 'J$"Q[1CH\0O9$F&$(2R-+50A';3]"F=Y&;,*-_\
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M^(?L,[CU+MG*N>%N.5FOB;-,K==L\%\B;@6HFR6Y[8+8;Z]1(Q6)&5,YY7[
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MREMZ='G#R&D)2^B)$DCKK;B,A9O?'HD?T4M"A&Z9<N?%^+S1CW:N5C3TSAE
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MN+ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MXJU-%7XCTNQU-L4LP/I+M5.PI$:5MO;DE<C[3;:G6W4-CK6[M3M$.X"5F8,
MV/B?R98:RD\'FA),U HC(')*PHTYMIV4#+?C_D092=;9F1'$/-[VA:=X92?
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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ML5*V:O-?Z68-TBN+G_Q53F6R\U:$1+[AMMZ(/MJ^[K>G'-*':L* \#>9:RY
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M,P!;)'6;L@'N:@FO4:BM3'[EME7/QI2*K;=/7_\ VY"4QOX@-);W](SM+[2
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M!J-8NM,08!48*?K=9'H.V82B#7;51R7-[$"DNA30Z07#F*66>AOQIJY#*_\
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M_P B;EOJ5]>E+=D+4K>][_H+;?*X\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MLAHJ'G7HS:7ONN.?4G>C-QZ;,X0P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M==:(,..-N6.'J0VY_'IUMQ;:TJ3O?S@ZW&6'#^Y/.)7F KJTJ\0JX&/5'=V
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M.\4B:^=:^A>IL92-J3)8VX1G*WVWCUS@MDJ9U&@7"$^;*UJ)(JUO 'VIUD"
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MS:9/X6X(;:GE:@CX#7U-K%VS'H3AEQ\_\O\ Q_VW@/G YP'_ (X# X^?]O\
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MG<HK\@%6HK%?GW3H!)PM-<G294^2Z46VXZXE#++"&]Z69MRVGW_3_;7^&O\
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MJCC P>&S &P&%NN/J:B0XZ&V&&U/.J5O2=:U]2M[_P!^$9O 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,:IU=V)^RDG99Q"+1O/Y6=$DV0P)IIJ\6RR<[#'QM6J7HRSVN40(3^4%V&#
MY/G24AB,$W8H3S9B+MZ=&D-2XK,6:<>77LW[-DURM7NQR^0C!4FOU0/?*-3;
M/T@T-OW3:9*YV?Z61,5JL@^3VA)M&@E<DM1':_(L<%MYE_9>2'1$DJ:)-;:[
M=7]U=*G68@%,\^J$DZ<Z'TB@\N #+S*&U C$$]-H-0IQGI5PD4<T;J!!L59W
MW""QL Q%VM&DLLN*4C>BW7"Q^%^[=]MZ%3:Q&Y2NN56[RY]>%663>&B!^/<!
M' N3=_)P9]0158<)%90$Z>H>P2:+O2'Y@_[GX2(\A+K=2ZXF4%<]O=&O71.,
M4BAT.L549?\ N5/%3CIJY231>;QB5_\ (A@NXZ%:HS<*K=#('?/4MO0[<DA&
M2*G-.((-REN)A1,88F]^VNYT7L]OKLKG7-"W/Z1UFZ4V3'@7LR.LA*CAJ1Y\
M.1;%(?FTF;%CVZ"5[ \M(UK6H4QA&FES(ZFM/R#768S^O:RJ9[U_O7CG;^QP
M>-64<(YA7:_<*9#.$#->1T:NVV0<B /N$+)1@N@99J2"7_(J',V *PV^SN(3
MG+^\VP2ZXJ!VG]DCM+=<@G>1"7S82/W4?=0=<Z>2-RJ[;>+4'T%T&-&20=Y:
M-"M4^]C//1"..(EY(0F_(F:5&%2V(DQYJX.M_AP?_8M;:@3E5ZT^?H2+%*MI
M;G-5B5+IEIOL<Q?@T2DFI<4E&K/#Y5O@555?O#"T3AX8P0W-C/,[&I8^U,<B
M]/M*.5>U;CV+N_.JH/H,.B\S-5^[Z/:L)Q!'HJ[G7.0\0ZK)$S*PP*A,UP.!
M:[#J"F8B;.60DP']J8C-+BN/BZX_=$ /[-HYB)2I\O@]J$P>H]9#<AYK,)'"
M(2.7-W$ &M-*,'=6ZC5:4+JSH;1ILP3'MF1P\D/A1(;Y11:,M%P=&?Y?^PXA
MUFP5@&"X=,!L6)P?:4E;Y="7.XJ^0&;'6JZ*M8)-[YQ7-V&\:>LB79 )&V12
M],*:@'"#SK#;K!=+%?V;]C5L*Q.>EZ9SX$!J=AY[2;U>21BY)FVP"STK@TSL
M]='U(>BK2*^2FU]V&J(0W/<91):_JTEI2OJ;A-4UMW['7:SN(-@\'M5CLT><
M2 6<$+,%BCX*XTH+<+-T^F;?JU!LJ=G*O6PX21%DS6QH:4JR,?ES1K##DC=P
MFNN9E8GH?V6=Y+9K[3:CSL0?F5*KRV46"R7"6&:3T<QQ[J?6J,/35AM7+RRU
M#=A<O=C&2B"$65!?EMZ9AR6TOO,Q),_LUIY_[E[R(,1 _3J]3[+8CYNA<]H8
M2N6= :L%[27X)YZOY S>[3(YS_,5>(3M'97WE.#QQ!J)%80PW%<6G2Y!JZ_"
MSY/[%C"K*;JH;@4XM.%3J/3FRB;\^S37NGVHMY]&D*SOH;'/Y]"GUT<WW]AR
M*2$DBTZ5L++U(&P6WH3LBG2^6SGGWT43[/9.I5*R42#S>R\T,L#Y%9?ML\U9
MW1DJ65A0#Q003I5/3%#FUB''AA 4^<#$(RO^G/\ R6I46/&;,<MH\(8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#C?^VO\
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M;V6V[?LZ<KPS1KQT$UZ"KW9.C1[/=IK5VI=GB. BBZPT9<KIH?H-(,B),D@
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MU*WE?3)E[V6;3V]TDZWI*=;_ *[TG6M[_P">M?&&'ZP& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M.2YD@ELMSZ5XCP9Z:'1:]2!O4*C)JX6.&KH[H*S!^OW$'5Z(=]6$*5,CTVN
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M[]V7G GHH\QOD_F=46VCB'1;J(KK=U[IT:K>B[?3.9RCI2D&;M4>*L12NH;
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MX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M.AH;KVF6T_3]&&IYD5[Z![7ZA#]GGANGVL3RBHH[O6@LB&#[MU#GO)HU7?\
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MDRA=X3Z @]#ZC=>86GT]-L,;Q-3.X4[G-M/G9T"#V"WV>YC;'"E<R8^:C*M
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MTCK/\-B?7/8.W\:'<S+<F$\H+Q+ITVG<N+-=(>N$=^"3O9=H4(,#W*NEQ#L
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M+BU*[C43M1JO+ZR?O\>0:K=V1'(Q)S>]#I$%:M.NMRX>W!CC*PNI_L!F\_\
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M2 VV@=8K88D_&#3(&F(Q\/+(AB:].H0MMQG:5"S#>7"& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M@;<(NM1''DE8_P"/7^AUZ,2A0YZ)3#K;"69*76U.)43]FN5A\3VWK%P#= ]
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MF](UO"6VS#=C"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M& P&!QO_ ,/]O\,#S;YZ;\CR/8L@36:-9A?;(Y#I;H^QRW K8$H;58.D;O\
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MW<36?+U<R,& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M 8# 8# 8# 8# 8# X^?\?^/]/G \Y:B<L<[U]%;=J'6*JWNU].B$&IG7.W&
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MSZ;)80P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MY,(K?K,6D"9NW DB,UMF?&UN,C:UMN;C.=<8^DVY[YZ_:!OP /YG<NH]$_\
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MK>1-O$>@V&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8'&_]O_I_A_WX'AG$H/[+J]ZF"DJHY9@? Y'JOI5LN(>(5YS+!6KF-N]#
MU.'%GGV3'\A:&X\3ACI.7#8'/PW69#2-K;4]I+:JU^./MK_V6P_MVOG1_:R/
M.YWK,?G]7[6*IM&DZ#\H@OPP07^\USHW"X5H@B)Q?\5Z?7-F91AUR)+:^]J(
M^K2'DX:_"29\X699Z[^X<;<*F<!V7H-DDE.W=3BSZPW*X6&Y>!H4'@U*A<S-
MGI"QKEG<J4SL;I>8_":7(FO:UMK:V&TL*4/P8_CT#]O<:_\ "[!>2?76^55J
M]3)O0 %QD<+F6FPT.9T.@1K QT"-6(3KLZ4-J[EKD5]L-(CNZ'I'_?\ N2M;
M1LMZ7XRV6]3=6]<73LOZ]H_FT1V&DU[I,EWH':*5*KU0'-AZ. [GY.8N,;M$
MRR1B&@T$;Q6V79AH>*FMEI)61'6PES4=:FHS,27+17E/./W!<M![IWT=551J
M[Y7J0"LU0)9^6$R3'09EKC-6@IJ^6R:9-RNG TRY<SZ7MO0Y@M"&6WFWMIVD
MOX6SX=*0/_>@]1+*P[/ZTS<9G ?,+DTM%>\^?;#W^ OD$3O$#G@..E*2MX,-
MILLU<B9)CPV'M26$Z6RX-4U2],_3=+T33OV:69_S'!YE>.@5R)$Y'R6/WLK1
M97(0DDCT<EU;FP?J\R>U9PQ]#<L=R278YL=(W6HC,UM"VONK0TVJ)KUYSY4+
M4!?[D[-T<*+M9#I5"II6F^)1-]/QB/"B; ^S1W^52/4-HH;7\?*_BG)<)ZR1
MYT1YB6A+K6W82E?5'2FM7_K_ %_+X<4X1^Q89^O$;R?K<;K4;MO/O3?!R-;B
M4GI-<;,RO.=:.<T-2A4&U.&E3S)"&&44C6UDM.>=*E6)BHRU07HK23-NO:6>
M%4UOA'[9J)QP:$$N]6W:^=4_T.)YP<1:>66:]5V);Z3XI*4T -F'9S8T\Q_>
MXGH\.*Z4_*(18;*M:D?7N&M9K.G\-F^]<_\ V.EKSX)ZAR<1T49T@'Q0+5NS
MZ=O//IM)%7(Y8*&3O WN0MQ<$3:1/]OBR:4D*] 3,04TU]A3;2U)QPS+KS/2
M,>?M_MI'W?R\2ZM$[L3YH)MG2B'H(.=(>=MVTW7$<4XRY41<S89+*7%.^H6+
MO^'H8\Q\41V&AY6I/T;2+UN7O8 (RC 006G!B%>F$AL*=* EE0U% TB5'0\Z
M,(*'R9L%4V$M>VW-LO.M[4G?TJ5KXWD89? 8# 8# 8# XWO_ &_Y?.!X\>=/
M-/[-_+W%>?\  >?]5\2'Z3S 7*K]9,VOG_:FK)/$++D2,1XV@5:T#=$M-S_I
M=VQK3:E:WO6M?/QBMVZWFY;9>0N&=RY6>])]$]"6[EMHZ%Z$ZQ6>@O1^0@;.
M!J%>%5/C7->1CAB&[<2)EIA"4SS_ /,?=VM+?U2/I2G_ "_U,VS$D]-UL(8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#XP.-)U
MK_#7Q_7Y_I_OW_QW_P =[P.<!@<?&OG2OC7SKYUK?^_6M_'SK7_#Y^-8'/Q@
M/C ?&L!@,!_M_M_PP& P& P& P& P& P& ^,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
2!@,!@,!@,!@,!@,!@,!@?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
